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Summary  
Mechanisms of multipass membrane protein biogenesis 
Patrick J. Chitwood 
A crucial aspect of cellular physiology is the ability of a single cell to remain 
autonomous and concentrate reagents to improve efficiency. Semi-permeable mem-
branes facilitate autonomy via an outer barrier (plasma membrane) and enclose func-
tional hubs (organelles) to efficiently carry out biological processes. However, cells 
do not live in isolation and must communicate with neighboring cells, uptake and 
traffic nutrients, and react to a dynamic extracellular environment. All these pro-
cesses require integral membrane proteins (IMPs), which are embedded within all 
cellular membranes. Highlighting their importance is a myriad of human diseases 
observed upon disruption of their biogenesis. This thesis aims to describe our recent 
contributions to the understanding of how membrane proteins are made at the endo-
plasmic reticulum (ER), the primary site of IMP biogenesis in the cell. 
Although IMPs are defined by a single feature, a transmembrane domain 
(TMD), the ~5000 encoded in the mammalian genome are diverse. While some con-
tain a single TMD, most feature many biophysically unique TMDs. Productive bio-
genesis of most “multipass” membrane proteins requires insertion in a defined to-
pology as well as packing of their TMDs into a helical bundle, often through inter-
actions between polar residues unstably located in the hydrophobic lipid bilayer. 
Neither the mechanisms that facilitate accurate topological insertion or the subse-
quent stabilization of polar TMDs during IMP biogenesis are completely under-
stood.  
First, we demonstrate the efficient topogenesis of many GPCRs requires the 
conserved ER membrane protein complex (EMC). This is supported by biochemical 
reconstitution of β1-adrenergic receptor (β1AR) insertion in-vitro, which placed 
EMC at an early step during co-translational insertion of the first TMD (TMD1). In 
the absence of EMC, TMD1 was topologically inverted or failed to insert altogether. 
EMC and SRP receptor were sufficient for the correct insertion of TMD1, while 
 
 
 
insertion of the next TMD required Sec61. Finally, EMC necessity could be by-
passed by enforcement of TMD1 topology via an N-terminal signal peptide. Follow-
ing accurate insertion of TMD1, we define the engagement of a newly identified 
intramembrane chaperone protein complex that we term the PAT complex. The PAT 
complex is an obligate heterodimer consisting of the highly conserved proteins 
CCDC47 and Asterix. A diverse set of multipass membrane proteins show impaired 
biogenesis upon PAT complex depletion, despite correct topological insertion. Bio-
chemical analyses demonstrate PAT complex engages nascent TMDs that contain 
unshielded polar amino acids but disengages upon substrate folding. Thus, EMC 
cooperates with Sec61 to co-translationally insert TMDs, ensuring accurate mem-
brane protein topogenesis, while the PAT complex acts after insertion to protect 
transmembrane domains during their assembly.  
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The membrane proteome 
Approximately 20-30% of the eukaryotic proteome is composed of proteins 
which are embedded within the hydrophobic environment of a lipid bilayer 
(Fagerberg et al., 2010; Kumar et al., 2002). Termed integral membrane proteins 
(IMPs), this important class is essential in many biological processes such as cell 
signaling, intracellular trafficking, inter- or intra-cellular communication, organelle 
biogenesis, and many more.  The minimal requirement for integration of an IMP is 
a single transmembrane domain (TMD): which optimally consists of a continuous 
stretch of 18-28 predominantly hydrophobic residues adopting an alpha-helical sec-
ondary structure (Argos et al., 1982; Engelman et al., 1986). All IMPs in the nuclear 
encoded genome must be synthesized by cytosolic ribosomes, inserted into the lipid 
bilayer and targeted to their appropriate membranes. The inherent necessity of cyto-
solic translation poses several biophysical challenges to the productive biogenesis 
of IMPs. First, stretches of hydrophobic polypeptide are energetically unfavorable 
in the aqueous cytosol and prone to off-pathway interactions or misfolding. Second, 
IMPs often contain functional domains localized on either side the membrane and 
premature folding (or misfolding) can preclude membrane insertion. Finally, IMPs 
are localized throughout the cell in a myriad of specialized membrane systems, mak-
ing direct targeting a logistical nightmare. These challenges are overcome by cou-
pling synthesis and insertion, producing them co-translationally on the surface of 
the largest endomembrane system, the endoplasmic reticulum (ER). Co-translational 
integration minimizes exposure of hydrophobic TMDs to the aqueous cytosol and 
completely bypasses premature folding. Additionally, localizing biogenesis to a sin-
gle membrane simplifies the targeting problem. Consistent with these energetic and 
logistic advantages, nearly all IMPs are produced and assembled at the ER before 
being trafficked to their final intracellular destinations (Figure 1). Similarly, all se-
cretory proteins are translated and translocated into the ER lumen prior to trafficking 
and secretion through the exocytic system. 
Few exceptions exist and are incompatible with co-translational integration. 
These include a small subset of proteins that elude recognition by the co-transla-
tional targeting machinery, and mitochondrial membrane proteins. Failure of co-
translational TMD recognition occurs as a result of terminating translation before a 
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TMD has been exposed to the cytosol (Kutay et al., 1993). This phenomena is ex-
plained by the shielding of ~35-40 residues in the ribosomal exit tunnel during trans-
lation (Malkin and Rich, 1967; Sabatini and Blobel, 1970). As a result, a minimum 
nascent chain length of ~50-60 amino acids is required for co-translational recogni-
tion and targeting (Walter and Blobel, 1981). Thus, extremely small IMPs or those 
with their TMD located <60 residues from the C-terminus must be targeted and in-
serted into the membrane “post-translationally” (Kutay et al., 1993). While few ex-
amples of small (<70 residues) functional membrane proteins exist (Chi et al., 1996; 
Navarre et al., 1994; Wawrzynow et al., 1992), the latter are termed tail-anchored 
(TA) proteins and constitute a small but essential part of the mammalian membrane 
proteome (Beilharz et al., 2003). Reflecting their importance, a widely conserved 
set of machineries have evolved to facilitate post-translational integration into the 
membrane. Termed the TRC40 pathway in mammals or the GET pathway in yeast, 
this is the primary route for post-translational integration into the ER membrane. As 
such, it is equipped with dedicated targeting machineries in the cytosol and an in-
sertase complex resident in the ER membrane (Hegde and Keenan, 2011). Similarly, 
mitochondrial membrane proteins (MMPs) bypass all ER dedicated targeting and 
insertion machinery. Not only do they require an entirely different targeting se-
quence, but also a set of translocases and chaperones resident in the multi-membrane 
system of the mitochondria (Becker et al., 2009). Thus, the key step determining 
both the location and machinery by which a newly synthesized IMP will be inserted 
is during recognition and targeting. This concept also holds true for the other two 
membrane insertion pathways described: peroxisomes and chloroplasts. In the case 
of peroxisomal membrane proteins (PMPs), a dedicated cytosolic chaperone/target-
ing factor recognizes PMPs and delivers them to the peroxisomal membrane via a 
resident targeting receptor (Hettema et al., 2014; Ma et al., 2011). Chloroplasts sim-
ilarly have their own dedicated targeting and insertion machineries that are most 
analogous to the system observed in mitochondria (Hofmann and Theg, 2005; Kim 
et al., 2019). The largest mystery in regard to the coordination of membrane protein 
targeting in the cell is how various IMPs bypass the predominant SRP mediated 
targeting mechanisms, so that they can be recognized by their organelle specific tar-
geting factors. In the case of tail-anchored proteins (present in all organelles) the 
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answer is rather straightforward, as the TMD is not exposed to the cytosol until 
translation terminates and thus never has the opportunity to be recognized by the 
ribosome associated SRP. However for chloroplast, mitochondria and some peroxi-
somal signal anchor proteins the mechanism remains unresolved. The recent discov-
ery of a chloroplast specific targeting factor, AKR2, has shed some light on a poten-
tial mechanism. AKR2 has affinity for the ribosomal protein RPL23A, positioning 
it near the ribosomal exit tunnel in order to capture a chloroplast specific TMD (Kim 
et al., 2019). However, the exact details of how such a targeting factor would be 
correctly recruited to a ribosome and how it would preclude/out-compete SRP in 
order to achieve specificity and efficient targeting, remains entirely unclear. 
Although all of these specialized membrane protein biogenesis pathways are 
essential for life in higher eukaryotes (Baker et al., 1990; Mukhopadhyay et al., 
2006), they represent alternatives and together accommodate a relatively small per-
centage of IMPs: 3-5% (TA-proteins) and 6-8% (MMPs) (Kalbfleisch et al., 2007; 
Reinders et al., 2006 and Figure 1.1), <1% (PMPs) and chloroplasts being plant spe-
cific ((Ma et al., 2011; Schlüter et al., 2007). Thus, co-translational integration at the 
ER represents the primary route for membrane protein biogenesis. Its importance in 
human physiology is further buttressed by evidence suggesting ~50% of small mol-
ecule drugs target membrane proteins integrated via this pathway (Santos et al., 
2017).  
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Figure 1.1 – The logistics of making the membrane proteome. The diagram depicts the three major types of 
membrane proteins as classified by their site of initial insertion into the lipid bilayer. The primary pathway for 
membrane protein biogenesis is the co-translational pathway, inserting proteins into the membrane of the endo-
plasmic reticulum [ER (shown in green), the nucleus is shown in light green]. Two other pathways facilitate the 
insertion of proteins that either evade the co-translational pathway or must be inserted into a different membrane 
system entirely [mitochondrial membrane proteins (MMPs)]. The majority of MMPs are inserted directly into 
the mitochondrial membranes after their synthesis by cytosolic ribosomes. The membrane embedded regions 
are kept insertion competent by cytosolic chaperones until their arrival and integration by specialized mitochon-
drial translocases. Mitochondria are depicted in red and their membrane embedded regions (orange) are depicted 
as distinct from ER destined TMDs (blue). Tail-anchored proteins destined for the ER are depicted on the right 
and have dedicated cytosolic and membrane components to keep them insertion competent and facilitate their 
insertion post-translationally, respectively. Plasma membrane is shown in dark grey. 
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Co-translational recognition and targeting of IMPs 
 Prior to the identification of machineries involved in membrane protein in-
sertion, early biochemical studies had both predicted (Milstein et al., 1972) and then 
established the minimal requirements for secretory protein translocation: (1) a signal 
encoded in the protein sequence (Blobel and Dobberstein, 1975), (2) a cytosolic fac-
tor recognizing the targeting signal (Walter and Blobel, 1980), and (3) a membrane 
resident factor facilitating translocation (Meyer and Dobberstein, 1980; Walter et 
al., 1979). Following these initial observations, later studies narrowed the minimal 
requirements for targeting to a stretch of 7-15 hydrophobic residues that can adopt 
an α-helical secondary structure (Rothe and Lehle, 1998; Valent et al., 1995). Fur-
thermore, the signal recognition particle (SRP) was unambiguously defined as the 
primary factor involved in the recognition and targeting of signal sequences (Walter 
and Blobel, 1982). Composed of multiple proteins and an RNA scaffold, the SRP is 
ideal for complementary binding of a translating ribosome and an ER targeting ele-
ment. Indeed, structural analysis of SRP associated ribosomes revealed tight inter-
actions between the two that place the functional domain of SRP (SRP54) near the 
ribosomal exit tunnel (Halic et al., 2004; Schaffitzel et al., 2006; Voorhees and 
Hegde, 2015). Also called the M-domain, SRP54 is unusually enriched with methi-
onine residues which line the hydrophobic groove responsible for signal engagement 
(Keenan et al., 1998; Zopf et al., 1990). Both the moderate hydrophobicity and flex-
ibility of methionine residues provides a molecular explanation for the broad prom-
iscuity of SRP and its role as the primary targeting factor. The general principles 
established by studying signal sequences nicely explained why TMDs, which are 
usually longer and more hydrophobic, are also recognized and targeted to the ER 
co-translationally (Ulbrandt et al., 1997). Modern genome-wide studies have con-
firmed SRP mediated targeting of nearly all ER destined TMDs, and the majority of 
signal-peptide containing proteins (Costa et al., 2018; Schibich et al., 2016).  
 Two remarkable features of the SRP-mediated targeting pathway are the se-
lectivity of SRP and the incredible efficiency by which substrates are targeted to the 
ER membrane. While the molecular mechanism remains ambiguous, SRP specific-
ity can be attributed to its ability to recognize ribosomes translating hydrophobic 
stretches, even before a hydrophobic element emerges from the exit tunnel (Chartron 
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et al., 2016; Ogg and Walter, 1995; Voorhees and Hegde, 2015). This allows SRP 
to “wait” for a signal to emerge and engage it immediately. Complementing this pre-
engagement strategy, targeting to the ER relies on the unique energy dependent in-
teraction between SRP and its cognate receptor, the SRP receptor (SR) (Gilmore et 
al., 1982a, 1982b). The SRP and SR both contain guanosine triphosphate (GTP) 
hydrolase (GTPase) domains, but no auxiliary nucleotide exchange factor or GTPase 
activating protein. Instead, GTP hydrolysis is induced via the SRP-SR interaction at 
the ER and substrate release requires GTP hydrolysis (Connolly and Gilmore, 1989; 
Powers and Walter, 1995). Thus, a hydrophobic element remains shielded in the 
cytosol and cooperative GTP hydrolysis ensures release only after successful target-
ing. The coincidence detection of a ribosome and ER targeting element, along with 
the unique reciprocal GTPase cycle, provides an extremely efficient targeting appa-
ratus. These general concepts have been supplemented with numerous technical 
studies that nicely validate the SRP-SR pathway as both necessary and sufficient for 
co-translational targeting of nearly all ER destined IMPs (Akopian et al., 2013; 
Keenan et al., 2001). 
 
Figure 1.2 – SRP mediated targeting to the endoplasmic reticulum. Model depicting the key aspects of SRP 
mediated recognition and targeting in the cytosol. SRP is positioned on the ribosome through interaction with 
its scaffold RNA and various protein elements interacting near the exit tunnel. As a hydrophobic element 
emerges from the ribosome exit tunnel, SRP54 (M-domain) is positioned to recognize and capture this TMD via 
hydrophobic elements. Targeting of the entire ribosome nascent chain complex (RNC) is facilitated by binding 
of the SRP GTPase domain to the GTPase domain of SRP receptor at the ER membrane. Cooperative GTP 
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hydrolysis causes release of the TMD so that it is free to engage insertion machinery present in the ER membrane 
(depicted in green). 
 
The translocation associated machinery 
 After targeting of a ribosome nascent chain complex (RNC) to the surface of 
the ER membrane, a TMD is now in the correct post code.  Long before any mech-
anistic understanding of membrane protein insertion, it was postulated that a pro-
teinaceous pore embedded within the ER membrane anchored the ribosome, facili-
tated insertion of TMDs, and translocated polypeptide across the membrane (Blobel, 
1980). This hypothesis was consistent with a handful of initial observations. First, 
membrane bound ribosomes were observed tightly bound to isolated ER micro-
somes (Adelman et al., 1973). Second, puromycin induced release of ribosome pep-
tide products were preferentially translocated into the lumen of ER vesicles 
(Redman and Sabatini, 1966). Finally, the observed ribosome-membrane interaction 
was prevented when ER microsomes were subjected to limited proteolysis (Borgese 
et al., 1974). However, a lack of easily manipulated functional assays hampered the 
identification of this putative “translocon”. Fortunately, the principles established 
from the SRP targeting pathway provided a framework for the development of ge-
netic and biochemical tools that ultimately led to its discovery. 
 Leveraging the sufficiency of signal sequences in targeting soluble proteins 
to the ER lumen, Deshaies and Schekman designed a genetic screen in yeast with an 
essential cytosolic enzyme artificially fused to a signal sequence (Deshaies and 
Schekman, 1987). Sequestration in the ER lumen was lethal and any mutants restor-
ing growth were indicative of failed translocation. Subsequent characterization re-
vealed mutations in three essential genes termed Sec61p, Sec62p, and Sec63p 
(Deshaies and Schekman, 1987; Rothblatt et al., 1989). Sec61/62/63 could be puri-
fied as a complex that was embedded in the ER membrane and therefore was an 
ideal candidate (Deshaies et al., 1991). Further genetic and biochemical studies es-
tablished Sec61p as the core component necessary for both secretory protein trans-
location and membrane protein integration (Sanders et al., 1992; Stirling et al., 
1992). The mammalian homolog of Sec61p is tightly associated with ribosomes and 
directly interacts with translocating nascent chains (Görlich et al., 1992a; Müsch et 
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al., 1992; Sanders et al., 1992). Together, these observations led to the purification 
of the heterotrimeric Sec61complex consisting of Sec61α, β, and γ (referred to as 
Sec61). When reconstituted into purified proteoliposomes, mammalian Sec61 was 
indeed confirmed to be the minimal machinery for translocation and insertion of 
model secretory and IMP substrates (Görlich and Rapoport, 1993) (Fig. 1.3). 
 A clear model for secretory and membrane protein biogenesis had begun to 
emerge with SRP targeting all hydrophobic elements, and Sec61 either integrating 
TMDs or translocating soluble polypeptide across the membrane (Fig. 1.3). How-
ever, both SRP-independent targeting and Sec62/63-dependent translocation had 
been observed. These conflicting results were reconciled with the discovery of a 
post-translational pathway. Substrates containing relatively hydrophilic signal se-
quences that escape recognition by SRP are kept translocation competent by cyto-
solic chaperones and delivered to the ER resident Sec62/63 complex (Plath and 
Rapoport, 2000). Sec62/63 partners with Sec61 and the luminal ATPase BiP in order 
to ratchet the soluble protein across the ER membrane (Matlack et al., 1999; Panzner 
et al., 1995; Plath et al., 1998). Two important points are worth highlighting. First, 
Sec62/63 occupies the ribosome binding site on the cytosolic face of Sec61α and 
therefore is mutually exclusive with the co-translational pathway (Itskanov and 
Park, 2019; Wu et al., 2019). Second, the post-translational system is specific for 
some secretory proteins and no IMPs appear to use this pathway (Costa et al., 2018). 
Thus, Sec61 is a generalist at the center of translocation but has limitations that can 
be overcome with aid from trans-acting factors to accommodate problematic sub-
strates.  
Many other translocation associated proteins have been identified and char-
acterized. Factors such as the oligosaccharyl transferase (OST) complex, signal pep-
tidase, and ER resident chaperones such as calnexin (CNX) play an essential role in 
protein folding and biogenesis. Additionally, several factors have been demonstrated 
to be in close association with Sec61 and engage a signal peptide or TMD during 
translocation. Examples include the translocating-chain associating membrane pro-
tein (TRAM) and the signal sequence receptor alpha (later termed TRAPα) (Görlich 
et al., 1992b; Wiedmann et al., 1988). However, the molecular contribution of these 
associated factors remains to be determined. Nevertheless, these studies illustrate 
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Sec61 is the primary conduit into the ER membrane but nearby auxiliary factors can 
also act post- or co-translationally on an incoming substrate.  
 
Figure 1.3 – A model for Sec61 mediated insertion of TMDs. Based on early biochemical and genetic studies, 
this model prevailed as the mode of TMD insertion. A newly targeted RNC would engage Sec61 via a high 
affinity interaction between the ribosome and Sec61. This places the TMD to engage Sec61 and then follow the 
most energetically favorable path into the membrane. Sec61 provides both a lateral path into the membrane for 
TMDs and a path through the membrane for soluble polypeptide being translocated into the ER lumen. For 
example, secretory proteins or soluble domains of membrane anchored proteins. 
 
The complexities of membrane protein biogenesis 
 While the exact function of many translocation associated proteins remains 
unknown, a role beyond insertion has been established for several trans-acting fac-
tors. There is a critical time window after targeting and during insertion where sev-
eral post-translational/post-translocational modifications will occur that can dramat-
ically affect the maturation of nascent membrane proteins. For example, cleavage of 
a signal peptide occurs shortly after the signal leaves the translocon and is recog-
nized by the translocon associated signal peptidase I. This specialized serine prote-
ase contains a hydrophobic groove to recognize the signal and place its C-terminal 
region in the active site for proteolytic cleavage (Paetzel et al., 1998). Failure to 
remove a signal from newly translocated proteins can cause misfolding and loss of 
function, explaining several human diseases resulting from inefficient cleavage (Ito 
et al., 1993; Racchi et al., 1993).  
For a large subset of membrane proteins, even modest modifications can af-
fect their folding, maturation and trafficking. A primary influencer at this early stage 
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is N-linked glycosylation. Nearly immediately after a nascent chain emerges from 
Sec61 it is scanned by the closely apposed OST for a glycosylation motif (Asn-X-
Thr/Ser), where a core oligosaccharide can be covalently attached to the side chain 
nitrogen of Asn (Helenius and Aebi, 2004; Nilsson and Von Heijne, 1993). The de-
gree to which glycans affect membrane protein biogenesis is highly variable but di-
rect and indirect influences have been reported. The modest contribution of glycans 
to protein folding is because, apart from the covalent linkage, there are few direct 
contacts between sugar moieties and the protein surface (Wormald et al., 2002). In-
stead, a glycan most likely influences protein folding by biophysically constraining 
the conformational profile during the initial stages of protein folding, as seen with 
short polypeptides (Imperiali and O’Connor, 1999). This hypothesis nicely explains 
several observations: 1) N-glycosidic linkages are commonly observed adjacent to 
secondary structure transitions (Petrescu et al., 2004), 2) already folded proteins are 
not destabilized by enzymatic removal or modification of glycans (Helenius and 
Aebi, 2004), and 3) glycans can directly increase the stability, solubility, and prote-
ase resistance of at least some proteins (Imberty and Pérez, 1995; Imperiali and 
O’Connor, 1999; Kundra and Kornfeld, 1999; Wormald and Dwek, 1999). Addi-
tionally, the importance of glycans is reflected in the partial reduction in folding or 
increased temperature sensitivity observed upon their removal (Helenius, 1994; 
Olden et al., 1982). An important aspect of glycobiology is that glycans remain 
somewhat independent appendices. This is important because it provides a means to 
bind a nascent polypeptide and monitor the folding status without perturbing protein 
structure or folding. The best understood example of this is the lectins CNX and 
calreticulin (CRT), which can recognize incompletely folded proteins through the 
presence of a single glucose (added to the core glycan structure), and upon their 
recruitment they act as molecular chaperones to prevent aggregation and subsequent 
degradation (Helenius and Aebi, 2004). Removal of this glucose by specific gluco-
sidases signals protein folding, disrupts CNX and CRT binding, and permits traf-
ficking out of the ER. Conversely, prolonged association will eventually direct the 
protein for degradation via ER associated degradation (ERAD) machineries 
(Trombetta, 2003). Thus, the addition of glycans to a protein can affect protein fold-
ing locally by providing biophysical constraints but can also influence folding and 
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maturation on a more global scale through recruitment of various chaperones and 
quality control factors. 
An even more influential modification on membrane protein biogenesis is 
the formation of intramolecular disulfide bonds. Not only do certain membrane pro-
teins strictly require them for folding (Perlman et al., 1995), but this greatly expands 
the conformational and functional scope of the mammalian proteome (Buchanan and 
Balmer, 2005), explaining why the number of disulfide bonds is greater  in higher 
organisms (Bošnjak et al., 2014). In mammalian cells the large majority of disulfide 
bonds are formed in the oxidizing environment of the ER lumen, during the initial 
stages of protein biogenesis (Sevier and Kaiser, 2002). Their formation is catalyzed 
by a family of chaperones known as thiol-disulfide oxidoreductases. As a general 
rule this family of enzymes mediates thiol-disulfide exchange reactions, in which 
the enzyme active site contains a disulfide bond that is reduced in order to oxidize 
the free thiols in its substrate (Noiva, 1999). Particularly relevant to membrane pro-
tein folding is protein disulfide isomerase (PDI), which acts both as a protein chap-
erone and is impressively versatile in its ability to oxidize, reduce, or isomerize di-
sulfide bonds (Noiva, 1999). Effectively, this allows PDI to not only aid in the for-
mation of disulfides but also monitor and isomerize incorrectly paired cysteines. 
Thus, disulfide bond formation is a critical aspect of membrane protein folding and 
as such is carefully monitored to improve the fidelity and efficiency of biogenesis. 
 There are two important points to keep in mind in regard to the relationship 
between membrane protein insertion/folding and the nuanced complexities of bio-
genesis. The first is that while many of these processes, such as glycosylation and 
disulfide bond formation, can occur concomitantly with co-translational insertion 
and folding, they are not strictly required. For example, many proteins can fold ef-
ficiently without their native glycans and a large number of proteins do not contain 
disulfide linkages (Bošnjak et al., 2014; Helenius and Aebi, 2004). Thus, these aux-
iliary modifications and the factors responsible can act in concert with insertion and 
folding machineries but are not obligately coupled. Secondly, an extremely im-
portant role for post-translational modifications is they provide a direct link to qual-
ity control mechanisms such as ERAD. Nascent membrane proteins that are either 
incompletely or incorrectly folded will have a longer resident time on factors such 
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as calnexin/calreticulin [untrimmed glycans, (Helenius et al., 1997)], PDI [oxidized 
thiols, (Tsai et al., 2001; Wang and Chang, 2003)], and general chaperones such as 
BiP [exposed hydrophobic patches, (Blond-Elguindi et al., 1993)]. As a result, spe-
cialized machineries will recognize these problematic substrates and target them for 
degradation (Reddy and Corley, 1998). This relationship necessitates a homeostatic 
balance between membrane protein biogenesis and degradation because the modes 
of substrate recognition are closely linked. In other words, if either process is left 
unchecked it can saturate or “out compete” the other, a very important consideration 
when monitoring the biogenesis of membrane proteins in cells or in vivo. 
 
Sec61 and the mechanism of TMD insertion 
 The pathway into the membrane via Sec61 became clear upon solving the 
structure of the archaeal homolog (van den Berg et al., 2004) (Figure 1.4). Sec61α 
is the functional unit consisting of 10 TMDs forming an hourglass shaped channel 
with a luminal plug to maintain the permeability barrier. Biophysical, biochemical 
and structural studies support plug displacement upon engagement of an RNC, thus 
opening a hydrophilic pore that is semi-continuous with the ribosomal exit tunnel 
(Beckmann et al., 1997; Crowley et al., 1993, 1994; Simon and Blobel, 1991). The 
membrane embedded architecture of Sec61α is arranged pseudo-symmetrically to 
form a vice-like structure with the β and γ subunits flanking the rear hinge region 
and a lateral gate between TMDs 2 and 7 (Plath et al., 1998). The lateral gate seems 
to passively open upon engagement of a suitably hydrophobic signal, explaining the 
observed (near-simultaneous) interactions of a TMD with both lipid and Sec61 (Do 
et al., 1996; Heinrich et al., 2000; Martoglio et al., 1995; Mothes et al., 1997). Struc-
tural analysis of ribosome bound Sec61 complexes during translocation confirmed 
these prior biochemical observations and provide a clear 2-step model for transloca-
tion (Voorhees and Hegde, 2016; Voorhees et al., 2014). Upon ribosome binding at 
the cytosolic face, Sec61 enters a “primed” state where the lateral gate becomes 
slightly cracked in a conformation that is more amenable to binding of a hydropho-
bic signal. However, this primed state does not alter the integrity of the luminal plug 
or open the channel. Engagement of a signal displaces all interactions between 
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TMDs 2 and 7, as well as the luminal plug, and opens the channel both laterally and 
axially (Voorhees and Hegde, 2016) (Figure 1.4).  
 One important point worth highlighting is that Sec61 is mechanistically con-
strained, despite its ability to service a large range of substrates. For example, prim-
ing of the channel upon ribosome binding exposes a hydrophobic patch that must be 
displaced (Voorhees and Hegde, 2016). Presumably, this serves to triage signals for 
the minimal hydrophobicity requirements. Consistent with this notion, hydrophilic 
signal peptides fail to be translocated even after productive targeting by SRP 
(Jungnickel and Rapoport, 1995). Furthermore, the hydrophobicity threshold is by-
passed by mutations disrupting this patch or the integrity of the closed channel 
(Derman et al., 1993; Junne et al., 2007; Osborne and Silhavy, 1993; Smith et al., 
2005; Trueman et al., 2012). Thus, signal engagement and opening of the channel is 
the rate limiting step. Prior to this, no polypeptide can enter the channel because the 
pore remains completely closed, even in the primed (ribosome bound) state 
(Voorhees et al., 2014). With this concept in mind, it is not surprising that TMDs 
challenged by poor hydrophobicity and unusual length are inefficiently inserted by 
Sec61 (Hessa et al., 2005, 2007; Jaud et al., 2009). These limitations become incred-
ibly important when considering the insertion of multipass (multispanning/poly-
topic) membrane proteins, which are enriched with biophysically challenging TMDs 
(Baker et al., 2017). 
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Figure 1.4 – The structural mechanics of Sec61 mediated insertion. The figure depicts two structures of the 
highly conserved Sec6α subunit of the Sec61 complex. The left most panels are cartoon representations of the 
peptide backbone, the center and right panels are surface representations. The two pseudo-symmetric halves of 
Sec61α are colored in tan (TM1-5) and maroon (TM6-10).  The top panels represent a structure of Sec6 from an 
archaeal homolog in a completely closed state (Van den Berg et al., 2004). The bottom panels represent the 
structure of mammalian Sec61 bound to a ribosome (not shown) and engaged by a signal peptide (blue cartoon) 
(Voorhees and Hegde, 2016). Notice, when engaged by a hydrophobic element (in this case a signal peptide) 
two major conformation changes occur. First, the luminal plug is displaced and a pore through the membrane 
opens to allow polypeptide translocation. Second, interactions between TMD2-7 at the lateral gate are broken 
and a pathway into the lipid bilayer becomes available. The signal peptide is places right at the lateral gate 
making key contacts with TMD2 of Sec61α, displacing it open the lateral gate. Comparing the views from the 
lipid bilayer, one can appreciate how the hydrophobic α-helix is positioned well to migrate into the lipid bilayer. 
 
Insertion of multipass membrane proteins 
 A mechanistic understanding of the targeting and translocation machinery 
came from a library of studies examining and manipulating simple model substrates. 
This included robust secretory proteins and idealized TMDs that are ~20 residues in 
length and particularly hydrophobic. However, the majority of TMDs are not simply 
membrane anchors but fundamental to protein function. The conserved sequence 
features that confer function often place major biophysical constraints on TMD in-
sertion and IMP folding. The simplest example is multipass membrane proteins, 
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where intramembrane interactions between TMDs results in a unique 3-dimensional 
fold (Illergård et al., 2011). This necessarily requires charged and polar residues 
within the TMD, explaining their high frequency in multipass IMPs (Baker et al., 
2017). Another biophysical constraint is a wide variation in both length and se-
quence characteristics due to differences in lipid composition at their final location 
(Sharpe et al., 2010), as well as unique folds which force TMDs away from a per-
pendicular arrangement in the lipid bilayer (Yernool et al., 2004). Furthermore, mul-
tipass membrane proteins must be oriented correctly. While single pass IMP topol-
ogy is heavily biased by the “positive-inside rule”, with charges flanking their single 
TMD (Hartmann et al., 1989; von Heijne, 2006), bioinformatic analysis of multipass 
TMDs revealed significantly less charge bias (Baker et al., 2017). Nevertheless, they 
all must be inserted into the ~30 angstrom lipid bilayer of the endoplasmic reticulum. 
The competing constraints of a single co-translational integration machinery and an 
extremely diverse set of TMDs imparts a massive challenge on multipass IMP bio-
genesis 
 How the cell overcomes this challenge remains entirely unclear. It has long 
been postulated that additional factors may act in concert with the translocation ma-
chinery in order to accommodate the large substrate pool (Shao and Hegde, 2011). 
In this thesis, I will discuss two of our recent contributions that shed light on the 
process of multipass IMP biogenesis. The first study characterizes a new molecular 
player in membrane protein insertion and topogenesis, while the second study iden-
tifies and characterizes a novel intramembrane chaperone required for multipass 
IMP biogenesis and folding. 
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The topogenesis problem 
 All TMDs within a multipass IMP are thought to have defined and fixed 
orientations relative to the bilayer, allowing flanking soluble domains to be segre-
gated amongst the two sides of the membrane (Blobel, 1980; Katz et al., 1977). Ac-
curately establishing an IMPs topology is therefore essential for proper maturation 
and function. As an example, the structure of most G-protein coupled receptors 
(GPCRs) require exoplasmic disulfide bonds for productive folding (Perlman et al., 
1995). Disulfide bond formation occurs during biogenesis and is stabilized by the 
oxidizing environment in the ER lumen, away from the reducing capacity of the 
cytosol. Consequently, insertion in the wrong orientation will result in misfolding 
and render it non-functional. Some proteins inserted incorrectly can even be domi-
nantly detrimental (Hegde et al., 1998). Thus, accurate topogenesis is not only es-
sential for membrane protein biogenesis but also to maintain overall protein home-
ostasis.  
While the topology of a multipass IMP appears more complex, a simple exami-
nation of known protein structures reveals a strong topological interdependence be-
tween TMDs. As a general rule, each TMD will adopt the inverse orientation of the 
preceding TMD. Fixing the topology of the first TMD would therefore constrain the 
remaining TMDs and define the topological ‘reading frame” (Blobel, 1980; Wessels 
and Spiess, 1988). This greatly simplifies the topogenesis problem for multipass 
IMPs, despite downstream TMD insertion complications (Öjemalm et al., 2012), 
and places topological control on recognition and insertion of the first TMD. 
The most well-defined topological determinant is an N-terminal signal sequence 
and ~50-70 amino acids of a soluble domain preceding one or more TMDs. Co-
translational engagement of Sec61 by the signal sequence initiates transport of the 
ensuing soluble domain into the ER lumen. This effectively commits the TMD to a 
topology where its flanking N- and C-terminus are exoplasmic and cytoplasmic, re-
spectively (designated Nexo). Of the ~5000 predicted human membrane proteins in-
serted at the ER, ~31% contain N-terminal signal peptides and use this mechanism 
to establish topology (UniProt Consortium, 2018). Another ~5% are tail-anchored 
membrane proteins, whose topology is dictated by their post-translational insertion 
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(Hegde and Keenan, 2011). The remaining ~64% of membrane proteins are thought 
to rely on their first TMD for targeting and setting the protein’s overall topology.  
How the sequence information encoded within a signal anchor contributes to to-
pology has remained fairly ambiguous. Several trends have emerged from mutagen-
esis studies demonstrating that length, hydrophobicity and flanking charges can in-
fluence a TMDs orientation (Higy et al., 2004). Additionally, for TMDs that can 
theoretically adopt either topology (short/flexible N-terminal domain), longer more 
hydrophobic TMDs and C-terminally flanking positive charges encourage the Nexo 
orientation  (Kida et al., 2006; Wahlberg and Spiess, 1997). However, it has been 
extremely difficult to define specific rules as all these factors appear to play minor 
roles and many native signal anchors contain contradictory features (Higy et al., 
2004; Ott and Lingappa, 2002). Only one absolute exists; an N-terminal domain that 
contains highly basic residues or folds prior to its translocation is retained in the 
cytosol (Beltzer et al., 1991; Denzer et al., 1995), and the signal anchor is forced 
into the respective topology (designated Ncyt). Despite these exhaustive studies on 
substrate contribution to topology, these trends are far from strict rules and little is 
known about how a cell correctly recognizes and orients signal anchors. 
The primary question regards the mechanism by which these sequence features 
are decoded to determine signal anchor topology. Decades of work on the SRP-SR 
system established that all signal anchors arrive at the membrane via this pathway. 
The path of the TMD after SRP release, but prior to engagement of Sec61, is far less 
clear. The assumption that Sec61 is the next point of contact is based on two obser-
vations. Its high affinity for the ribosome, and end-point assays using crosslinking 
methods to show model signal anchors of either topology are in proximity to Sec61 
(High et al., 1993a). Similarly, reconstitution studies demonstrated Sec61was suffi-
cient for insertion of several model substrates, but necessity was only established for 
those containing a signal peptide (Görlich and Rapoport, 1993; Heinrich et al., 2000; 
Oliver et al., 1995). Collectively, a strong argument was made for Sec61 or its asso-
ciated factors being the main contributors to topogenesis. However, an exhaustive 
analysis of structure informed Sec61 mutations revealed only modest defects in to-
pology, even with a topologically challenged substrate (Goder et al., 2004; Junne et 
al., 2007).  
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Equally promising are the variety of proteins known to be near the site of trans-
location such as p180, RAMP4, the TRAP complex, TRAM, and others (Dudek et 
al., 2015). Of these, TRAM has been implicated in TMD insertion on the basis of its 
proximity and a stimulatory effect in proteoliposomes with purified Sec61 complex 
and SR (Do et al., 1996; Görlich and Rapoport, 1993; Heinrich et al., 2000). How-
ever, functional deficiencies in membrane protein topology or insertion have not 
been documented in loss of function studies. Furthermore, its closest homologs in 
yeast did not seem to have a role in translocation or TMD insertion (Barz and Walter, 
1999), leaving in doubt any general and conserved role in membrane protein bio-
genesis.  
More recently, the highly conserved ER Membrane protein Complex (EMC) has 
been functionally and biochemically linked to membrane protein biogenesis. Since 
its discovery in yeast as a complex needed for ER protein homeostasis (Jonikas et 
al., 2009), EMC has been associated with highly pleiotropic phenotypes in many 
organisms (Bircham et al., 2011; Lahiri et al., 2014; Louie et al., 2012; Richard et 
al., 2013; Satoh et al., 2015; Savidis et al., 2016). Among them, several studies have 
documented reduced levels of various integral membrane proteins (Bircham et al., 
2011; Richard et al., 2013; Satoh et al., 2015), some of which are retained in the 
early secretory pathway. The only process for which a direct role of EMC has been 
shown is the post-translational insertion of tail-anchored membrane proteins into the 
ER (Guna et al., 2017). This reaction can be reconstituted with purified EMC in 
liposomes, suggesting that EMC can directly facilitate TMD transfer from the cyto-
sol into the lipid bilayer. Whether this biochemical activity is used for other types 
of membrane proteins that are inserted co-translationally remains a matter of specu-
lation (Guna and Hegde, 2018). 
The phenotypic consequence of EMC disruption for different types of multi-pass 
membrane proteins motivated us to investigate whether and how EMC might affect 
their biogenesis. Given earlier reports of EMC’s effect on the levels of the GPCR 
rhodopsin in Drosophila (Satoh et al., 2015) and a related family member in yeast 
(Bircham et al., 2011), and the exceptional importance of GPCRs to nearly all as-
pects of human physiology (Hauser et al., 2017) we sought to understand the molec-
ular basis of EMC’s potential impact on this family of multi-pass membrane 
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proteins. Our biochemical dissection of GPCR biogenesis has revealed that EMC is 
a critical and previously unknown determinant of membrane protein topogenesis. 
EMC proved to be both necessary and sufficient for accurate insertion of many Nexo 
signal anchor sequences, a step critical to the biogenesis of GPCRs and many other 
membrane proteins.  
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EMC is required for optimal β1-adrenergic receptor biogenesis in cells 
Among the several membrane proteins reported to be impacted by EMC disrup-
tion, we chose GPCRs for several reasons. First, they are monomeric and relatively 
small (Rosenbaum et al., 2009), making them amenable to biochemical analysis in 
vitro (Sonnabend et al., 2017). This contrasts with very large (Louie et al., 2012) or 
multimeric complexes (Richard et al., 2013) whose reconstitution in vitro is daunt-
ing. Second, their 7-transmembrane topology is unambiguous and the structures of 
many examples are known (Venkatakrishnan et al., 2013). Third, the first TMD, 
which is a key determinant of topogenesis and serves as a signal anchor for ~90% 
of GPCRs, is highly diverse in sequence, properties, and flanking regions. This pro-
vides ample substrate diversity within a single class of proteins from which to in-
vestigate topogenesis. Finally, GPCRs are the largest class of multi-pass membrane 
proteins in vertebrates (~820 in human) and are of wide physiologic importance. 
Thus, GPCRs represented a tractable and important class of membrane proteins for 
investigating the potential role of EMC. 
Earlier analysis had placed EMC’s role at an early stage of rhodopsin functional 
expression in Drosophila (Satoh et al., 2015), but could not distinguish between ef-
fects on translation, maturation, degradation or trafficking. To investigate this, we 
analyzed post-translational effects of EMC disruption on the vertebrate β1-
adrenergic receptor (β1AR) using a flow cytometry based assay. The C-terminus of 
a well-characterized β1AR construct (Warne et al., 2008) was appended with GFP 
and RFP separated by a viral P2A sequence (Fig 2.1A). Translation of this mRNA 
will generate two products due to peptide bond skipping at the P2A sequence (De 
Felipe et al., 2006): the β1AR-GFP fusion protein and a separate RFP. Thus, meta-
bolically stable RFP serves as a ‘counter’ for the number of times this construct is 
translated, effectively integrating mRNA levels and translation efficiency into a sin-
gle metric. Because one β1AR-GFP is synthesized for each RFP, any reduction in 
GFP levels relative to RFP necessarily reflects post-translational degradation.  
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Relative to the baseline distribution of GFP:RFP ratios for the β1AR reporter in 
wild type U2OS cells, the distribution was clearly reduced (by ~2-fold) in cells lack-
ing EMC5, a core subunit of EMC (Fig 2.1B). Similar results were obtained in 
HEK293 cells disrupted for EMC6, a different core EMC subunit (Fig 2.1C), argu-
ing against cell-type or subunit-specific effects. Acute reintroduction of EMC5 via 
an inducible promoter in EMC5-knockout cells restored the complete EMC (Guna 
et al., 2017) and completely rescued the reduced stability of the β1AR reporter. Very 
similar effects of EMC disruption were observed for the tail-anchored protein squa-
lene synthase (Fig 2.1B), a protein whose insertion into the ER is established to be 
EMC-mediated (Guna et al., 2017). Reporter cassettes lacking an insert or contain-
ing the single pass membrane protein, asialoglycoprotein receptor (ASGR1), 
showed no GFP:RFP ratio changes in EMC-knockout or rescue cells relative to wild 
type cells. 
 
Chapter II: EMC is required to initiate accurate membrane protein topogenesis 
 
24  
Figure 2.1 - EMC is required for optimal β1AR biogenesis in cells. (A) Diagram and topology of con-
structs for analysis of protein biogenesis by flow cytometry. All constructs contain GFP and RFP separated by 
a viral 2A peptide that mediates peptide bond skipping. Changes in the stability of a test protein fused to one of 
the fluorescent proteins changes the GFP:RFP fluorescence ratio. (B) Histograms of flow cytometry data mon-
itoring the fluorescence protein ratio in the indicated U2OS cell lines for each construct. “∆EMC5” indicates a 
knockout of EMC5, while “rescue” indicates ∆EMC5 cells rescued by inducible re-expression of a stably inte-
grated EMC5. (C) Histograms of flow cytometry data monitoring the fluorescence protein ratio in unmodified 
(wild type) or EMC6-disrupted (∆EMC6) HEK293 TREX cells. These experiments were done with help from 
S. Juszkiewicz. 
 
These results indicate that post-translational β1AR stability is dependent on EMC, 
the absence of which leads to its elevated degradation. The absence of any apprecia-
ble effect on ASGR1 excludes non-specific perturbation of protein biosynthesis or 
trafficking. More specifically, SRP-dependent targeting, Sec61-dependent insertion, 
and the stimulatory effect of TRAM, each of which is essential for optimal ASGR1 
biogenesis (Görlich and Rapoport, 1993; Spiess and Lodish, 1986), are all appar-
ently normal in EMC-disrupted cells.  
 
Reconstitution of EMC-dependent β1AR biogenesis in vitro 
The altered β1AR stability in EMC-disrupted cells is compatible with several 
explanations including altered biogenesis, trafficking, promiscuous degradation, and 
others. Of these, we favored an effect on biogenesis due to the previously observed 
EMC interaction with other biosynthetic factors such as OST and the Sec61 complex 
(Savidis et al., 2016). To investigate β1AR biogenesis, we used an in vitro translation 
system composed of reticulocyte lysate (RRL) and ER-derived rough microsomes 
(RMs). This system recapitulates membrane protein insertion, but is not confounded 
by post-translational degradation or vesicular trafficking out of the ER. 
In preliminary experiments, we established the conditions and assays to monitor 
membrane insertion, topology, and folding of newly synthesized 35S-methionine-
labeled β1AR (Fig. 2.2). Correct topogenesis was inferred by a combination of 
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glycosylation, selective accessibility to cytosolically added protease, and immuno-
precipitation (Fig. 2.3).  
 
Figure 2.2 - System for assessing insertion and folding of β1AR in-vitro: Diagram of constructs used to 
characterize β1AR topogenesis. ∆CL3 refers to the shortening of the cytosolic loop 3 between TMD5 and 
TMD6. The sites that should be accessible to cytosolically added proteinase K (PK) are indicated for each con-
struct. 
 
Analysis of parallel cassettes containing either the native sequence of β1AR, or a 
version with an N-terminal affinity tag and a glycosylation site (Fig. 2.2), confirmed 
accurate insertion of the tagged β1AR (Fig. 2.3A). Glycosylation serves as a fiducial 
marker for N-terminal translocation, while the epitope tag allows for topological 
analysis in protease protection assays. When translated in the absence of mem-
branes, radiolabeled β1AR migrated at ~45kDa by SDS-PAGE while the tagged ver-
sion migrated slightly slower on the gel (Fig. 2.3A, lane and 7). Approximately 50-
60% of the product was glycosylated when RMs were included in the reaction and 
the construct contained a glycosylation motif (lane 10). In all constructs tested, ex-
posure to cytosolic protease produced a protected fragment that was dependent on 
the presence of membranes but readily digested upon the addition of detergent (Fig. 
2.3A-B), suggesting integration into the lipid bilayer. Based on its size, this fragment 
agrees with insertion of the first 5 TMDs, suggesting the third cytosolic loop within 
β1AR (CL3) is accessible to protease (see Fig. 2.2). Similar experiments in which 
the large protease accessible loop was removed (β1AR∆CL3) confirmed this assess-
ment, and produced a fragment whose size corresponded to insertion of all 7 TMDs 
(Fig. 2.3B). Furthermore, the inserted population appears to be capable of efficient 
folding as judged by protease resistance even in the presence of detergent (Fig. 
2.3B). Consistent with this interpretation, this population binds to immobilized 
alprenolol, a β1AR antagonist, and selectively elutes with the agonist isoproterenol 
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(Fig. 2.3C). These results demonstrated that ~50-60% of β1AR could be inserted 
properly in this system. 
 
 
Figure 2.3 - Monitoring β1AR insertion in vitro. (A, B) 35S-methionine labeled β1AR (or the N-terminally 
HA-tagged version with a glycosylation site) was translated in RRL in the absence or presence of canine pan-
creas-derived rough microsomes (cRM). The translation products were either left untreated or digested with 
proteinase K without or with detergent (subscripted d) as indicated. The samples were either analyzed directly 
(total translation products) or after immunoprecipitation via the N-terminal HA tag (anti-HA IPs) and analyzed 
by SDS-PAGE and autoradiography. Asterisks indicate ubiquitinated products; green arrows indicate glycosyl-
ated products; red downward arrows indicate PK-protected N-terminal fragments; red upward arrows indicate 
the protease-resistant 7-TMD core of β1AR left after digestion of the N- and C-terminal tails in the ∆CL3 vari-
ants. These assigned identities of the bands can be deduced by a combination of their size, change in migration 
upon addition of the N-terminal glycosylation site, change in digestion pattern upon shortening of CL3 to make 
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it proteaese-inaccessible, and IP via the HA epitope. (C) 35S-methionine labeled β1AR (or one of the indicated 
variants) was translated in RRL in the absence or presence of microsomes (cRM). An aliquot of the sample was 
analyzed directly (total in vitro translation) or solubilized and incubated with immobilized alprenolol (a β1AR 
antagonist). The resin was washed, then eluted in buffer without or with isoproterenol (ip; a β1AR agonist). 
Efficient recovery is only observed when β1AR is synthesized with cRM and eluted with isoproterenol. For all 
immunoprecipitations presented, the total represents 10% of the reaction and the IPs are 25% of the total reac-
tion. These experiments were performed by S. Shao. 
 
These assays provided three metrics which could be used to assess the conse-
quences of EMC-disruption on β1AR biogenesis using RMs derived from wild type 
(WT) versus EMC6-knockout (∆EMC6) HEK293 cells: 1) protease protection, 2) 
glycosylation efficiency and 3) ligand binding. Importantly, accurate insertion of 
β1AR was recapitulated in RMs derived from HEK293 cells, albeit with lower effi-
ciency (Fig. 2.4-2.5). The protease-protected N-terminal fragment, diagnostic of 
correct topogenesis of the first five TMDs (Fig. 2.4A), was reduced by more than 
50% in RMs from ∆EMC6 cells relative to WT cells (Fig. 2.4B).  Furthermore, the 
deficiency was recapitulated in assays monitoring a glycosylated version of β1AR, 
and a corresponding reduction in glycosylation efficiency was observed (Fig. 2.4C, 
top panel). Parallel experiments monitoring the ∆CL3 mutant revealed a similar dis-
ruption in integration of the stable 7TMD core (Fig. 2.4C, bottom panel), suggesting 
a rather dramatic instability during insertion and folding.  
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Figure 2.4 - Impaired insertion of β1AR upon EMC knockout in vitro. (A) Diagram of the protease suscep-
tible portions of an inserted β1AR and the resulting protease resistant fragment (PF) indicative of correct inser-
tion. (B) 35S-methionine labeled β1AR was translated in reticulocyte lysate (RRL) in the absence or presence 
of HEK293-derived rough microsomes (hRM) from wild type (WT) or ∆EMC6 (∆) cells. The translation prod-
ucts were digested with proteinase K (+PK) or left untreated (-PK), then analyzed directly (total products) or 
after immunoprecipitation via the HA epitope tag (HA IPs). The positions of full length β1AR and the PF are 
indicated. (C) Protease protection assay on the indicated constructs performed as in A, but with either cRM or 
HEK293-derived microsomes (hRM) from either wild type (WT) or ∆EMC6 (∆EMC) cells. Asterisks indicate 
ubiquitinated products; green arrows indicate glycosylated products; red downward arrows indicate PK-pro-
tected N-terminal fragments; red upward arrows indicate the protease-resistant 7-TMD core of β1AR left after 
digestion of the N- and C-terminal tails in the ∆CL3 variants. For all immunoprecipitations presented, the total 
represents 10% of the reaction and the IPs are 25% of the total reaction 
 
Additionally, β1AR in ∆EMC6 microsomes was less efficiently captured by im-
mobilized alprenolol than in WT microsomes (Fig. 2.5A), while a folding-deficient 
construct (∆TMD3) was not recovered at all. Further analysis in matched experi-
ments revealed specific recovery of glycosylated β1AR by alprenolol pull-downs 
(Fig. 2.5B), establishing glycosylation as an authentic read-out for inserted and 
folded β1AR and further supporting EMC dependence. Despite these clear disrup-
tions in biogenesis upon EMC deletion, equal amounts of β1AR was recovered in  
 
Figure 2.5 - EMC dependent folding of β1AR. (A) 35S-methionine labeled β1AR or a mutant lacking the third 
transmembrane domain (∆TMD3) were tested for binding to immobilized alprenolol. The starting translation 
products (input) and alprenolol pulldowns (Alp. PD) are shown. (B) 35S-methionine labeled gHA-β1AR was 
translated in reticulocyte lysate (RRL) in the presence of wild type (WT) or ∆EMC6 (∆) hRM. The samples 
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were analyzed directly (total) or after selective capture by immobilized alprenolol and elution with isoproterenol 
(alp. PD). (C) 35S-methionine labeled β1AR translation products produced in WT or ∆EMC6 hRMs were iso-
lated by sedimentation of the hRMs and analyzed directly (input) or after extraction with Na2CO3 at pH 11.5 
(Na2CO3 resistant; 4-fold excess was analyzed). β1AR was visualized by autoradiography, while the integral 
membrane ER protein calnexin (CNX) and ER-lumenal protein disulfide isomerase (PDI) were detected by 
immunoblotting. Unless otherwise indicated in the individual figure panel, all immunoprecipitations were loaded 
such that the total represents 10% of the reaction and the IPs are 25% of the total reaction 
 
membranes pelleted from these two reactions (Fig. 2.5C, lanes 1, 2) and were simi-
larly resistant to alkaline extraction (Fig. 2.5C, lanes 3, 4). Calnexin and protein 
disulfide isomerase (PDI) provided fiducial markers for the behavior of integral 
membrane proteins and soluble (extracted) luminal proteins, respectively. Although 
membrane targeting and integration of β1AR is uninterrupted (i.e. equal alkaline re-
sistance), there is a clear disruption in its biogenesis upon EMC depletion (glycosyl-
ation/ligand pull-downs). 
Collectively, our prior characterization in-vitro allowed us to infer the fidelity of 
β1AR biogenesis using a single metric, reduced glycosylation (Fig. 2.3-2.5). Glyco-
sylation of the GPI-anchored prion protein (PrP) and the multipass membrane pro-
teins TRAM2 were unaffected in ∆EMC6 microsomes (Fig. 2.6A-B). EMC inde-
pendent insertion/translocation of these proteins was further supported by protease-
protection assays. Furthermore, the biogenesis deficiency in ∆EMC6 RMs could not 
be overcome by using more microsomes in the reaction (Fig. 2.6C), suggesting an 
intrinsic problem in making β1AR correctly rather than saturation in the in vitro sys-
tem. Τhus, the observed defect in β1AR biogenesis cannot be explained by global 
defects in targeting, insertion or translocation.  
Chapter II: EMC is required to initiate accurate membrane protein topogenesis 
 
30  
 
Figure 2.6 - An intrinsic β1AR dependence on EMC. (A) 35S-methionine labeled mammalian prion protein 
(PrP) was translated without or with the indicated hRM and analyzed by the PK-protection assay. Asterisks 
indicate ubiquitinated products; green arrows indicate doubly-glycosylated products (PrP contains two glyco-
sylation sites). (B) 35S-methionine labeled human TRAM2 was translated without or with the indicated hRM 
and analyzed by the PK-protection assay. Green arrows indicate TRAM2 glycosylated in the loop between the 
first and second TMD. After protease digestion, only the cytosolic-facing N- and C-terminal ends of the protein 
are digested, leaving behind a folded core (upward red arrows) comprising all eight TMDs. This product is 
recovered with ConA, verifying that it is the glycosylated central core. Note that no difference in TRAM2 gly-
cosylation or protease-protection is seen between reactions performed with hRM from wild type or ∆EMC cells. 
(C) 35S-methionine labeled gHA-β1AR was translated in RRL without or with wild type (WT) or ∆EMC6 (∆) 
hRM at various relative concentrations (WT and ∆EMC hRM were normalized to have equal total protein con-
centration as judged by absorbance at 280 nm). The samples were analyzed directly (left panel) and the percent 
of translation product that is glycosylated was quantified by phosphorimager and plotted (right panel). 
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In direct comparisons using glycosylation or signal peptide cleavage we 
found that biogenesis of the secretory protein prolactin, the GPI-anchored prion pro-
tein PrP, and the membrane proteins ASGR1 and TRAM2 were unaffected in 
∆EMC6 microsomes (Fig. 2.7A). These substrates represent the major types of 
model proteins analyzed in earlier work and collectively report on the integrity of 
SRP-dependent targeting, Sec61-mediated translocation and membrane insertion, 
the modulatory functions of TRAM and the TRAP complex, and the enzymatic ac-
tivities of signal peptidase and OST. Indeed, immunoblotting verified that these 
components do not differ appreciably between WT and ∆EMC6 microsomes (Fig. 
2.7B). Thus, the selective β1AR biogenesis defect observed in EMC-deficient cells 
(Fig. 2.1) can be recapitulated in vitro (Fig. 2.7A). Furthermore, the observation that 
glycosylation of an acceptor site near the N-terminus of β1AR (prior to the first 
TMD) is diminished in ∆EMC6 microsomes suggested that a relatively early step of 
β1AR biogenesis may be impaired. 
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Figure 2.7 - A specific and direct role for EMC in β1AR biogenesis. (A) The indicated proteins were translated 
without or with the indicated hRMs and analyzed for translocation by their glycosylation (downward green 
arrows) or signal peptide cleavage (upward green arrows). The % glycosylated or signal cleaved was quantified 
and shown below the gel. See also Fig. 2.6. (B) Different relative amounts of WT or ∆EMC6 hRMs were ana-
lyzed by immunoblotting for the indicated ER-resident proteins. Note that the WT and ∆EMC6 samples that are 
being compared were analyzed on the same gel and processed together. 
 
EMC is required for accurate TMD1 topogenesis of β1AR 
To facilitate the analysis of early events in β1AR biogenesis, we sought a 
simplified construct that still showed EMC-dependence. Serial truncations of β1AR 
from the C-terminus revealed that the glycosylation defect was retained even in a 
construct that only contained the first TMD (Fig. 2.8).  
 
Figure 2.8 - EMC is required for biogenesis of a simplified β1AR. (A) 35S-methionine labeled gHA-β1AR 
constructs terminated after the indicated number of TMDs was translated in RRL in the presence of wild type 
(WT) or ∆EMC6 (∆) hRM. The samples were analyzed directly (total) and the proportion of polypeptide that is 
glycosylated was quantified by phosphorimaging.  
 
This simplified construct (termed β1AR-TMD1) was effectively glycosyl-
ated at the N-terminus in WT microsomes, but significantly impaired in ∆EMC mi-
crosomes (Fig. 2.8, 2.9A). Protease digestion produced a protected fragment recov-
ered by immunoprecipitation via a N-terminal HA epitope tag. As expected from the 
glycosylation analysis, this N-terminal fragment was substantially reduced in 
matched reactions containing ∆EMC6 microsomes (Fig. 2.9A). Thus, insertion of 
β1AR-TMD1 in the correct topology is EMC-dependent, recapitulating the EMC-
dependence of full length β1AR in vivo and in vitro. Unexpectedly, pulldowns of the 
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same samples via a C-terminal His6-tag revealed a protease-protected fragment 
preferentially in the ∆EMC6 samples (Fig. 2.9A-B). This fragment was also seen at 
low levels in WT samples, albeit to a much lesser degree. Importantly, no protease 
protected fragments were observed in samples lacking RMs. This suggests that both 
WT and ∆EMC6 microsomes are comparably efficient in β1AR-TMD1 insertion, 
consistent with the alkaline extraction results with full length β1AR (Fig. 2.5C). 
However, the topology of around half of β1AR-TMD1 molecules is inverted in 
∆EMC6 microsomes, explaining the consistently impaired N-terminal glycosylation 
of truncated β1AR constructs (Fig. 2.8). A β1AR-TMD1 construct lacking the N-
terminal glycosylation site also showed topologic inversion in ∆EMC6 microsomes 
(Fig. 2.9B), arguing against glycosylation influencing topogenesis. 
  
 
 
Figure 2.9 - EMC is required for accurate TMD1 topogenesis of β1AR. (A, B) 35S-methionine labeled β1AR-
TMD1 (shown in the diagram) or a non-glycosylated version (B) was translated in the absence or presence of 
wild type (WT) or ∆EMC6 (∆) hRMs, subjected to PK digestion as indicated, and the products recovered by 
either immunoprecipitation via the N-terminal HA tag (N-term. IPs) or pulldowns via the C-terminal His6 tag 
(C-term. pulldowns). The positions of unmodified full length (FL) product, glycosylated product (+glyc), and 
N- and C-terminal protease-protected fragments (N-PF and C-PF, respectively) are indicated.  All immunopre-
cipitations were loaded such that the total represents 10% of the reaction and the IPs are 25% of the total reaction 
 
Earlier analysis both in vivo and in vitro confirmed faithful targeting via the SRP 
pathway based on several well characterized substrates with known SRP depend-
ence (Fig. 2.1, 2.6, 2.7). However, the insertion defect observed for a reporter con-
sisting of only TMD1 suggested perturbations at very early steps, perhaps reflecting 
unanticipated disruptions in β1AR TMD1 targeting. Direct analysis of SRP-
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engagement was analyzed using ribosome-nascent chain complexes (RNCs) in 
which a ribosome fails to terminate translation of a truncated mRNA, producing a 
polypeptide tethered to the ribosome via the peptidyl-tRNA (Fig 2.10). Nascent 
chains of defined length were generated, placing the TMD outside the ribosomal exit 
tunnel near the site of SRP54 association. As expected for a signal anchor sequence 
(Chartron et al., 2016; Costa et al., 2018; Sakaguchi et al., 1987; Spiess and Lodish, 
1986), 96-residue long cytosolic RNCs of β1AR-TMD1 were associated with SRP 
similarly to the previously established Nexo and Ncyt model membrane proteins LepB 
(leader peptidase from E. coli) and ASGR1, respectively (Fig. 2.10).  
 
Figure 2.10 - β1AR TMD1 faithfully engages SRP targeting pathway. 35S-methionine labeled ribosome-
nascent chains (stalled 39 residues downstream of the indicated TMDs) produced in reticulocyte lysate were 
affinity purified via an N-terminal FLAG epitope tag and analyzed by autoradiography to detect the nascent 
chains or immunoblotting for ribosomal proteins (RPL8 and RPS24) and SRP54. Controls either lacked a TMD 
or mRNA. All immunoprecipitations were loaded such that the total represents 10% of the reaction and the IPs 
are 25% of the total reaction. This experiment was performed by S. Juszkiewicz 
 
To determine the point at which topogenesis diverges, we turned to the analysis 
of RNCs of different lengths representing intermediates in the targeting and insertion 
of β1AR-TMD1 (Fig. 2.11A). When translated in the absence of membranes, prote-
ase digestion of such RNCs removes the exposed N-terminus, leaving behind a 
tRNA-associated C-terminal fragment protected by the ribosome [CTF2 (Fig. 
2.11A-B)]. A minor, slightly larger product may either represent partial protection 
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by SRP, or some heterogeneity in the precise site of protease digestion. When 116-
residue long β1AR-TMD1 RNCs are presented to RMs, translocation of the N-ter-
minus enables glycosylation, and this product is fully shielded from cytosolic pro-
tease by the ribosome and membrane [FL+glyc. (Fig. 2.11A-B)]. Relative to the 
situation in WT microsomes, ∆EMC6 microsomes show less glycosylation and less 
full-length protease protection (Fig. 2.11C). Instead, there is increased amounts of a 
non-glycosylated product whose N-terminus is accessible to protease (CTF1). Be-
cause the protected fragment is slightly larger than that seen in the absence of mi-
crosomes, it appears that the membrane affords protection of ribosome-proximal re-
gions of the nascent chain (see Fig 2.11A diagram), reflecting insertion of the TMD 
in the Ncyt topology.   
 
 
Figure 2.11 – A system to monitor early steps of β1AR-TMD1 insertion. (A) Diagram representing the full 
length β1AR-TMD1 and relative positions of the TMD, epitope tags and glycosylation site (top diagram). The 
bottom diagram shows the interpretation of the different products: Nexo-inserted nascent chains are glycosylated 
and fully protected from PK; non-inserted nascent chains are non-glycosylated and accessible to PK outside the 
ribosome and generate a C-terminal fragment (CTF2); Ncyt nascent chains are also non-glycosylated and acces-
sible to PK, but have some regions protected by the membrane to generate a slightly larger C-terminal fragment 
(CTF1). (B) 35S-methionine labeled 116-residue ribosome-nascent chain complexes of gHA-β1AR (see dia-
gram) truncated 60 residues beyond the TMD were produced in RRL. They were incubated without or with 
canine pancreas-derived microsomes (cRMs) and subjected to digestion with PK as indicated. An aliquot of the 
PK-digested sample was subsequently immunoprecipitated via the N-terminal HA tag without or with RNAse 
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digestion as indicated. (C) As in B, 116-residue nascent chains of β1AR were targeted to WT or ∆EMC6 hRMs 
and analyzed by the PK protection assay. All immunoprecipitations were loaded such that the total represents 
10% of the reaction and the IPs are 25% of the total reaction. 
 
This difference in insertion between WT and ∆EMC6 microsomes is observed 
across a range of nascent chain lengths (Fig. 2.12). Of note, the difference was not 
as prominent for the 96-residue RNC that is truncated only 39 residues beyond the 
TMD (Fig. 2.12, right panel). At this length, the TMD has barely emerged from the 
ribosome and is just long enough for membrane insertion in the Nexo topology, but 
cannot achieve the Ncyt orientation. Thus, the EMC requirement can apparently be 
partially bypassed by constraining the RNC to only the Nexo option and providing it 
far more time for insertion than would be available during co-translational full-
length β1AR biogenesis. The fact that even this highly biased situation still shows 
an appreciable difference in insertion suggests that the deficiency observed in 
∆EMC6 microsomes is not simply a kinetic problem; rather, the microsomes are 
intrinsically less capable of TMD1 insertion in the Nexo topology.  
 
Figure 2.12 – EMC is required at early steps of β1AR-TMD1 insertion. Ribosome-nascent chain complexes 
of gHA-β1AR truncated at the indicated lengths were produced in RRL, incubated with wild type (WT) or 
∆EMC6 (∆) hRM, and analyzed directly (total IVT, -PK) or subjected to digestion with proteinase K (PK) before 
analysis (total IVT, +PK). The products are labeled as in Fig. 2.11.   
 
Chemical crosslinking of RNCs via a cysteine preceding the TMD validated the 
conclusions from the protease protection assay. In the crosslinking assay, we 
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monitored crosslinks between the nascent chain and a single cytosolic cysteine in 
Sec61β to assess the cytosolic disposition of sequences preceding the TMD (Fig. 
2.13A). At each length, crosslinking to Sec61β was greater in ∆EMC6 microsomes 
than matched WT reactions (Fig. 2.13B, bottom panel). This is the mirror image of 
the extent of glycosylation in these same samples (top panel) because cysteine avail-
ability in the cytosol is mutually exclusive with glycosylation of an acceptor site 
four residues away. This indicates that RNCs that fail successful Nexo insertion in 
∆EMC6 microsomes are at the Sec61 translocon with the N-terminus facing the cy-
tosol. For the reasons articulated above, this difference is less prominent for the 96-
residue RNCs. Taken together, the findings with β1AR-TMD1 suggest that nascent 
β1AR normally engages SRP, targets to the ER, and inserts in the Nexo orientation in 
a reaction that is stimulated by EMC. In the absence of EMC, Nexo insertion is less 
efficient resulting in the non-inserted β1AR being observed near the Sec61 trans-
locon, demonstrating topological inversion at the earliest point of TMD insertion.  
 
 
Figure 2.13 – Topological inversion occurs at early stages of β1AR-TMD1 insertion. (A) Diagram showing 
position of N-terminal Cys located upstream of TMD1 and the interpretation of the chemical crosslinking assay. 
(B) 35S-methionine labeled β1AR nascent chains of the indicated lengths were targeted to WT or ∆EMC6 hRMs 
(top panel), then subjected to sulfhydryl-mediated crosslinking. The crosslinked products were immunoprecip-
itated using antibodies against Sec61β and shown in the bottom panel. Controls lacking either mRNA (mock) 
or a cysteine in the nascent chain showed no Sec61β immunoprecipitated products. All immunoprecipitations 
were loaded such that the total represents 10% of the reaction and the IPs are 25% of the total reaction. 
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TMD1 of most GPCRs requires EMC for optimal insertion 
To determine whether the first TMDs of other GPCRs also rely on EMC, we 
analyzed constructs containing TMD1 and flanking regions of sixteen GPCRs in a 
context similar to β1AR-TMD1. Using glycosylation of an N-terminal site in 116-
residue RNCs as the readout, we found that all GPCRs tested showed at least a par-
tial dependence on EMC, ranging from ~20% to over 90% impairment in its absence 
(Fig. 2.14). Collectively, this sample of GPCRs represents a distribution of Nexo sig-
nal anchors with diverse sequences and biophysical properties such as hydrophobi-
city (TMD tendency) and flanking charge distribution (Table 2.1). However, there 
was no obvious unifying property between substrates that could easily provide an 
explanation for EMC dependence (Table 2.1 and Fig. 2.14). Consistent with the lack 
of effect in cells (Fig. 2.1A), ASGR1 showed little or no deficiency in insertion into 
∆EMC6 microsomes, while LepB showed a very small but reproducible EMC-de-
pendence (Fig. 2.14). 
 
Figure 2.14 - TMD1 of most GPCRs requires EMC for optimal insertion. Constructs containing TMD1 and 
flanking regions from the indicated GPCRs (see Table S1) were analyzed by glycosylation of nascent chains 
targeted to wild type (WT) or ∆EMC6 (∆) hRMs. The % decrease in ∆EMC6 hRM was quantified from three 
experiments and plotted and error bars represent standard deviation from the mean. Example data from the three 
GPCRs indicated by grey bars are shown in the inset. The model proteins ASGR1 and LepB were also analyzed 
for EMC-dependence and plotted for comparison. These experiments were aided by A. Guna. 
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Table 2.1 - Sequences of TMD regions analyzed in this study (related to Fig. 2.14). The GPCR-TMD1 
cassette depicted in Fig. 3A was populated with the first TMD and adjacent flanking regions (~10 residues on 
either side) of the indicated GPCRs. The TMD regions of the model proteins bacterial leader peptidase (LepB) 
and ASGR1 are shown for comparison. The TMD region (as annotated by Uniprot) is underlined, and flanking 
basic and acidic residues are shown in red and blue, respectively. The calcuated TM tendency score and charge 
difference are indicated for each TMD region. Note that the Uniprot annotated TMD may not be precise in 
defining the boundaries, so parameters such as TMD length and hydrophobicity should be interpreted with this 
caveat in mind. 
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Conclusions from glycosylation analyses were verified by protease protection as-
says and N-terminal immunoprecipitation (three examples are shown in (Fig. 2.15). 
Importantly, analysis of RNC intermediates for three native GPCR N-terminal se-
quences showed a similar degree of impaired insertion in ∆EMC6 microsomes as 
seen for the respective epitope-tagged TMD1 constructs (Fig. 2.15). This observa-
tion not only validates earlier assays in the assessment of EMC dependence using 
tagged TMD1 variants, but also suggests the sequence information imposing EMC 
dependence is encoded within our simplified constructs, i.e. the TMD and 10 flank-
ing N- and C-terminal residues (Table 2.1). Thus, early events in the biogenesis of 
most GPCRs differs at least partially in EMC-deficient microsomes.  
 
 
Figure 2.15 – EMC is required for early events in GPCR biogenesis. Ribosome-nascent chains (stalled ~60 
residues downstream of the indicated TMDs) were targeted to wild type (WT) or ∆EMC6 (∆) hRMs and ana-
lyzed by the PK-protection assay as in. ‘HA’ indicates an N-terminal HA tag and glycosylation site (see Fig. 
2.9A), while ‘Nat.’ indicates the native N-terminal domain. The PK-digested samples from the HA-containing 
constructs were also subjected to immunoprecipitation (HA IPs). All immunoprecipitations were loaded such 
that the total represents 10% of the reaction and the IPs are 25% of the total reaction. 
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Three full-length GPCRs were analyzed in U2OS cells for impaired biogenesis 
using the dual-color flow cytometry assay (Fig. 2.16). As expected for expression in 
a heterologous cell type, the steady state levels of each receptor varied somewhat, 
with the Type 2 angiotensin II receptor (AGTR2) expressing better than either a1A-
adrenergic receptor (ADA1A) or Cannabinoid receptor 2 (CNR2). Nevertheless, the 
steady state level of the GFP-tagged GPCR was reduced in ∆EMC5 cells for each 
protein, but restored to WT levels when EMC5 was re-expressed. Thus, the insertion 
impairment of TMD1 seen in ∆EMC6 microsomes in vitro corresponds to reduced 
post-translational stability of the full GPCR in ∆EMC5 cells.  
 
Figure 2.16 – EMC is required for full-length GPCR biogenesis in cells. The indicated GPCRs were tagged 
as in Fig. 2.1A and analyzed by flow cytometry as in Fig. 2.1. Gray trace is WT cells, red trace is ∆EMC5 cells, 
and blue trace is EMC5-rescued ∆EMC5 cells.  The above experiment was performed with help from S. Juszkie-
wicz. 
 
Prior studies analyzing sequence properties such as charge bias, hydrophobicity, 
and TMD length demonstrated relatively modest effects, of each individual feature, 
on topology. More puzzling was the machinery responsible for actually decoding 
these properties in order to bias orientation. Indeed, extensive mutagenesis of Sec61 
revealed only modest effects on topology, and only on already topologically com-
promised substrates (Goder et al., 2004; Junne et al., 2007). Nevertheless, general 
trends demonstrate C-terminally flanking positive charges, increasing hydrophobi-
city, and short TMDs favor Nexo insertion of a signal anchor (Higy et al., 2004). 
Similar analyses of β1AR-TMD1 mutants show a link between TMD topology and 
EMC dependence (Fig. 2.17A, Table 2.2), with reduced length, increased 
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hydrophobicity, and flanking charges that favor a cytosolic C-terminus all reducing 
EMC dependence. Conversely, LepB could be made highly EMC dependent by 
lengthening its TMD with three non-hydrophobic residues (Fig. 2.17B-C, Table 
2.2). These observations partially explain the variable EMC dependence observed 
amongst the natural signal anchors of GPCRs and also correlatively link EMC to 
topological determination. However, how these biophysical features are recognized 
and what determines the fate of a signal anchor will require more in-depth analysis. 
 
 
Figure 2.17 - Properties of TMD influencing EMC dependence. (A) The indicated β1AR constructs (see 
Table 2.2) were tested for insertion into wild type and ∆EMC hRM as in Figure 2.15-2.16. Glycosylation was 
used to quantify the amount of insertion in the correct (Nexo) orientation. The relative difference in correct 
insertion between wild type and ∆EMC microsomes was used to determine EMC-dependence (i.e., 60% inser-
tion in ∆EMC relative to wild type would mean 40% EMC-dependence). All of the constructs were analyzed 
together. The wild type is re-plotted in each of the three graphs for comparison. Note that EMC-dependence of 
the β1AR TMD is influenced by hydrophobicity, TMD length, and to a lesser extent, flanking charge bias. (B, 
C) Ribosome-nascent chains of the indicated constructs (Table 2.2) were analyzed for insertion by the glycosyl-
ation assay using WT and ∆EMC6 hRMs. Panel C shows quantification of the autoradiograph shown in panel 
B. 
 
 
 
Chapter II: EMC is required to initiate accurate membrane protein topogenesis 
 
43  
 
 
Table 2.2 - Sequences of TMD mutants analyzed in this study (related to Fig. 2.16). The β1AR-TMD1 and 
LepB constructs were mutated as indicated (green residues indicate changes). The calcuated TM tendency score 
and charge difference are indicated for each TMD region. The TMD is underlined. Note that the assignment of 
the TMD for β1AR is different from that indicated in Uniprot (Table S1) and is based on the known structure of 
β1AR. Although not shown here, we have verified that the effect of 3L and ∆3 are due to the increase in hydro-
phobicity and decrease in TMD length, respectively, and not to the specific residues that are mutated. This was 
done by mutating or deleting three other residues in the TMD to achieve the same approximate hydrophobicity 
and length. 
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Nexo signal anchor insertion can occur without the Sec61 complex 
Despite the clear relationship between established topological determinants 
and EMC dependence (Fig 2.17), analysis of native GPCR TMDs argued that com-
peting biophysical properties could partially bypass EMC necessity (Fig. 2.14, Table 
2.1). The TMDs that display EMC-dependence (whether partial or near-complete) 
are diverse but the unifying feature of these proteins is their Nexo topology. By con-
trast, proteins whose targeting elements acquire the Ncyt topology at the membrane 
are EMC-independent: the cleavable signal peptides of prolactin and PrP, and the 
signal anchor of ASGR1. This correlation suggested the hypothesis that EMC might 
use its insertase activity (Guna et al., 2017) to co-translationally insert Nexo signal 
anchors, while the Sec61 complex accommodates Ncyt targeting elements (Voorhees 
and Hegde, 2016). In support of this idea, it is noteworthy that tail-anchors inserted 
by EMC are similar to Nexo signal anchors in having relatively short translocated 
domains (Fig. 2.18A) and basic residues enriched on the cytosolic flank of the TMD 
(Fig. 2.18B).  
 
Figure 2.18 – The shared properties of EMC dependent substrates. (A) Plot of TM tendency score versus 
length of the translocated domain for all non-signal-containing GPCRs and ER-localized TA proteins in the 
human genome. The translocated domain of almost all TA and Nexo signal anchors is less than ~40 residues. (B) 
Histogram of the charge difference for the dataset in panel A. Charge difference is calculated based on the sum 
of the C-terminal charges subtracted by the sum of N-terminal charges ∆(C-N).  Note that in both cases, there is 
a slight preference for net positive charges facing the cytosol. 
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To investigate this hypothesis, we examined GPCR TMD1 insertion into mem-
branes depleted of the Sec61 complex. RMs were solubilized, mock- or immuno-
depleted of the Sec61 complex, and the remaining proteins reconstituted into prote-
oliposomes (PLs) by slow removal of detergent. Sec61 was verified to be thoroughly 
depleted (by over 95%; Fig. 2.19A), while the overall protein profile was otherwise 
unchanged (Fig. 2.19B). As shown previously (Görlich and Rapoport, 1993), Sec61-
depleted PLs are completely deficient in prolactin translocation (Fig. 2.19C). Fur-
thermore, they cannot detectably insert the Ncyt signal anchored protein ASGR1 as 
measured by protease protection assays. Remarkably however, the Nexo signal an-
chor from β1AR can be inserted into to Sec-depleted proteopliposomes with near 
equal efficiency (Fig. 2.19C). 
 
 
Figure 2.19 – β1AR Nexo signal anchor insertion is Sec61-independent. (A) Immunoblotting of proteolipo-
somes (PLs) reconstituted from total ER proteins (Tot.) or Sec61-depleted ER proteins (∆Sec) shows that under 
conditions where even 5% of total PLs show readily detectable Sec61, none is seen in ∆Sec PLs. EMC levels 
are comparable. Verifying that Sec61 was depleted with >95% efficiency (B) Total proteins in the proteolipo-
somes were visualized by Sypro Ruby, with the position of Sec61a indicated by the red arrow. (C) The protease-
protected (and hence, translocated) products were recovered by immunoprecipitation using the respective tags 
Prl (Ab against native Prl N-term), β1AR-TMD1 (HA tag), ASGR (HA tag), and SQS (3F4 tag) to verify inser-
tion/translocation. These experiments were performed with help from R.S. Hegde. 
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Additionally, several different Nexo signal anchored proteins from GPCRs can be 
inserted into Sec61-depleted PLs. Protease-protection assays and IPs via an N-ter-
minal tag showed that the N-terminus is protected from digestion in mock- and 
Sec61-depleted PLs, but not empty liposomes (Fig. 2.20). Importantly, the exten-
sively studied model protein LepB whose insertion was thought to require the Sec61 
complex (Heinrich et al., 2000) was inserted almost equally well in non-depleted or 
depleted PLs (Fig. 2.20).  
 
Figure 2.20 – Multiple Nexo signal anchors insert independently of Sec61. (A) Ribosome-nascent chain com-
plexes of constructs containing the indicated TMD1 regions (see Table 2.1, 2.2) truncated ~60 residues beyond 
the TMD (corresponding to residue 116 in the β1AR-TMD1 construct) were produced in RRL. They were in-
cubated without anything, with liposomes, or with PLs from total ER proteins (Tot.) or Sec61-depleted ER 
proteins (∆Sec). An aliquot of the sample was analyzed directly (-PK) or subjected to digestion with proteinase 
K (+PK). (B) An aliquot of the PK-digested sample was subsequently immunoprecipitated via the N-terminal 
HA tag after RNAse digestion (N-term. IPs). FL indicates full length product protected from protease, indicative 
of successful insertion. CTFs indicate C-terminal fragments from non-inserted products. All immunoprecipita-
tions were loaded such that the total represents 10% of the reaction and the IPs are 25% of the total reaction. 
These experiments were performed with help from R.S. Hegde. 
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Although glycosylation is relatively inefficient in PLs, over-exposed autoradio-
graphs showed that an N-terminal acceptor site is glycosylated comparably effi-
ciently for several different Nexo signal anchors in both mock- and Sec61-depleted 
PLs (Fig. 2.21). This observation is important for two reasons. First, it provides an 
orthogonal verification of correct insertion and the fidelity of downstream enzymatic 
events acting on the nascent chain, effectively further validating the reconstituted 
system. Second, glycosylation establishes productive translocation of the N-termi-
nus in to the ΕR lumen and confirms the interpretations from assays using protease 
protection and N-terminal IPs (Fig. 2.19-20). 
 
Figure 2.21 – Accurate insertion of Nexo signal anchor insertion independently of Sec61. The total IVT 
products from Fig. 2.20 shown from an overexposed autoradiograph to visualize the minor glycosylated product 
(+glyc). Glycosylation is relatively inefficient in PLs compared to native microsomes. These experiments were 
performed with help from R.S. Hegde. 
 
While insertion of some of these signal anchors was reduced by ~50% upon 
Sec61 depletion, others were essentially unaffected. As discussed below, this reduc-
tion may be due to an inability of ribosomes to stably dock at the membrane in the 
absence of Sec61 (Kalies et al., 1994). Despite this limitation, the data illustrate that 
Nexo signal anchors do not strictly require Sec61 for insertion, in stark contrast to a 
signal peptide or Ncyt signal anchor. In light of this result, it is noteworthy that Nexo 
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signal anchors are the only class of substrates completely resistant to a potent Sec61 
inhibitor (McKenna et al., 2017) that prevents opening of the Sec61 channel by sig-
nals and TMDs (Baron et al., 2016; MacKinnon et al., 2014). Both of these obser-
vations can be explained by a model where EMC, not Sec61, plays a primary role 
during insertion of Nexo signal anchors. 
 
EMC is sufficient for Nexo signal anchor insertion 
To test whether EMC’s insertase function can explain Sec61-independent 
insertion of Nexo signal anchors, we prepared PLs containing purified EMC without 
or with SRP receptor and tested their capacity for translocation and membrane in-
sertion. Inclusion of SR in the proteopliposomes improves targeting of RNCs and 
greatly enhances the efficiency of insertion in a purified system (Görlich and 
Rapoport, 1993). Importantly, we verified that EMC and EMC/SR PLs are not con-
taminated with any detectable Sec61 complex (Fig. 2.22A-B). Consistent with a 
strict requirement for Sec61 complex, neither prolactin nor ASGR1 showed detect-
able translocation in EMC or EMC/SR PLs. By contrast, the β1AR-TMD1 was in-
serted into EMC-containing PLs. The additional presence of SR stimulated insertion 
of β1AR-TMD1, but not of the tail-anchored protein squalene synthase (Fig. 2.22C). 
It is likely that this stimulation is due to SR facilitating dissociation of the TMD 
from SRP. SR alone had no translocation or insertion activity, suggesting that simply 
delivering β1AR-TMD1 to the membrane surface is insufficient to allow insertion. 
Importantly, EMC mediated insertion in the purified system was observed with ei-
ther a terminated nascent chain, or an RNC in which β1AR-TMD1 is still tethered to 
the ribosome (Fig. 2.22D). The latter represents a situation in which unregulated 
insertion would be highly unlikely due to the biophysical constraints of being teth-
ered to the extremely large ribosome. The overall lower insertion efficiencies into 
these purified EMC PLs relative to PLs containing total ER proteins is probably 
explained by the lower level of EMC in the purified system (Fig. 2.22A-B) and the 
absence of a ribosome docking site normally provided by the Sec61 complex (Kalies 
et al., 1994). These limitations notwithstanding, we conclude that after targeting, 
EMC is sufficient to mediate insertion of not only tail-anchored proteins like SQS, 
but also Nexo signal anchors.  
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Figure 2.22 – EMC is sufficient for Nexo signal anchor insertion. (A) The indicated PLs were analyzed by 
immunoblotting for Sec61 and EMC to verify no Sec61 contamination of either EMC or SRP receptor (SR) PLs. 
The serial dilution on the right-hand side of the gel represents total proteoliposomes reconstituted in parallel (B) 
Proteins in the proteoliposomes were visualized by Sypro Ruby. 10-fold excess of the first four lanes were loaded 
to detect the purified proteins. (C) The indicated constructs were analyzed by the protease-protection assay for 
translocation and immunoprecipitated. Abbreviations: liposomes (Lipos), proteoliposomes reconstituted from 
total ER proteins (Tot.), and proteoliposomes containing the indicated purified proteins (SR is SRP receptor). 
(D) Insertion assay as in (C) into the indicated proteoliposome preparation. The terminated β1AR-TMD1con-
struct (as in C) was compared to the same construct stalled at residue 116 (~60 residues downstream of the 
TMD). Shown is the immunoprecipitated protease-protected N-terminal fragment diagnostic of successful in-
sertion in the Nexo topology. Note that specificity and efficiency of insertion is comparable for the terminated 
and stalled versions of β1AR-TMD1. These experiments were performed with help from R.S. Hegde. 
 
EMC and Sec61 can function sequentially to insert two TMDs 
The findings thus far indicate that EMC is needed for efficient insertion of TMD1 
of GPCRs in the Nexo topology, that Sec61 complex is not strictly required for this 
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step, and that purified EMC is sufficient in a reconstituted system to mediate Nexo 
signal anchor insertion. In the context of a full length GPCR, the next step after 
TMD1 insertion is TMD2 insertion in the opposite orientation. The reconstitution 
experiments with ASGR1 indicate that co-translational insertion in this topology re-
quires Sec61 and cannot be mediated by EMC.  
To test whether TMD2 of β1AR requires Sec61, we analyzed a two-TMD con-
struct (Fig. 2.23 and 2.24) for insertion in reconstituted PLs containing or lacking 
the Sec61 complex. We first characterized insertion of TM1+2 in native RMs using 
a construct containing glycosylation sites and epitope tags at both the N- and C-
terminus (Fig. 2.23A-B). These initial analyses showed that its insertion in the cor-
rect double-spanning topology results in the addition of two glycans and a protein 
that is fully shielded from cytosolic protease due to the inaccessibility of the short 
intervening cytosolic loop (Fig. 2.23C, and diagram in Fig. 2.23B). The identity of 
each molecular weight species was confirmed by inhibition of glycosylation with 
saturating amounts of acceptor peptide (AP) and immunoprecipitations via either 
terminus. Polypeptides that fail insertion entirely are digested by cytosolic protease, 
while those with only the first TMD inserted in the Nexo topology generate a pro-
tected N-terminal fragment that can be recovered by an N- but not C-terminal IP 
(Fig. 2.23C).  
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Figure 2.23 – Characterization of TMD1+2 insertion in ER rough microsomes. (A) Diagram of the two-
TMD β1AR construct (β1AR-TMD1-2), (B) and its topology when TMD2 inserts or fails to insert into the 
membrane. Only the single-spanning form would be accessible to proteinase K (PK) digestion due to the short 
loop between TMD1 and TMD2. In addition, the double-spanning topology can be glycosylated twice, while 
the single spanning topology is only glycosylated once. (C) 35S-methionine labeled β1AR-TMD1-2 was trans-
lated in reticulocyte lysate (RRL) in the presence of canine pancreas-derived rough microsomes. Where indi-
cated, the translation reaction contained an acceptor peptide (AP) inhibitor of N-linked glycosylation. The trans-
lation products were either left untreated or digested with proteinase K without or with detergent (subscripted 
d) as indicated. The samples were divided in two and recovered via the N- or C-terminal tag and analyzed by 
SDS-PAGE and autoradiography. The positions of unglycosylated, singly-glycosylated (1x glyc) or doubly-
glycosylated (2x glyc) products are indicated. Green arrows indicate products that are fully protected from pro-
tease digestion and represent the double-spanning topology. Red arrows indicate N-terminal protease-protected 
fragments. Some heterogeneity is observed in the size of these fragments presumably due to heterogeneity in 
where the protease digestes the exposed polypeptide. 
 
To determine whether Sec61 was necessary for insertion of the second TMD in 
β1AR we turned to a simplified construct, in which the second C-terminal glycosyl-
ation site had been removed. This variant behaved identically by protease protection 
assays but provided a simplified readout for direct comparison in proteoliposomses 
(Fig. 2.24A), which have substantially reduced glycosylation efficiencies. Little or 
no protease-protection was observed in reactions containing empty liposomes, or if 
the PLs were added post-translationally to the reaction (Fig. 2.24B). Notably, inser-
tion of the first TMD occurred in the absence of Sec61, generating the N-terminal 
protected fragment that could be immunoprecipitated solely by the N-terminal 
epitope tag (Fig 2.24B and Fig. 2.24C). Insertion in the correct double-spanning 
topology was observed in mock-depleted PLs, but sharply reduced in Sec61-de-
pleted PLs (Fig. 2.24B and Fig. 2.24C). Thus, co-translational topogenesis of the 
first two TMDs of β1AR requires Sec61. The point at which Sec61’s role becomes 
critical is TMD2 insertion, as TMD1 insertion can proceed in its absence. TMD1 
insertion can be mediated solely by EMC (Fig. 2.22), although EMC’s absence is 
partially tolerated by β1AR presumably because its insertion by Sec61 occurs in the 
correct orientation for a subset of molecules. This indicates that although the correct 
double-spanning topology can be achieved without EMC, optimal topogenesis re-
quires the combined functions of EMC and Sec61 for insertion of TMD1 and TMD2, 
respectively.  
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Figure 2.24 – EMC and Sec61 cooperate to insert multiple TMDs. (A) Diagram of the two-TMD β1AR 
construct and its topology when TMD2 inserts or fails to insert into the membrane. Only the single-spanning 
form is accessible to proteinase K (PK) digestion. The two-TMD construct from panel C was analyzed in the 
indicated proteoliposome preparations by the protease-protection assay. (B) The two-TMD β1AR construct (as 
shown in A) was analyzed in the indicated proteoliposome preparations or canine-pancreas derived microsomes 
(cRM) by the protease-protection assay. Samples were analyzed directly without immunoprecipitation. The left 
panel shows the experiment when membranes are present during the translation reaction (co-translational), while 
the right panel shows the experiment when incubation with membranes was post-translational. Red asterisks 
indicate ubiquitinated products, green arrow indicates the glycosylated product, “1+2” indicates the protected 
product indicative of the double-spanning topology, and “1 only” indicates the single-spanning topology. (C) 
The panel shows the PK-digested products shown in (B) after recovery via N- or C-terminal tags as indicated. 
“1+2” indicates the protected product indicative of the double-spanning topology, and “1 only” indicates the 
single-spanning topology. 
 
Bypass of EMC dependence by constraining TMD1 topology 
The biochemical analyses using simplified N-terminal regions of β1AR show 
that one explanation for the observed requirement for EMC in cells (Fig. 2.1) is its 
role in topogenesis of TMD1. To investigate whether EMC is required for inser-
tion, folding, or maturation steps beyond TMD1 insertion, we designed versions of 
β1AR whose TMD1 would necessarily insert via Sec61. Sec61 is both necessary 
and sufficient for signal sequences and Ncyt signal anchors to initiate translocation 
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without any appreciable role for EMC. We therefore extended the N-terminus of 
β1AR with either a cleavable signal sequence and the secreted protein lysozyme 
(termed SS-T4L- β1AR; see diagram, Fig. 2.25A) or a signal anchor from manno-
sidase I with a short linker (termed ManI- β1AR). Both of these extensions should 
mediate targeting, initiation of translocation, and commitment of protein topology 
before TMD1 emerges from the ribosome. Because the polypeptide at this stage 
would be threaded within the Sec61 channel, TMD1 will enter Sec61 and can in-
sert via its lateral gate in the correct orientation, thereby bypassing EMC’s in-
sertase function.  
In vitro translocation and protease protection analysis of SS-T4L- β1AR and 
ManI- β1AR showed that its insertion occurs similarly in WT and ∆EMC6 RMs 
under conditions where β1AR insertion is significantly impaired (Fig. 2.25A). 
Analysis in cells using the dual-color fluorescent reporter assay showed no differ-
ence in either SS-T4L- β1AR or ManI- β1AR between WT and ∆EMC5 cells (Fig. 
2.25B). SS-T4L similarly rescued the EMC-dependence of AGTR2 and ADA1A 
(Fig. 2.25B). 
This result has three important implications. First, it strongly argues against any 
indirect effects of EMC on GPCR levels. Hence, explanations such as globally al-
tered trafficking, degradation, or other general perturbations leading to the reduced 
GPCR levels (as seen in Figs. 2.1 and 2.14) seem highly unlikely. Second, the bio-
chemically demonstrated EMC-dependent step of TMD1 insertion characterized in 
vitro must be the mechanistic explanation for reduced GPCR levels in ∆EMC cells 
observed in vivo. Third, the insertase function of EMC used for TMD1 topogene-
sis appears to be the only step during GPCR biogenesis where EMC is required. 
Thus, we conclude that EMC’s role in facilitating the biogenesis of many GPCRs 
is due to its requirement during TMD1 insertion in the Nexo topology. 
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Fig. 2.25 - A Sec61-targeted signal sequence or TMD can bypass EMC-dependence in vitro and in vivo. 
(A) Diagram comparing the β1AR, SS-T4L-β1AR, and ManI-β1AR constructs (top) and their analysis of inser-
tion into wild type (WT) or ∆EMC6 (∆) hRM as in Fig. 2.4. PF indicates the protected N-terminal fragment 
generated by digestion of successfully inserted protein at the loop between TMD5 and TMD6 (see diagrams). 
(B) Flow cytometry analysis of the indicated constructs in wild type or ∆EMC5 U2OS cells as in Fig. 2.1. Note 
that in contrast to the matched constructs lacking the SS-T4L or ManI domains (Figs. 2.1 and 2.16), no appre-
ciable consequence of EMC deletion is observed. The experiments in panel B were performed in parallel with 
the experiments shown in figure 2.1B as a single experiment, although they are displayed in separate figures. 
Please refer to figure 2.1B for the positive control in which β1AR-GFP-2A-RFP shows EMC dependence. The 
experiments in panel B were performed with help from S. Juszkiewicz. 
 
A model for EMC mediated co-translational insertion 
We have identified a role for EMC in the co-translational biogenesis of GPCRs, 
defined the specific step at which EMC is needed, reconstituted its function in vitro, 
and used these insights to bypass EMC, thereby validating our conclusions in vivo. 
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Although we have focused on GPCRs, our mechanistic studies suggest that EMC is 
generally needed for initiating the accurate topogenesis of most membrane proteins 
containing an Nexo signal anchor. In support of this: a) all GPCR TM1 variants tested 
show some EMC dependency despite diverse sequences (Fig. 2.14 and Table 2.1), 
b) a non-GPCR (LepB) shows a minor dependence on EMC but can be made sub-
stantially EMC dependent by lengthening the TMD while maintaining overall TMD 
helicity (Fig. 2.17), c) EMC dependence does not act on a single sequence feature 
but appears to be necessary when a combination of biophysical features disrupt ef-
ficient insertion of Nexo signal anchors. Based on current prediction algorithms, 64% 
of the ~5000 human membrane proteins lack a signal peptide and therefore initiate 
topogenesis using a signal anchor. A large proportion of these adopt the Nexo topol-
ogy and will therefore require EMC for optimal biogenesis. Thus, we propose that 
EMC is a widely conserved and extensively used insertion factor that operates in 
both co-translational and post-translational (Guna et al., 2017) membrane protein 
insertion at the eukaryotic ER. 
Based on the available information, a working model for the role of EMC in sig-
nal anchor topogenesis can be proposed (Fig. 2.26). Extensive biochemical 
(Sakaguchi et al., 1987; Spiess and Lodish, 1986), structural (Hainzl et al., 2011; 
Janda et al., 2010; Keenan et al., 1998; Voorhees and Hegde, 2015), and whole-
genome analysis (Chartron et al., 2016; Costa et al., 2018), suggest that a nascent 
signal anchor would be recognized by SRP and targeted to the ER membrane via the 
SRP receptor. At this stage, the signal anchor would be partially within or barely 
outside the ribosomal tunnel (Voorhees and Hegde, 2015), then dissociate from SRP 
and be located near the membrane. This is the critical time window in which EMC 
must act. At a later stage the accessibility to the nascent chain will likely be pre-
cluded by the tight interaction between Sec61 and the ribosome, biasing a nascent 
TMD towards Sec61. In the case of an Nexo signal anchor, this will result in either 
topological inversion or failure to insert altogether. The complete sufficiency and 
necessity of Sec61 for the insertion of Ncyt signal anchors [Fig. 2.19C and (Görlich 
and Rapoport, 1993)] supports the inference that topologically inverted β1AR is in-
serted incorrectly via Sec61. 
Chapter II: EMC is required to initiate accurate membrane protein topogenesis 
 
56  
We favor a model in which Nexo substrates are inserted by EMC and the ribosome 
will then quickly dock on Sec61, positioning the second and remaining TMDs for 
insertion via the translocon (Fig. 2.24). This model is nicely supported by previous 
crosslinking studies demonstrating  nascent Nexo signal anchors are near the trans-
locon (Heinrich et al., 2000; High et al., 1993a). Our in vitro reconstitution of the 
biogenesis of multi-pass membrane proteins that depend on both EMC and the Sec61 
complex, and the identification of specific steps where each is needed, now paves 
the way for mechanistic and structural dissection of this poorly understood process. 
 
 
Fig. 2.26 - Working model for the roles of EMC and Sec61 complex in multipass membrane protein bio-
genesis. The left half of the diagram shows the normal situation (wild type), and the right half depicts the con-
sequence of EMC deletion (∆EMC). After targeting via SRP, the Nexo signal anchor is inserted via EMC. 
Downstream TMDs are inserted by Sec61. In the absence of EMC, the Nexo signal anchor of  most of the 
nascent chains fails to insert in the correct topology, resulting in a misfolded and degraded protein. Depending 
on the substrate, some nascent chains are inserted appropriately by the Sec61 complex even in the absence of 
EMC, leading to a small population of correctly folded final protein. 
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The multipass IMP folding problem 
Since the earliest studies on the denaturing and refolding of soluble proteins 
(Haber and Anfinsen, 1962), it has been well established that protein folds reside in 
free energy minima;  adopting a final conformation that shields patches of polypep-
tide from energetically unfavorable interactions with the surrounding environment. 
However, the energetically preferred conformation is not always a functional prod-
uct. For example, hydrophobic patches in cytosolic proteins can avoid the aqueous 
environment through productive folding or misfolding and aggregation (Pelham, 
1986). A particularly vulnerable timeframe is during protein synthesis, when incom-
plete polypeptide is partially exposed to the cytosol but unable to interact with distal 
sequence features and fold into its final tertiary structure. Improper interactions are 
avoided through the action of molecular chaperones (Ellis, 1988; Pelham, 1986) 
which shield vulnerable segments of polypeptide, keeping them competent for fold-
ing. This process is well understood on a genome wide scale for soluble proteins and 
their associated co-translational chaperones have been thoroughly characterized 
(Blond-Elguindi et al., 1993; Döring et al., 2017; Stein et al., 2019). 
  Conversely, the assembly of multipass IMPs and multi-subunit membrane 
protein complexes is far more mysterious. An important distinction in intramem-
brane folding events is the inability of the lipid bilayer, as a solvent, to form hydro-
gen bonds (Popot and Engelman, 2000). Energetically, this places a large penalty on 
unpaired hydrogen donors/acceptors within a TMD, driving α-helix formation 
(Popot and Engelman, 1990) and simplifying the folding problem. While the ideal 
TMD is primarily hydrophobic on its surface (Engelman et al., 1986; Ulmschneider 
et al., 2005), the chemistry of purely aliphatic side chains is extremely limited and 
polar effects are necessary for forming the defined functional clefts and cavities ob-
served in multipass IMPs (Engelman et al., 2003). However, polar properties within 
the membrane come with an energetic cost that must be offset to form an energeti-
cally stable protein (Chang and Bowie, 2014; Chen and Gouaux, 1999; Krishnamani 
et al., 2012; Lau and Bowie, 1997).  
The large library of available membrane protein structures reveals how this is 
accomplished. TMDs are typically organized such that the hydrophilic regions face 
each other, presenting a mostly uninterrupted hydrophobic surface to the 
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surrounding lipid bilayer (Vinothkumar and Henderson, 2010). Thus, multi-span-
ning proteins often exploit polar and charged side chains for intramembrane inter-
actions that facilitate TMD packing and protein folding (Harrington and Ben-Tal, 
2009; Lear et al., 2000; Lu et al., 2018; Venkatakrishnan et al., 2013; Zhou et al., 
2000). Similar to soluble proteins, nascent TMDs are most vulnerable to off pathway 
interactions during translation, when the full protein has not been synthesized. How 
semi-hydrophilic TMDs are temporarily stabilized within the membrane until their 
assembly with distal TMDs is not well understood.  
It has been speculated that nascent TMDs might engage hypothetical chaperones 
within the lipid bilayer co-translationally (Shao and Hegde, 2011; Shurtleff et al., 
2018). The physical proximity of a nascent TMD to various resident ER proteins has 
supported this idea (Andrews et al., 1991; Conti et al., 2015; McCormick et al., 2003; 
Meacock et al., 2002; Sadlish et al., 2005; Saksena et al., 2004), but these candidates 
are poorly studied. For example, the protein TRAM is found near signal sequences 
(Görlich et al., 1992b; High et al., 1993b) and some TMDs (Do et al., 1996; Heinrich 
et al., 2000), but no consequences of its depletion have been reported for either TMD 
insertion or membrane protein assembly. EMC has also been proposed to act as a 
chaperone for multi-spanning membrane proteins (Shurtleff et al., 2018), but this 
has been questioned by studies showing EMC is a TMD insertase (Guna et al., 2017) 
that aids in determining the first TMD’s topology (Chitwood et al., 2018). Thus, ER-
resident intramembrane chaperones that act on TMDs after their insertion have not 
been unambiguously identified.  
 
An in vitro system for monitoring multipass membrane protein biogenesis. 
After successful targeting and processing of a membrane targeting element 
(e.g. a TMD or signal peptide) the ribosome is firmly docked on the translocon and 
steric constraints bias newly translated polypeptide towards Sec61. Thus, TMDs are 
most vulnerable before Sec61 engagement and directly after integration. We sought 
to identify novel machineries acting to stabilize intermediates in the latter step, using 
incomplete multipass membrane proteins as a model. A truncated mRNA containing 
the first two TMDs of mammalian rhodopsin (Rho TM1+2) was translated in-vitro 
in the presence of human derived ER rough microsomes [Fig. 3.1A, similar to 
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(Meacock et al., 2002)]. Preliminary experiments established that tagged constructs 
coding for Rho TM1+2 were inserted in the appropriate orientation in hRMs isolated 
from HEK293 cells (3.1B). Insertion of both TMDs was confirmed by protease re-
sistance followed by N-terminal immunoprecipitation and was unaffected by substi-
tution with a single cysteine at position 53 or a variable N-terminal epitope tag (Fig. 
3.1B, D). Accurate orientation could be inferred by both the size of the protected 
fragment and the addition of a glycan to an N-terminal acceptor site (Fig.3.1B). 
Consistent with this interpretation, direct comparison of a truncated RNC and a ter-
minated version containing a stop codon confirmed complete and accurate insertion 
of the first 2 TMDs of rhodopsin using this system (Fig 3.1C, D). 
 
 
 
Figure 3.1 - Characterization of a multipass membrane protein intermediate. (A) Diagram of Rho TM1+2 
constructs used throughout this chapter. Variations on this construct include different N-terminal epitope tags, 
the presence or absence of a glycosylation site near the N-terminus, the presence or absence of a cysteine within 
TMD1, various mutations within TMD1, and the presence and identity of TMD2. All of the constructs were 
tested either by protease protection or glycosylation to verify that no appreciable differences were observed in 
their insertion efficiencies. Note that although the exact amino acid numbering varies depending on the N-ter-
minal tag, the numbering system corresponding to the FLAG-tagged version is used throughout. Thus, the 
146mer refers to a truncation at the 146th codon in the numbering scheme indicated, even in constructs contain-
ing a different tag. (B) Representative example of insertion assays on two different tagged versions of Rho 
TM1+2. The TwinStrep tagged version (Strep) lacking a glycosylation site was compared to an HA tagged 
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version containing a glycosylation site. Identical constructs containing either the wild-type Rho TM1 sequence 
or a point mutant (F53C) were tested in parallel to confirm no insertion defects result from insertion of a cysteine 
in TM1 (used for BMH-mediated crosslinking in later experiments). In this experiment, ribosome nascent chain 
complexes (RNCs) of 181 amino acids were produced by translation in the presence of ER-derived rough mi-
crosomes (RMs) after which the microsomes were isolated and resuspended. Aliquots of the reactions were left 
untreated or digested with proteinase K (PK) and analyzed directly by SDS-PAGE (left panel). Green arrow 
heads represent the fully inserted and PK-protected population and red arrowheads denote the non-inserted and 
proteolytically cleaved products. The cleaved product contains the region of polypeptide protected by the ribo-
somal tunnel and the attached tRNA. Aliquots of the PK-digested sample were treated with EDTA and RNase 
to release the polypeptide from the ribosome and digest tRNA and immunoprecipitated (IP) via the N-terminal 
tag. Only the fully inserted products are recovered by IP (green arrowheads). (C) Diagram representing the 
interpretation of the experiments in panels B and D. The relatively short cytosolic loop between TMD1 and 
TMD2 is not accessible to PK digestion either as an RNC or a terminated product. (D) Comparison of the topol-
ogy of truncated RNCs and terminated Rho TM1+2. In this experiment, the FLAG-tagged Rho TM1+2 contain-
ing a glycosylation site with (term.) or without (trunc.) a stop codon was translated in the presence of RM after 
which the RMs were isolated by centrifugation. Aliquots of the isolated RMs were analyzed directly (-PK), after 
PK digestion (+PK), or after PK digestion in the presence of detergent (+PK/det). Where indicated, the +PK and 
+PK/det samples were released from the attached tRNA and immunoprecipitated via the N-terminal tag. Note 
comparable glycosylation near the N-terminus and complete protection from PK for both the truncated and ter-
minated products. All immunoprecipitations were loaded such that the total represents 10% of the total reaction 
and the IP represents 25% of the total reaction. 
 
Detection and characterization of an intramembrane interacting factor 
With the above tools and assays in hand, we took advantage of staged integration 
intermediates and the cysteine specific crosslinking reagent, bismaleimidohexane 
(BMH), to monitor the molecular environment of TM1 during different stages of 
insertion (Fig 3.2). Stalled translation complexes containing different lengths of nas-
cent polypeptide were crosslinked to adjacent proteins via a single cysteine intro-
duced into TMD1 (Fig. 3.2 upper cartoon). Consistent with previous reports 
(Keenan et al., 2001; Rapoport, 2007), early intermediates (lanes 1-3) crosslinked to 
well-characterized ribosomal and ribosome-associated proteins including the SRP54 
subunit of the targeting factor SRP (Keenan et al., 2001) and the Sec61a subunit of 
the translocation channel (Rapoport, 2007). Thus, this assay provided a faithful 
readout for the position of a TMD and the relative timing of engagement of several 
established interacting partners during insertion. Intermediates where TMD2 was 
emerging from the ribosome (lanes 4-6) showed diminished TMD1-Sec61a cross-
links and the appearance of crosslinks to a ~10 kD protein which we presume is 
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identical to a previously observed crosslinking partner dubbed PAT10 for “protein 
associated with the ER translocon of 10 kD” (Meacock et al., 2002). At all subse-
quent lengths, the PAT10 crosslink persisted at approximately the same efficiency 
while the Sec61a crosslink remained low. 
 
Figure 3.2- A protein engages nascent membrane proteins. Cysteine-based crosslinking of 35S-labeled ribo-
some nascent chain complexes (RNCs) representing intermediates during targeting and insertion of a rhodopsin-
based construct (see upper diagram) encoding the first two transmembrane domains (see Fig. 3.1A). Nascent 
chains ending at the indicated amino acid were produced by in vitro translation containing ER-derived rough 
microsomes (RMs) from HEK293 cells, treated with bismaleimidohexane (BMH; a cysteine-reactive cross-
linker), and subject to denaturing immunoprecipitation (IP). The upper gel shows the translation products and 
all of their crosslinks as visualized by autoradiography of IPs via the nascent chain’s N-terminal FLAG tag. 
Indicated on the right are the non-glycosylated (-glyc.) and glycosylated (+glyc) translation products and the 
crosslinks to PAT10, Sec61α, and SRP54 (verifed by IPs; lower gels). All of the RNCs contain attached tRNA 
which is removed by RNAse digestion prior to analysis on SDS-PAGE (see Fig. 3.1). All immunoprecipitations 
were loaded such that the total represents 10% of the total reaction and the IP represents 25% of the total reaction. 
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Importantly, the observed crosslinking adducts were highly specific to the addi-
tion of BMH and observed with the tRNA associated species, consistent with co-
translational association (Fig. 3.3). These experiments also allow for the independ-
ent analysis of ΤΜD insertion via the N-terminal glycosylation site, early interme-
diates show relatively little glycosylation (pre-insertion) while later intermediates 
demonstrate an increase in insertion efficiency as determined by the ratio of glyco-
sylated to unglycosylated products (Fig. 3.3). One technical point is worth highlight-
ing; the observed decrease in intensity for the PAT10 adduct at longer nascent chain 
lengths does not reflect a decrease in PAT10 association, but instead reflects de-
creased translation efficiency (i.e. total product, see left panel). A key metric is the 
ratio of intensity between the inserted product (glyc.) and the PAT10 crosslinked 
product, which objectively remains relatively constant throughout extension of the 
nascent chain (Fig. 3.2 and 3.3). 
 
 
 
Figure 3.3 - Characterization of insertion and crosslinking to Rho TM1+2 RNCs. 35S-labeled FLAG Rho 
TM1+2 ribosome nascent chains (RNCs) of varying lengths (as described in Figure 3.2) were generated by in-
vitro translation in the presence of RMs. Membranes were isolated by centrifugation through a sucrose cushion 
and resuspended in physiological salt buffer (PSB). An equivalent amount of each translation reaction was taken 
before (-BMH) and after (+BMH) the addition of BMH for analysis by SDS-PAGE. The tRNA-linked nascent 
chains and free nascent chains are indicated. The free nascent chains arise from partial hydrolysis of the tRNA 
during electrophoresis under moderately basic conditions. Glycosylation is first observed at the 96mer length, 
which is 38 amino acids downstream of the end of TMD1. This matches the length of the ribosome tunnel, and 
indicates that membrane insertion and glycosylation occurs only after the full TMD is exposed outside the ribo-
some. Crosslinks to Sec61α are most prominent for the 106mer. Crosslinks to PAT10 are most prominent from 
the 126mer onwards, after the Sec61α crosslinks diminish. Note that all of the crosslinked adducts are seen to 
the tRNA-attached nascent chain, verifying that they are co-translational. The Sec61α crosslink and others are 
not as visible when total translation products are analyzed, which is why we typically immunoprecipitate the 
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sample via the nascent chain (e.g., in Fig. 3.2). Furthermore, we usually digest the samples with RNAse after 
the experiment but before SDS-PAGE to remove the tRNA, thereby avoiding the heterogeneity. 
 
Modification of the sequence downstream of TMD1 allowed us to manipulate the 
relative timing of TMD1 migration into the lipid bilayer and correspondingly mon-
itor PAT10 engagement (Fig. 3.4A). Initial direct comparisons of Rho TM1+2 var-
iants, at a single nascent chain length, displayed no significant differences in trans-
lation or insertion efficiency (Fig. 3.4B). Replacement of TMD2 with an efficiently 
inserted TMD from asialoglycoprotein receptor (ASGR) displaced TMD1 from 
Sec61a more efficiently than native TMD2 (Fig. 3.4C). By contrast, replacement of 
TMD2 with a flexible soluble segment of polypeptide delayed TMD1 movement 
away from the Sec61 complex (Fig. 3.4D). In each case however, the appearance of 
PAT10 crosslinks coincided with the diminishment of Sec61a crosslinks. Thus, 
PAT10 engages TMD1 upon its departure from the Sec61 complex, placing its func-
tional role at step downstream of TMD insertion. This result is consistent with pre-
vious observations in Figures 3.2-3.3 demonstrating a persistent PAT10 crosslink. 
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Figure 3.4 - PAT10 engagement occurs after the TMD departs from Sec61α. (A) Diagram of the three 
matched constructs used to assess timing of PAT10 engagement via BMH crosslinking to the single cysteine 
located in Rho TMD1. A parent Rho TM1+2 construct (Figure 3.2) was modified by replacement of TMD2 with 
either the TMD of asialglycoprotein receptor (ASGR1) or a soluble domain. (B) Radiolabeled 146mer RNCs 
encoding the 3 different construct variants shown in panel A were generated by in-vitro translation in the pres-
ence of RMs and analyzed by SDS-PAGE to visualize total translation products. No appreciable difference in 
insertion efficiency was observed between constructs as monitored by glycosylation efficiency. SDS-PAGE 
causes a small amount of hydrolysis of the tRNA-peptidyl bond and both the tRNA associated (+tRNA) and the 
non-tRNA associated (-tRNA) products can be observed. (C, D) Analysis of Rho TM1-ASGR1 and Rho TM1-
soluble exactly as in Fig. 3.2. Notice the abrupt decrease in crosslinking efficiency of TMD1 to Sec61α observed 
in panel C. This suggests that the hydrophobic TMD of ASGR1 displaces TMD1 from Sec61α. By contrast, 
TMD1 crosslinking to Sec61α is observed over a much wider range of lengths when it is not followed by another 
TMD, suggesting that it remains near the Sec61 complex. In both cases however, the appearance of crosslinks 
to PAT10 correlate with the decrease in Sec61α crosslinks. Thus, PAT10 engagement occurs coincident with 
TMD1 moving away from Sec61α. 
 
Substrate crosslinking to PAT10 did not depend on glycosylation (Fig. 3.5A), and 
crosslinks were also observed from other cysteine positions within TMD1 (Fig. 
3.5B-C), consistent with earlier observations (Meacock et al., 2002). Additionally, 
a very weak crosslink to the β subunit of Sec61 was observed only after substantial 
enrichment via immunoprecipitation using a Sec61β specific antibody (Fig. 3.5A). 
A noteworthy point is the presence of a single cysteine in the unstructured cytosolic 
domain of Sec61β, consistent with crosslinks to the non-inserted (unglycosylated) 
Rho TM1+2 and the substantially reduced crosslinking efficiency in comparison to 
factors that directly engage a TMD (e.g. SRP54, Sec61α). Conversely, PAT10 cross-
linking to inserted (i.e., glycosylated) TMD1 was over extremely efficient (Fig. 3.2 
and Fig. 3.5A) indicating that a high proportion of inserted nascent chains sample 
this factor. PAT10 appears to be both conserved and widely expressed, as the inter-
action is preserved in a system using ER rough microsomes derived from canine 
pancreas (Fig. 3.5C). In combination with the high degree of substrate engagement 
after insertion, this argues for a general factor that engages TMDs in the membrane. 
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Figure 3.5 - PAT10 engages inserted TMDs independent of glycosylation. (A) Radiolabeled 146mer RNCs 
of FLAG-tagged Rho TM1+2 were produced by in vitro translation in the presence of RMs, then treated with 
BMH. The construct either contained or did not contain a cysteine at position 53 (Cys53) and/or a glycosylation 
site near the N-terminus (Glyc). The crosslinking reactions were digested with RNAse and either analyzed di-
rectly (left panel), or the indicated reaction was subjected to immunoprecipitation (IP) via the FLAG tag or 
Sec61β under denaturing conditions. The IP samples were either left untreated or digested with PNGase F to 
remove the N-linked glycans. Equivalent amounts were loaded in each lane. Note that Sec61β is not an appre-
ciable crosslinking partner of these RNCs, and to the extent a crosslink is observed, it migrates slightly faster 
than the PAT10 crosslink. (B) The indicated Rho TM1+2 variants were translated in vitro in the presence of 
RMs and treated with BMH as indicated. In this experiment, the crosslinking was done directly on total transla-
tion reactions, not after isolation of the microsome fraction. Instead, translation reactions were diluted 5-fold 
with buffer to dilute the reduced glutathione and reduce quenching of BMH. An aliquot of each reaction was 
analyzed directly by SDS-PAGE. Cross-linking efficiency is reduced compared to other experiments because 
membranes were not isolated by centrifugation through a sucrose cushion to remove reduced glutathione from 
translation extract. One aliquot of the BMH-treated translation reactions was treated with RNase A and EDTA, 
denatured, and IPed via the N-terminal FLAG tag (IP). (C) As in panel B except Rho TM1+2 variants were 
generated in the presence of RMs derived from either canine pancreas (cRM) or HEK293 cells (hRM). In this 
experiment, the microsomes were isolated by centrifugation through a sucrose cushion prior to BMH crosslink-
ing (note higher crosslinking efficiency). While the PAT10 crosslink is seen in both cRM and hRM, cross-
linking efficiency of the inserted (glycosylated) product is significantly lower in cRMs, which is one reason we 
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used HEK293-derived RMs for most of the experiments. All immunoprecipitations were loaded such that the 
total represents 10% of the total reaction and the IP represents 25% of the total reaction. 
 
The extremely efficient interaction observed between PAT10 and a nascent 
TMD (as judged by crosslinking efficiency) argued strongly for a coordinated inter-
action with newly translated membrane proteins at the translocon. We reasoned di-
rected action and engagement of TMDs was unlikely to be coordinated by a single 
~10kDa membrane protein. In support of this, the natively solubilized ribosome-
released TMD1-PAT10 complex migrated at an apparent molecular weight of >100 
kD by sucrose gradient sedimentation (Fig. 3.6). This is far larger than would be 
expected if the interaction were between a PAT10 molecule in isolation (~10kDa) 
and a nascent chain (~14kDa). PAT10 is therefore part of a larger assembly (the 
PAT complex) which is adjacent to a TMD as it releases from the Sec61 translocon. 
Because efficient maleimide-mediated crosslinking requires an aqueous environ-
ment (Lee and Samuels, 1964), the PAT complex seems to provide a membrane-
embedded partially hydrophilic environment where TMD1 binds.  
 
 
Figure 3.6 – PAT10 is part of a larger molecular weight complex (the PAT complex). Sucrose gradient 
separation of the 35S-labeled membrane-targeted 146mer RNC after BMH crosslinking, native solubilization, 
and release from the ribosome by RNAse digestion. The migration of endogenous hemoglobin (~60 kD) from 
the translation extract was visualized by Coomassie staining of the gel. 
 
The PAT complex is composed of CCDC47 and Asterix 
To identify components of the PAT complex, we solubilized the crosslinking reac-
tions under non-denaturing conditions, released the nascent chain from the 
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ribosome, affinity purified via the FLAG tag on the nascent chain, and identified the 
co-purifying proteins by quantitative mass spectrometry (Fig. 3.7). Six proteins were 
enriched more than 2-fold relative to a control substrate containing a Strep tag: 
Sec61a and Sec61b, the lectins Calnexin and Galectin-7, signal peptide peptidase 
(SPP), and CCDC47. Of note, none of these proteins was a ~10 kD candidate for 
PAT10.  
 
Figure 3.7 – Identification of potential PAT complex members. BMH-crosslinked 146mer RNCs containing 
a FLAG or Strep tag were released from the ribosome by RNAse digestion, subjected to native FLAG IPs, and 
analyzed by quantitative mass spectrometry. Proteins enriched 2-fold or more in the FLAG-tagged RNCs are 
indicated. Note, the value plotted on the y-axis is the enrichment of peptides recovered in the experimental 
(FLAG) vs control (Strep tag) and therefore does not reflect abundance of products but rather their signal relative 
to background recovery of proteins during the IPs. 
 
Sec61a and Sec61b presumably were recovered due to their direct crosslinking 
to the nascent chain (Fig. 3.2 and Fig. 3.5B). Preliminary analysis of the complex 
bound to Rho TM1+2, with the glycosylation acceptor site removed, demonstrated 
a substantial decrease in molecular weight by sucrose gradient fractionation (Fig. 
3.8A). Consistent with this observation, native solubilization of crosslinked sub-
strate followed by immunoprecipitation demonstrated a glycan-dependent associa-
tion with Calnexin (Fig. 3.8B). Therefore, lumenal acting chaperones (e.g. lectins) 
can simultaneously engage substrate with PAT-10, but these interactions are uncou-
pled. Similarly, SPP demonstrated direct crosslinks to Rho TM1+2 (Fig. 3.8C), as 
previously reported (Crawshaw et al., 2004; Schrul et al., 2010). However, these 
were comparatively weak and not observed unless enriched using immunoprecipi-
tations against SPP (Fig. 3.8C). Furthermore, under native IP conditions SPP did not 
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enrich for the PAT10 associated complex. Rather a subtle but significant enrichment 
for the non-inserted product was observed (see unglycosylated substrate in SPP IP). 
  
 
Figure 3.8 – Characterization of non-PAT complex TMD interactors. (A) 146mer RNCs containing a FLAG 
tag were generated by in vitro translation in the presence of RMs. Membranes were isolated by centrifugation 
through a sucrose cushion, subjected to BMH crosslinking, released from ribosomes and treated with RNase A 
followed by native solubilization and fractionation on a 5-25% sucrose gradient before analysis by SDS-PAGE 
and autoradiography. Red asterisks denote peak fractions containing the PAT complex as detected by the PAT10 
crosslinking product. The PAT complex crosslinked to unglycosylated Rho TM1+2 migrates slightly smaller on 
the gradient than glycosylated Rho TM1+2, likely the result of CNX (~90 kD) no longer associated with the 
nascent chain. (B) Radiolabeled 146mer RNCs of FLAG tagged Rho TM1+2 containing (-) or lacking a glyco-
sylation site (+) were generated by in vitro translation with RM, crosslinked with BMH, then immunoprecipi-
tated under native conditions via the N-terminal FLAG tag on the substrate (Nterm) or with an antibody recog-
nizing the C-terminus of calnexin (CNX). Only the glycosylated substrate is recovered with CNX, consistent 
with its binding via the glycan. (C) Aliquots of samples in panel A containing or lacking a glycosylation site 
were generated then analyzed by SDS-PAGE. One aliquot of the BMH treated reactions were solubilized under 
native conditions and IPed with either an antibody raised against an HA epitope tag (Cntrl) for a specificity 
control, or an antibody against signal peptide peptidase (SPP). As previously reported, direct crosslinks to SPP 
are observed as two distinct adducts seen on very long exposures, but native IPs do not enrich for a PAT10 
engaged substrate. All immunoprecipitations were loaded such that the total represents 10% of the total reaction 
and the IP represents 25% of the total reaction. 
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For the remainder of our efforts, we focused on CCDC47 because unlike the oth-
ers, the PAT10 crosslink was strongly enriched in native IPs using anti-CCDC47 
antibodies (Fig. 3.9A). Direct crosslinks to CCDC47 were never observed, however 
inspection of the CCDC47 native TMD sequence indicated no cysteines so a direct 
interaction with substrate cannot be ruled out. Even in the absence of crosslinking, 
CCDC47 selectively enriched the inserted population of nascent chains (Fig. 3.9B). 
This is in contrast to SPP which fails to pull out the PAT10 crosslinked substrate, or 
any substrate in the absence of BMH, when the two are directly compared by native 
immunoprecipitation (Fig. 3.9A-B). Direct crosslinks to SPP are only visible after 
long exposure times and using large scale reactions that are then IPed with SPP (Fig. 
3.8C). This interaction was specific because recovery of the nascent chain was com-
pletely lost when microsomes prepared from CCDC47 knockout cells were used 
(Fig. 3.9A), or when the sample was denatured prior to immunoprecipitation. 
 
 
 
Figure. 3.9 – CCDC47 is the primary interacting partner of the TMD-PAT10 complex. (A) 146mer RNCs 
targeted to RMs prepared from WT or ∆CCDC47 (∆) cells were treated with BMH, released from the ribosome 
with RNAse, and IPed under denaturing (denat.) or native conditions with the antibodies indicated. (B) 146mer 
RNCs containing or lacking either a glycosylation site (Glyc.) or cysteine at position 53 (Cys53) were cross-
linked with BMH and analyzed directly (input) or after native IP using antibodies against CCDC47 or signal 
peptide peptidase (SPP). Nascent chains were released from the ribosome with RNAse A before IP. All im-
munoprecipitations were loaded such that the input represents 10% of the total reaction and the IP represents 
25% of the total reaction. 
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Importantly, CRISPR mediated knockout of CCDC47 completely abrogated protein 
expression in HEK cells (Fig. 3.10A). Strikingly, TMD1 crosslinking to PAT10 was 
strongly reduced in microsomes lacking CCDC47 (Fig. 3.10B). Together with the 
data demonstrating direct interaction with a PAT10 engaged substrate (Fig. 3.9), this 
firmly establishes CCDC47 as a previously unknown interactor of nascent mem-
brane proteins and a stable subunit of the PAT complex.  
 
Figure 3.10 – Substrate crosslinking to PAT10 is dependent on CCDC47. (A) Western blot of RMs prepared 
from wild type (WT) or CCDC47 knock-out (∆CCDC47) HEK293 cells comparing CCDC47 levels relative to 
Sec63, another ER resident protein. (B) The insertion and BMH mediated cross-linking for 146mer RNCs of the 
parent Rho TM1+2 construct or versions lacking a cysteine (NoCys) or lacking a glycosylation site (Cys53No 
Glyc.). The radiolabeled RNCs were produced by in vitro translation in the presence of RMs isolated from wild 
type (WT) or two different CCDC47 KO cell lines (∆1 and ∆2) generated from two different guide RNAs. 
Aliquots of the reaction before (-BMH) and after (+BMH) addition BMH were analyzed by SDS-PAGE. No 
appreciable difference in insertion efficiency was observed in KO microsomes for Rho TM1+2 as monitored by 
glycosylation efficiency. Red arrowheads indicate the PAT10 crosslink which is lost upon CCDC47 KO. The 
faint crosslinked adduct observed in the KO samples (black asterisks) migrates slightly faster on the gel and 
likely represents weak Rho TM1+2 crosslinks to Sec61β (see Extended Data Fig. 4). 
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A stable association between CCDC47 and PAT10 provided a new molecular 
handle to isolate and identify PAT10 from natively solubilized hRMs. Affinity col-
umns made with two different anti-CCDC47 antibodies each recovered CCDC47 
and a prominent ~10 kD protein (Fig. 3.11A). While mass spectrometry of tryptic 
digests failed to identify this protein (explaining why it was not identified in the 
initial mass spectrometry experiment above), digestion with other proteases pro-
duced peptides that matched Asterix (also called WDR83OS). No other stoichio-
metric and specific interaction partners were observed in the purifications or identi-
fied by mass spectrometry. Additionally, Asterix contained putative transmembrane 
domains, was 12kDa in size, and contains cysteines within its predicted TMDs (See 
Fig. 3.12). Further analysis by direct immunoprecipitation of Asterix (Fig. 3.11B), 
and its immunodepletion during CCDC47 pull-downs (Fig. 3.11C), confirmed As-
terix directly interacts with newly inserted Rho TM1+2 and forms a stable complex 
with CCDC47.  
 
Figure 3.11 – Asterix and CCDC47 form the PAT complex. (A) Affinity purification of CCDC47 from na-
tively solubilized RMs using two unrelated CCDC47 antibodies (#1 and #2). The elution samples represent 
~200-fold more than the input and flow-through (FT) samples. (B)  35S-radiolabeled 146mer RNCs of Rho 
TM1+2 containing or lacking Cys53 or a glycosylation site were targeted to RMs, treated with BMH, digested 
with RNAse, and analyzed directly (input) or after denaturing IP with anti-Asterix antibodies. (C) Affinity pu-
rification via CCDC47 as in panel A, but with a negative control using anti-HA antibodies. Asterix and CCDC47 
were detected by immunoblot. The elution samples represent 4-fold more than the input and FT samples. Unless 
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otherwise indicated in the figure panel, all immunoprecipitations were loaded such that the total represents 10% 
of the total reaction and the IP represents 25% of the total reaction. 
 
The PAT complex  
CCDC47 and Asterix are poorly studied but are widely conserved across all eu-
karyotes (Figure 3.12A-B) and are widely expressed in all tissues. Furthermore, loss 
of CCDC47 in mice is embryonic lethal with a wide range of developmental prob-
lems (Yamamoto et al., 2014) and mutations in humans causes numerous develop-
mental phenotypes with early death (Morimoto et al., 2018). Cells lacking either 
subunit of the PAT complex show reduced fitness across multiple mammalian cell 
lines (Wang et al., 2015) but are viable, show activated ER stress responses, and 
have several otherwise unrelated membrane-associated phenotypes (Yamamoto et 
al., 2014). While observations on the consequences of Asterix depletion at the level 
of an organism are absent, CCDC47 and Asterix form an obligate complex because 
knockout of either protein results in substantial loss of the other (Fig. 3.12C), alt-
hough the exact stoichiometry remains to be determined. Consistent with a role in 
protein homeostasis, genetic knockout of the PAT-complex results in elevated levels 
of the ER chaperones BiP and PDI (Fig. 3.12C), however it does not appreciably 
affect the expression levels of any previously established biogenesis proteins (Fig. 
3.12C). At the expression level, the PAT complex is distinct from EMC as both are 
unaffected by loss of the other, although both seem to induce an unfolded protein 
response as judged by similar increases in BiP and PDI.  
Further analysis of the PAT complex predicts CCDC47 to be an ER-resident sin-
gle-pass membrane protein with a well-conserved cytosolic domain (Fig. 3.12). To-
pology analysis of Asterix by in vitro translation and protease protection assays sug-
gest that it is a three-TMD membrane protein whose N-terminus faces the cytosol 
and C-terminus faces the ER lumen (Fig. 3.13A-B). Reintroduction of Asterix vari-
ants in ∆Asterix HEK cells and PEG-Maleimide labelling of single cysteines, placed 
as topological identifiers, support a 3-TMD Ncyt topology (Fig. 3.13C-D). Of note, 
the three putative TMDs are only ~15 amino acids each, populated by numerous 
moderately hydrophilic amino acids, and contain multiple cysteines that explain its 
efficient crosslinking to nascent TMDs via BMH (Fig. 3.12B). These features, when 
Chapter III: An intramembrane chaperone facilitates multipass membrane protein 
biogenesis 
 
74  
considered in the context of the phenotypic consequences of PAT complex depletion 
described in other studies, and PAT complex engagement of a TMD released from 
the translocon, strongly argue for a role in membrane protein biogenesis. 
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Figure 3.12 – PAT10 and Asterix are widely conserved and associated with protein homeostasis. (A) Con-
servation score plotted for each amino acid of human CCDC47. Annotated sequences for CCDC47 homologs 
were downloaded from the OMA orthology database and aligned using the Clustal W alignment plugin in 
Jalview. The conservation scores were assigned based on physio-chemical properties of amino acids, with iden-
tities scoring highest. (B) Alignment of Asterix homologs for five divergent species with a bar chart representing 
conservation scores of each amino acid. TMDs were based on the annotation in Uniprot, except that the very 
long single TMD from amino acids 44 to 78 was deduced to represent two closely spaced TMDs (see Fig 3.13). 
Note the high abundance of hydrophilic amino acids within the TMD regions and also the presence of multiple 
cysteines, explaining the robust crosslinking efficiency observed with BMH. (C) ER rough microsomes were 
isolated from WT, ∆CCDC47 and ∆EMC6 HEK293 cells and normalized to an absorbance of 75 at 280nm. 
Serial dilutions of each sample were analyzed by SDS-PAGE and immunoblotting for the indicated antigens. 
Note that BiP levels are elevated in both knockout cell lines consistent with an activated UPR caused by altered 
ER homeostasis. 
 
 
  
Figure 3.13 – The topology of Asterix. (A) Schematic of the relative size of Asterix and its topologically 
defined domains. (B) Two matched human Asterix constructs containing either an N- or C-terminal FLAG tag 
were generated by in vitro translation in the presence of RMs. One aliquot of the reaction was set aside for 
analysis by SDS-PAGE of total translation products (IVT). The remainder of the reaction was treated with pro-
teinase K (+PK) without or with detergent (det). These protease-digested samples were either analyzed directly 
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or after immunoprecipitation (IP) via the FLAG tag. Red arrowheads indicate fragments protected from PK in 
the absence, but not presence of detergent. The PK-protected fragment from the C-terminally tagged Asterix 
was recovered by IP, suggesting that the C-terminus is located within the ER lumen and the N-terminus is located 
in the cytosol. The relative size difference between the N-and C-terminally tagged constructs observed after PK 
digestion can be attributed to digestion or protection of the FLAG tag. Below the gel is a cartoon depiction of 
one possible topology based on the results and the protease protected fragments that remain after digestion with 
PK. The other possible topology is a single-spanning orientation with HD2 and HD3 in the lumen. (C) Schematic 
of human Asterix with a C-terminal FLAG tag in its predicted 3-TMD topology based on the protease digestion 
results in panel B. To test this prediction, a cysteine-free version of Asterix (No Cys) was modified with single 
cysteines at the position indicated by the red-asterisks. If the topology prediction is correct, only the N-terminal 
domain (NTD) cysteine and the Loop 2 cysteine should be accessible to sulfhydryl modifying reagents added to 
the cytosolic side of them membrane. If the protein only spans the membrane once with the N-terminus facing 
the cytosol, then the Loop 2 cysteine should not be modified. As shown in Fig. 3.12B, wild type Asterix naturally 
has four cysteines, only one of which should be exposed to the cytosol because it is in the NTD. (D) Asterix KO 
HEK-293 cells were transiently transfected with the indicated Asterix-FLAG constructs, semi-permeabilized in 
0.01% digitonin, washed to remove digitonin, and treated with PEG-Maleimide (average molecular weight 5 
kDa) in order to modify any cytosolically exposed cysteine residues. WT Asterix contains 4 native cysteine 
residues, one in the N-terminus preceding TMD1 and 3 others within the putative TMD regions. Modification 
was only observed for the NTD cysteine and the cysteine in Loop 2, supporting a 3-TMD topology as depicted 
in panel B and C. The single cysteine present in the cytosolic domain of Sec61β was used as a positive control 
demonstrating equal modification efficiency in all samples, and the No Cys construct verifies sulfhydryl-de-
pendent modification. Protection of the cysteines in TMD1 and TMD2 from modification verifies that membrane 
integrity was maintained in the experiment. All immunoprecipitations were loaded such that the total represents 
10% of the total reaction and the IP represents 25% of the total reaction. 
 
Asterix is the substrate binding unit of the PAT complex. 
Direct interactions between Rho TM1+2 and Asterix through BMH cross-
linking firmly establish Asterix as having substrate binding capacity. The contribu-
tion of CCDC47 to this interaction remains unclear due to the absence of cysteines 
in its TMD. However, the absence of any highly conserved residues within the entire 
N-terminus of CCDC47, including the bulk of the TMD region (Fig 3.12), argues 
strongly against any direct role in substrate engagement within the membrane. To 
better define the native PAT complex-substrate interactions, we probed direct inter-
actions of the β1AR TMD1 using site-specific incorporation of the photoactivatable 
non-natural amino acid, benzoyl-phenylalanine (Bpa) (Fig. 3.14A) (Lin et al., 2019). 
Initial characterization of UV-activated crosslinking confirmed complete translation 
and Bpa incorporation of an amber suppressed prolactin RNC (Fig. 3.14B). Addi-
tionally, UV dependent crosslinking to previously characterized signal peptide 
Chapter III: An intramembrane chaperone facilitates multipass membrane protein 
biogenesis 
 
77  
interacting partners at this nascent chain length were observed. Immunoprecipita-
tions confirmed crosslinks to SRP54, TRAM, TRAPα, and Sec61α. This provides a 
highly specific system for further characterization of TMD-PAT complex interac-
tions.  
 
 
 
Figure 3.14 – A system to site-specifically probe PAT complex interactions. (A) Schematic of the strategy 
for site-specific incorporation of the photo-crosslinking amino acid Benzoyl-phenylalanine (Bpa) during in vitro 
translation (IVT). Bpa, a synthetic amber-suppressor tRNA, and recombinant Bpa tRNA synthetase are added 
to an IVT reaction. The nascent protein that is produced incorporates Bpa at an amber codon. UV irradiation 
results in Bpa activation and crosslinking to adjacent proteins. (B) The photo-crosslinking strategy was tested 
using a well-validated translocation intermediate: the 86mer of the secretory protein prolactin. The amber codon 
was installed at position 9, within the hydrophobic core of the signal sequence. At this length, the majority of 
the nascent chain is precursor (pre), with a small amount that is signal-cleaved (s.c.). The primary crosslinks to 
SRP54 and components of the translocation site (Sec61α, TRAM, and TRAPα) were verified by immunopre-
cipitation. All immunoprecipitations were loaded such that the total represents 10% of the total reaction and the 
IP represents 20% of the total reaction. 
 
We initially monitored the interactions of β1AR TMD1 with Bpa incorpo-
rated at a single position (aa-52), near the middle of the TMD (Fig. 3.15A). RNCs 
were generated by in vitro translation at a length in which the TMD is 75aa from the 
PTC. This allows the TMD to effectively insert and migrate into the lipid bilayer, 
away from the Sec61 translocon, explaining why no crosslinks to Sec61α were ob-
served. Additionally, several prominent UV specific crosslinks were accounted for 
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with subsequent immunoprecipitations under denaturing conditions. Unsurprising, 
these were identified as SRP54 and another well-established TMD chaperone, Ubiq-
uilin 2 (UBqln2) (Itakura et al., 2016). Notably, the intensity of these crosslinks di-
minished significantly when insertion efficiency increased, indicated by an increase 
in the glycosylated product (Fig. 3.15B, middle panel). The only other prominent 
interaction with TMD1 was verified to be Asterix and no appreciable interaction 
between the nascent TMD and CCDC47 was observed. Subsequent experiments in-
corporating Bpa at 11 different positions along the TMD confirmed no TMD-
CCDC47 crosslinks (Fig. 3.15B) Additionally, these experiments permitted us to 
define the boundaries of the Asterix engagement (Fig. 3.15B-C). Consistent with the 
relatively short predicted Asterix TMDs (Fig. 3.15), Bpa positioned towards the 
edges or outside the TMD region did not form crosslinks with Asterix (Fig. 3.15B-
C). Conversely, positions within the middle of the TMD readily formed crosslinks. 
Importantly, 4 sequential positions provided a complete 360-degree accounting of 
the TMD interactions with Asterix (Fig. 3.15C). Thus, consistent with the chemical 
crosslinking experiments, Asterix is the substrate-interacting subunit of the PAT 
complex, while CCDC47 is needed for Asterix stability 
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Figure 3.15 – Asterix is the substrate binding subunit of the PAT complex. (A) Site-specific photo-cross-
linking of a 141mer RNC containing the UV-activated photo-crosslinking amino acid benzoyl-phenylalanine 
(Bpa) at position 52 within TMD1. Total translation products recovered by IP via an HA tag on the nascent 
chain are shown adjacent to parallel IPs using the indicated antibodies. RNCs that failed to engage SRP crosslink 
to UBQLN2, a quality control factor that binds exposed TMDs. A subset of RNCs fail to release from SRP and 
crosslink to SRP54. Of the membrane-inserted RNCs, the main crosslink is to Asterix. At this length, the TMD 
has moved away from Sec61α, so crosslinks to this factor are minimal. No crosslinking to CCDC47 were ever 
observed. (B) Site-specific photo-crosslinking of a 141mer RNC containing the UV-activated photo-crosslink-
ing amino acid benzoyl-phenylalanine (Bpa) at the indicated amber positions (Amb). The diagram above the 
autoradiographs shows a schematic of the construct with the appropriate amino acid numbering. Amino acids in 
red show the strongest crosslinks to Asterix, pink show reduced crosslinks, and grey no detectable crosslinks. 
Total translation products recovered by IP via an HA tag on the nascent chain are shown adjacent to parallel IPs 
of selected samples using the indicated antibodies. Although not all IPs are shown, each position was tested for 
crosslinking to Asterix and CCDC47. RNCs that failed to engage SRP crosslink to UBQLN2, a quality control 
factor that binds exposed TMDs. Note that this crosslink diminishes markedly when increased RMs are used in 
the reaction (lanes 9-16, compared to lanes 5-8), presumably because the RMs contribute SRP, which is other-
wise limiting in the reaction. A subset of RNCs fail to release from SRP and crosslink to SRP54. The crosslink 
indicated by the hashtag (#) is likely to be a mixture of similarly migrating crosslinks. The middle panel (lanes 
9-16) represents a sseparate experiement in which 2x the amount of microsomes were added to the reaction 
mixture. As a result the insertion efficiency is higher in this experiment as can be observed by the qualitative 
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ration between the glyc. and unglyc. species. Because this crosslink diminishes substantially with increased RMs 
( see lanes 9-16) similar to the UBQLN2 crosslink), it is likely to be SGTA, another TMD-binding factor in the 
cytosol of this size. A small proportion of this crosslink could be the similarly sized Sec61a or TRAM. Of the 
membrane-inserted RNCs, the main crosslink is to Asterix, seen prominently for residues 52 to 63. At this length, 
the TMD has moved away from Sec61a, so crosslinks to this factor are minimal. No crosslinking to CCDC47 
were ever observed. Note that by testing five sequential positions in the center of the TMD, all sides of the helix 
have been sampled.  (C) Summary of Asterix crosslinks observed (or not) from different positions in or near 
TMD1 of β1AR. No CCDC47 crosslinks were seen from any of these positions. All immunoprecipitations were 
loaded such that the total represents 10% of the total reaction and the IP represents 15% of the total reaction. 
 
The PAT complex facilitates multipass membrane protein biogenesis 
Using the dual-color ratiometric assay for protein stability (see Fig. 2.1), we found 
that CRISPR-mediated disruption of CCDC47 or Asterix in HEK293 cells led to 
reduced levels of the GPCR angiotensin Type-II receptor 2 (AGTR2) relative to an 
internal control for translation levels (Fig. 3.16). Neither the tail-anchored mem-
brane protein squalene synthase (SQS) nor the type II single-pass membrane protein 
asialyloglycoprotein receptor (ASGR) were affected in the knockout cells using the 
same assay. These controls indicate that the TMD insertase EMC (used by SQS 
(Guna et al., 2017) and the first TMD of many GPCRs (see chapter II))and the Sec61 
complex (used by ASGR (Görlich and Rapoport, 1993)) are functioning correctly in 
cells lacking the PAT complex. This is consistent with immunoblotting revealing no 
substantial alterations in the expression of these and other biogenesis factors includ-
ing the oligosaccharyl transferase, CNX, and Sec63 (Fig. 3.12C). 
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Figure 3.16 - The PAT complex is required for multipass membrane protein biogenesis. The diagrams 
depict dual-color fluorescent reporters for protein stability as an indirect measure of successful biogenesis. The 
membrane protein of interest is tagged with one fluorescent protein (FP), which is separated from a second FP 
by the viral 2A peptide sequence. When the 2A sequence is translated, peptide bond formation is skipped without 
perturbing elongation by the ribosome. Thus, translation results in two separate proteins made in a 1:1 stoichi-
ometry that are separated at the 2A sequence. If biogenesis of the membrane protein is impaired, it will be 
degraded along with its tagged FP, resulting in an altered ratio of the two FPs. Thus, treatment conditions that 
impair biogenesis of the membrane protein will be reflected as a relative change in the ratio of FPs. The three 
reporters encoding angiotensin type-II recepor 2 (AGTR2), squalene synthase (SQS) and Asialglycoprotein re-
ceptor (ASGR) were transiently transfected into wild-type (WT), CCDC47 KO (∆CCDC47) or Asterix KO 
(∆Asterix) HEK293 cells and analyzed by dual-color flow cytometry. Histograms represent the distribution of 
FP ratio in WT (black), ∆CCDC47 (red) and ∆Asterix (blue) cells. A biogenesis defect is only seen for the 
multipass membrane protein AGTR2, but not for the tail-anchored protein SQS or the signal-anchored single 
pass protein ASGR. 
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Because these knockout cell lines were unstable and seemed to adapt over time, 
we used acute PAT complex depletion to analyze a broader range of membrane pro-
tein reporters stably expressed from a single, doxycy-
cline inducible promoter. This strategy allowed us to 
acutely challenge PAT complex depleted cells with 
newly synthesized multipass membrane proteins. As-
terix depletion, which co-depletes CCDC47 (Fig. 3.17), 
had minimal effects on SQS but showed reduced bio-
genesis of AGTR2 (as seen with knockout cells) and 
rhodopsin (Fig. 3.18A), which was used to characterize 
the PAT complex interaction. We further evaluated the 
broad necessity of the PAT complex using a sample population of membrane pro-
teins with varying topologies, biophysical characteristics and number of TMDs. 
Three other GPCRs demonstrated an increase in post-translational degradation upon 
depletion of the PAT complex (Fig. 3.18B), these included the beta-1-adrenergic 
receptor (β1AR), melatonin-related receptor (MTR1L), and the muscarinic acetyl-
choline receptor M1 (CHRM1). Importantly, reduced biogenesis was also seen for 
the ER resident protein TRAM2 and the cation channel ANO6, two unrelated pro-
teins with different topology and folding demands (Fig. 3.18C). Furthermore, con-
straining the insertion and topology of AGTR2 by addition of an N-terminal signal 
peptide (SS-T4L- AGTR2) did not bypass the necessity of the PAT complex (Fig. 
3.18C). This is in stark contrast to the requirement for EMC and argues strongly that 
while both factors are necessary for biogenesis, they act at two distinct steps. Thus, 
the PAT complex is needed for optimal biogenesis of various multipass membrane 
proteins and is likely acting at a later step (after accurate insertion occurs). This 
result explains why both genes were recovered in a recent screen for factors that 
impair surface expression of a mutant TRP6 channel (Talbot et al., 2019).  
 
 
 
 
 
Figure 3.17 – siRNA deple-
tion of PAT complex. Repre-
sentative blot of negative con-
trol siRNA treated cells com-
pared to cells treated with As-
terix or CCDC47 siRNA. 
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Fig. 3.18 - The PAT complex facilitates biogenesis of multipass membrane proteins. (A, B, C) Each set of 
proteins analyzed contains a cartoon depicting the topology, number of TMDs, and fluorescent proteins for the 
membrane protein reporters tested in a panel above the data panels. The viral P2A peptide sequence results in 
two proteins from a single translation reaction as indicated. Stable cell lines containing the indicated inducible 
reporters were treated with scrambled (Scr) or Asterix-targeting siRNAs, reporter expression was induced for 
~6 hours, and the cells were analyzed by flow cytometry. The top plot in each column shows the histogram of 
fluorescent protein ratios in control cells (grey) and Asterix-knockdown cells (blue). The dashed black line in-
dicates the mode for the control population and defines a gate used for quantification. The bottom plots show 
individual cells with those above the gate in red and below the gate in grey. The percent of cells above the gate 
is indicated. 
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TMDs with polar residues engage the PAT complex 
Analysis of substrate insertion and crosslinking in microsomes lacking the 
PAT complex showed that TMD1 insertion is unimpaired (Fig. 3.10), unlike the 
failed insertion phenotype seen when microsomes lack the EMC insertase (see 
Chapter II). Furthermore, the timing of TMD1 interaction with and release from 
Sec61 was not appreciably changed by PAT complex depletion (Fig. 3.19). Thus, 
the PAT complex does not participate in targeting and is neither an insertase nor a 
facilitator of TMD release from Sec61a, explaining why single-pass membrane pro-
teins like SQS and ASGR are unaffected by PAT complex depletion. Instead, the 
PAT complex acts after a TMD accesses the lipid bilayer. 
  
 
 
Figure. 3.19 - The PAT complex is not required for TMD1 insertion. Rho TM1+2 RNCs of varying nascent 
chain lengths (indicated at top of gels) were translated in vitro in the presence of RM prepared from ∆CCDC47 
or ∆Asterix HEK293 cells as indicated. Membranes were isolated by centrifugation through a sucrose cushion 
and treated with the chemical crosslinking reagent BMH. The samples were denatured in 1% SDS and immuno-
precipitated via the N-terminal FLAG tag. Notice that the glycosylation of substrate is very similar in efficiency 
and timing as that seen in RM prepared from wild type HEK293 cells (see Fig. 3.2 for comparison). Furthermore, 
the appearance and disappearance of the SRP54 and Sec61α cross linking adducts are not appreciably altered 
from the results seen in RM prepared from wild type cells. Thus, the early steps of Rhodopsin biogenesis are 
not impaired appreciably in the absence of Asterix or CCDC47. As expected, the crosslink to Asterix/PAT10 is 
not seen. Crosslinking products seen at the approximate size of the Asterix crosslink are therefore other pro-
tein(s).   
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Replacement of the sole polar amino acid (asparagine) in TMD1 with leucine 
markedly reduced the Asterix-TMD1 interaction at all nascent chain lengths that 
were examined (Fig. 3.20A-B). Reintroduction of polar or charged residues at other 
positions in the TMD partially restored crosslinking to Asterix (Fig. 3.20C). These 
data indicate Asterix engages TMDs that expose hydrophilic residues within the li-
pid bilayer in a mostly position-independent manner. Dependence on charged resi-
dues for PAT complex association was corroborated via native immunoprecipitation 
(Fig. 3.20D), ruling out altered cysteine reactivity/accessibility as the explanation 
for the reduced crosslinking efficiency seen in figure 3.30C.  This explains previous 
observations that PAT10 can crosslink with TMDs of either orientation and of dif-
ferent unrelated sequences (Meacock et al., 2002).  
 
Figure 3.20 - The PAT complex engages TMDs via exposed polar residues. (A) A diagram of the Rho TM1 
construct diagram containing the N52L mutation and further reintroduction of new polar residues (underlined). 
(B) Analysis by chemical crosslinking of the N52L construct depicted in A. Compared to the identical construct 
without the N52L mutation (Fig. 3.2), crosslinks to Asterix are markedly diminished and strong crosslinks to 
Sec61α are only seen for the 118mer. This is consistent with a more hydrophobic TMD leaving the translocon 
and migrating into the lipid bilayer faster. (C) Crosslinking reactions of 146mer RNCs of Rho TM1 containing 
the indicated mutations. (D) Translation reactions as in panel B (but without crosslinking) were either analyzed 
directly (input) or subjected to native IP using anti-CCDC47 antibodies. Nascent chains were released from the 
ribosome with RNase A before IP. The glycosylated substrate recovered with CCDC47 was visualized by auto-
radiography. Note that the efficiencies of crosslinking to Asterix in panel C corelate to the efficiencies of 
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recovery with CCDC47. All immunoprecipitations were loaded such that the total represents 10% of the total 
reaction and the IP represents 25% of the total reaction. 
 
Substrate folding triggers PAT complex dissociation 
Although the PAT complex initially engages TMDs co-translationally as a peptidyl-
tRNA, the complex remains associated even after termination releases the nascent 
chain from the ribosome-Sec61 complex (Fig. 3.21A). This observation, together 
with the finding that exposed hydrophilic residues within a TMD influence PAT 
complex interaction, suggested PAT complex dissociation might be triggered when 
TMDs pack correctly to shield exposed hydrophilicity. To test this, we determined 
whether PAT complex interaction is selective to immature but not a folded mem-
brane protein. Exploiting the fact that an engineered b1AR folds efficiently after in 
vitro translation (see chapter II), we compared its interaction with the PAT complex 
relative to truncation products intended to mimic biogenesis intermediates. A pooled 
mixture of intermediates truncated after each TMD produced by in vitro translation 
was subjected to native IP using anti-CCDC47 antibodies. Full length b1AR was 
recovered substantially less efficiency than each of the intermediates, suggesting  the 
PAT complex dissociates upon correct folding of b1AR (Fig. 3.21B). Furthermore, 
this result was corroborated when probing the interaction of an intermediate product 
vs. a full-length b1AR, in native membranes, using photo-crosslinking of a BpA 
placed in the first TMD (Fig. 3.21C). In vitro translation of full-length b1AR inher-
ently produces intermediate products which either represent stalled translation, or 
premature termination (Figure 3.21C, see blue stars). Satisfyingly, these intermedi-
ate products appear to crosslink to Asterix and can be recovered via immunoprecip-
itations under denaturing conditions. Conversely, crosslinks to the full length b1AR 
are not recovered despite similar levels of total translated product (Fig. 3.21C, see 
red stars). Thus, the PAT complex engages partially translated products to shield 
hydrophilicity from the surround lipid environment and releases substrate upon 
complete folding. Considering all previous observations, this defines the PAT com-
plex as an intramembrane molecular chaperone.  
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Figure 3.21 The PAT complex releases substrate upon folding. (A) Terminated (Term.) or truncated (RNC) 
Rho TM1+2 was inserted into RMs and treated with BMH where indicated. Before SDS-PAGE, some of the 
samples were digested with RNase A as indicated to remove the tRNA. (B) Full length β1AR (FL) or constructs 
truncated after each TMD were translated in the presence of RMs and analyzed either individually (left panel) 
or pooled before analysis. All constructs contained a stop codon and are terminated. The membrane-targeted 
population from the pooled reaction was isolated by sedimentation and divided in two aliquots. One aliquot was 
set aside (Total Pool) and the other was used for a native IP with anti-CCDC47 antibody. Both samples were 
then subjected to denaturing pulldown via the C-terminal His tag to ensure that only completed translation prod-
ucts were visualized. The graph below the gel represents scanning densitometry of the last two lanes. Note that 
substantially less full length β1AR is recovered with CCDC47 relative to each of the truncation products. (C) 
Top cartoon depicts the experimental strategy for comparing Asterix interaction with a membrane protein inter-
mediate versus full length product. In this experiment, the photo-crosslinking amino acid Bpa (yellow star) is 
incorporated into position 52 within TMD1 of b1AR by in vitro translation. The intermediate is represented by 
the TM1-3 product containing the first three TMDs of b1AR. The full length (FL) b1AR contains all seven 
TMDs followed by a long flexible linker. TM1-3 is stalled 35 amino acids downstream of TMD3 (with TMD4 
inside the ribosomal tunnel), allowing TMD3 to be outside the ribosome. b1AR FL is stalled 152 amino acids 
downstream of TMD7, providing a sufficiently long tether for all seven TMDs to have emerged, inserted into 
the membrane, and assembled together. The translation products are then irradiated with UV light to activate the 
Bpa and any crosslinking to Asterix is subsequently detected by denaturing IP via Asterix. The microsomes from 
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the IVT reaction were isolated, resuspended, irradiated with UV light (or left untreated), and denatured. The 
samples were then divided in two and immunoprecipitated via the nascent chain or via Asterix. Six-fold more 
of the Asterix IPs were loaded on the gel relative to the nascent chain IPs. As expected, the Bpa in TMD1 
crosslinks to Asterix in the TM1-3 intermediate. Note that the crosslinked band in the 6x Asterix IP is the same 
intensity as the glycosylated band in the 1x nascent chain IP. Although elongation to the full-length product was 
somewhat inefficient, clear glycosylated and non-glycosylated products are observed in the nascent chain IPs. 
No band is seen in the 6x Asterix IP sample that is of comparable intensity to the glycosylated band in the 1x 
nascent chain IP. This argues that the proximity of TMD1 to Asterix has diminished substantially in the full-
length nascent chain relative to the TM1-3 intermediate. Of note, a heterogeneous set of crosslinks (marked by 
red stars) are seen at a lower part of the gel in the 6x Asterix IP. These correspond to the sizes expected for 
Asterix crosslinks (i.e., shifted by ~10 kD) to the major incomplete translation products (marked by blue stars). 
These crosslinks provide an internal control and further supports the conclusion that incomplete products engage 
Asterix, while a complete 7-TMD product does not. 
 
A model for the PAT complex as an intramembrane chaperone 
Our findings indicate that the PAT complex is a widely conserved ER resident 
complex that directly interacts with nascent TMDs, releases its substrates upon cor-
rect folding, and is needed for optimal membrane protein biogenesis. These features 
define the PAT complex as an intramembrane chaperone. Its preference for TMDs 
with exposed hydrophilic amino acids within the lipid bilayer is analogous to soluble 
chaperones that prefer hydrophobic patches exposed to the aqueous environment 
(Blond-Elguindi et al., 1993; Döring et al., 2017; Stein et al., 2019). The more fa-
vorable TMD-TMD interactions that accompany correct folding likely displaces the 
PAT complex, whose interaction must necessarily be more generic and hence 
weaker. Just as the binding cleft of chaperones like Hsp70 are hydrophobic (Mayer 
and Bukau, 2005), the substrate-interaction domain of Asterix may be hydrophilic, 
consistent with a large number of conserved hydroxylated amino acids in its TMDs. 
Analogous intramembrane interactions with hydrophilic TMDs have been pro-
posed to facilitate recognition of misfolded membrane proteins during quality con-
trol (Natarajan et al., 2019; Sato et al., 2009, 2003). By binding to and shielding 
similar motifs in a nascent protein, the PAT complex probably prevents promiscuous 
degradation. This would explain why its depletion leads to post-translational reduc-
tion of various multipass membrane proteins. The PAT complex may have priority 
over quality control factors for two reasons. First, the PAT complex is highly abun-
dant, comparable to or even exceeding the Sec61 complex (Ghaemmaghami et al., 
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2003; Itzhak et al., 2016). Second, the cytosolic domain of CCDC47, which is en-
riched in basic amino acids, may have some affinity for the ribosome to recruit the 
PAT complex in vicinity of the Sec61 complex. This interaction is likely to be weak 
and dynamic as the PAT complex has not been seen in proteomic analysis of ribo-
some translocon complexes (Conti et al., 2015). 
Even though there are severe phenotypes associated with loss of CCDC47 at the 
level of an organism and in humans (Morimoto et al., 2018; Yamamoto et al., 2014), 
loss of the PAT complex is tolerated at the cellular level and substrates still mature 
at a reasonable efficiency. Many proteins can fold without assistance from chaper-
ones, whose primary role is to reduce off-pathway interactions and maximize pro-
ductive folding (Ellis and van der Vies, 1991). Furthermore, individual chaperone 
disruptions often have only modest cellular phenotypes due to their considerable 
redundancy (Wang et al., 2015). Thus, there may be many other intramembrane 
chaperones that can partially compensate for the PAT complex in its absence. While 
several substrate-specific chaperones have been proposed for particular membrane 
proteins (Brechet et al., 2017; Gu et al., 2016; Kota and Ljungdahl, 2005), our find-
ings suggest that the PAT complex is an abundant generalist for semi-hydrophilic 
TMDs that are found in nearly all of the over 2500 multi-pass membrane proteins in 
humans. 
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Chapter IV 
A model for multipass membrane protein 
biogenesis 
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The cooperative action of insertion machineries and an intramembrane chap-
erone. 
 In this thesis I have provided two significant insights into the mechanisms 
governing multipass membrane protein biogenesis. The first involves the long-
standing question in the field of how topogenic determinants are recognized and 
decoded by cellular machinery to accurately insert membrane proteins in the correct 
orientation. The second insight illuminates the action of a new intramembrane chap-
erone complex (the PAT complex) acting to offset destabilizing features of nascent 
TMDs until complete synthesis and folding.  
Our studies demonstrate Nexo signal anchors use EMC for insertion, while Ncyt 
TMDs and signal sequences go through the Sec61 complex. Thus, the mechanism 
involves two separate machineries for the insertion of the first hydrophobic element, 
determining topology. This dichotomy is supported by our observations that a range 
of Nexo TMDs do not require Sec61 for their insertion using in-vitro insertion assays 
(Figs. 2.19, 2.20. 2.21) but demonstrate a strong dependence on EMC both in-vitro 
and in-vivo (Figs. 2.14, 2.15, 2.16). Consistent with previous mutagenesis assays 
(von Heijne, 2006), Nexo TMDs that are short, hydrophobic and  contain cytosoli-
cally localized positive charges can be tolerated by Sec61. This explains why the 
classical Nexo substrate, leader peptidase (LepB), could be inserted in a purified sys-
tem (Görlich and Rapoport, 1993). However, extension of the LepB TMD by three 
additional amino acids rendered it completely EMC dependent (Fig. 2.17). Further-
more, this model nicely reconciles previous observations in which potent Sec61 in-
hibitors, that block opening of the lateral gate, only inhibit insertion of Ncyt TMDs 
and signal sequences, but not Nexo signal anchors (Luesch and Paavilainen, 2020).  
Fundamentally, the major remaining question regarding EMC function is when 
exactly it acts on substrate during co-translational insertion. Considering our recent 
findings suggesting two separate paths for insertion (described above), we can make 
a reasonable inference that the observed topological inversion of β1AR-TMD1(in 
the absence of EMC) is a result of Sec61-mediated insertion. This necessarily means 
EMC must be acting at a step prior to ribosome docking on the translocon, when a 
TMD will be heavily biased towards engaging Sec61, and EMC action will be ste-
rically blocked by the tight interface (Voorhees et al., 2014). Therefore, we propose 
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a model in which a hydrophobic element emerges from the ribosome exit tunnel and 
is engaged by the substrate binding domain of SRP54 (Fig. 2.10). SRP will target 
the RNC to the ER membrane via interaction with SRP receptor with cooperative 
GTP hydrolysis triggering release. At this crucial intermediate the ribosome has not 
engaged Sec61 and the targeting element is accessible to EMC, which is highly 
abundant and can readily diffuse through the ER membrane. If EMC engages a Nexo 
signal anchor with appropriate sequence features (i.e. positive cytosolic charges), 
the TMD will be inserted via EMC in the correct orientation. Conversely, insertion 
of signal sequences and Ncyt TMDs will be rejected and defer to Sec61. This model 
remains largely speculative as the mechanistic underpinnings that allow substrate 
selection/rejection by EMC will require structural analysis. Nevertheless, in a puri-
fied system EMC appears to only be capable of Nexo insertion (Fig. 2.22, 2.23) and 
Sec61 optimized for Ncyt insertion (with the exception of ideal Nexo TMDs).  
While Nexo signal anchors would not obligately use Sec61 for insertion, they can 
probably engage Sec61 at its lateral gate after insertion. This idea is favored by 
Sec61’s close proximity to the nascent chain via ribosome binding (Kalies et al., 
1994), the signal-binding capacity of Sec61’s lateral gate (Gogala et al., 2014; Li et 
al., 2016; Plath et al., 1998; Voorhees and Hegde, 2016), and the observed Sec61-
TMD crosslinking (High et al., 1993a). The signal anchor would then be positioned 
ideally for interacting with the next TMD, whose insertion would occur via Sec61 
(Fig. 2.24).  
At this point, the first TMD can leave the immediate environment of the trans-
locon and engage the PAT complex, if it contains destabilizing hydrophilic residues 
(Fig. 3.20). A single TMD would very likely be stable within the membrane as an 
α-helix (Krishnamani et al., 2012; Lau and Bowie, 1997), consistent with careful 
biophysical measurements demonstrating hundreds of ATP molecules are required 
to remove a TMD from the membrane (Yang et al., 2018).  The primary challenge 
faced by a multipass membrane protein is off-pathway interactions disrupting as-
sembly, or premature degradation by quality control mechanisms (Chen and 
Gouaux, 1999). Consistent with this assessment, in a completely purified system 
two halves of rhodopsin can be synthesized separately, but assemble into a func-
tional whole upon reacquaintance (Huang et al., 1981). Thus, the PAT complex acts 
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to shield “naked” TMDs until assembly with their distant counterparts and the inter-
action is severed upon productive folding (Fig. 3.21).  
The introduction of two new molecular players in the process of multipass mem-
brane biogenesis greatly increases our understanding of this essential and complex 
process. The studies presented here will pave the way for future mechanistic dissec-
tion and a structural understanding of both EMC and the PAT complex. 
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Cell lines 
All cell lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 
10% fetal calf serum (FCS). In cases where the cells contained a stably expressed 
doxycycline-inducible reporter, tetracycline-free FCS was used as well as 15 μg/ml 
blasticidin and 100 μg/ml hygromycin. All cell lines used in chapter II have been 
described and characterized previously (Guna et al., 2017). They include the follow-
ing: Flp-In 293 T-Rex cells (wild type and ∆EMC6), and U2OS Flp-In cells (WT, 
∆EMC5, ∆EMC5+EMC5 rescue). Stable cells lines in chapter III were generated 
using the FRT Flp-In system according to manufacturer’s protocol (Invitrogen). Sta-
bly expressed cell lines included GFP-2A-RFP-SQS, β1AR-GFP-2A-RFP, AGTR2-
GFP-2A-RFP, SS-T4L-AGTR2-GFP-2A-RFP, TRAM2-GFP-2A-RFP, Ano6-GFP-
2A-RFP, CHRM1-GFP-2A-RFP, MTR1L-GFP-2A-RFP, and Rhodosin-GFP-2A-
RFP. CCDC47 and Asterix knockout cells were generated by transient transfection 
with the px459 plasmids containing the appropriate guide RNAs. After 24 h, trans-
fected cells were selected for 48hrs with 1 µg/ml puromycin then trypsinized and 
diluted into 96-well plates at a concentration of 0.5cells/well to select for single cell 
colonies. After ~2weeks, single colonies were expanded and clones displaying un-
detectable CCDC47 or Asterix were chosen for further analysis.  
 
Antibodies 
CCDC47 antibody #1 (A305-100A) and CCDC47 antibody #2 (A305-101A) were 
obtained from Bethyl-laboratories. FLAG immunoprecipitations were performed 
using FLAG-M2 affinity gel (Sigma). Anti-HA antibody was generated in house 
(Itakura et al., 2016). Signal Peptide Peptidase (SPP) antibody was purchased from 
Bethyl Laboratories (A304-404A). Anti-Asterix (WDR83OS) antibody was pur-
chased from Sigma/Human Protein Atlas (HPA065685). Anti-UBQLN2 antibody 
was clone 5F5 obtained from Sigma (WH0029978M3). Anti-SRP54 was from BD 
Biosciences (610940). Custom antibodies against Sec61a, Sec61b, TRAPa, and 
TRAM have been described and characterized previously (Fons et al., 2003). All 
antibodies for western blotting in figures 2.7 and 3.12 have been described previ-
ously (Chitwood et al., 2018). 
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Constructs 
The parent β1AR construct for in vitro translation was created by inserting the coding 
region of residues 20-424 of turkey β1AR-B6m23 (Warne et al., 2009) into an SP64 
based vector containing an HA affinity tag at the N-terminus and the unstructured 
cytosolic domain of Sec61β (residues 2-69, with the single Cysteine and predicted 
Glycosylation acceptor sequence mutated to Serine and Glutamine, respectively) 
followed by a 6-Histidine tag at the C-terminus. A glycosylation acceptor site (NGT) 
was introduced at residues 22-24 within the β1AR sequence. From this parent con-
struct, versions lacking the HA tag, glycosylation site, cytosolic loop 3 (CL3 resi-
dues 233-262), and TMD3 (residues 109-148) were generated by standard subclon-
ing methods. β1AR-TMD1 was created by deleting everything downstream of the 
beginning of TMD2 from the parent cassette. Similar approaches were used to create 
constructs β1AR-TMD1-2 through β1AR-TMD1-6. All GPCR-TMD1, B1AR 
TMD1 mutants, and LEP TMD mutant constructs were made by replacing the β1AR 
TMD1 with the respective first TMDs of indicated GPCRs, or mutants of either 
β1AR TMD1 or LEP TMD1, including up to 15aa of the N-terminal native sequence 
(or the entire native N-terminus where indicated) and the entire cytosolic loop 2 
(CL2) sequence preceding TMD2. Any native cysteines were mutated to serine. Me-
thionines were added where necessary by mutating hydrophobic residues to allow 
for efficient detection by autoradiography. The coding sequences for human ASGR1 
(Görlich and Rapoport, 1993) and bacterial leader peptidase (LEP) with the TMD2 
removed (Heinrich et al., 2000), were placed into an SP64 based vector containing 
a 3F4 epitope at the C-Terminus or 3xHA and glycosylation tag at the N-terminus, 
respectively. For the construction of the in-vivo β1AR fluorescent reporter, the se-
quence encoding HA-β1AR was sub-cloned into a pcDNA3.1 based vector contain-
ing a C-Terminal GFP-P2A-RFP reporter. For all other fluorescent reporters, a par-
ent cassette was first created by sub-cloning the GFP-P2A-RFP fluorescent reporter 
into a pcDNA5/FRT/TO vector backbone. The coding sequences of CNR2 
(NP_001832.1), AGTR2 (NP_000677.2), and ADA1A (NP_000671.2) were then 
inserted into this parent cassette with the GFP-P2A-RFP reporter at the C-Terminus. 
The coding regions for both ASGR and SQS were inserted at the 3’ end of the GFP-
P2A-RFP reporter within the pcDNA5 cassette. A gene block (IDT) encoding the 
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signal sequence of prolactin followed by an HA-epitope tag and the sequence for 
full-length Phage T4 Lysozyme was appended to all GPCR-GFP-P2A-RFP cassettes 
using Gibson Assembly (NEB). The T4 Lysozyme sequence (residues 2-161) had 
all native cysteines and predicted glycosylation acceptor sites mutated to serine or 
glutamine, respectively). Additionally, the N-terminal HA-epitope tag preceding the 
GPCR sequence was removed and replaced by the appended SS-HA-T4L sequence. 
SS-T4L-β1AR for in-vitro expression in an SP64 based cassette was cloned in a sim-
ilar manner. A gene block (IDT) encoding an HA tag and the TMD of MAN1A1 
(NP_005898.2), including native N and C-terminal flanking residues (aa 33-75), was 
appended to the N-terminus of β1AR in both the SP64 cassette and the pcDNA5 
GFP-P2A-RFP cassette using Gibson Assembly. As indicated in the Key Resources 
Table, several β1AR TM1 constructs and LEP TM1 constructs were ordered as 
gBlocks containing the SP6 promoter and coding sequence of interest. PCR for sub-
sequent in-vitro transcription was carried out directly from these gBlocks. TRAM2 
was PCR amplified from a human cDNA library and then inserted into the SP64 
cassette using restriction cloning. Subsequently, the coding sequence of the TRAM2 
mRNA was PCR amplified and inserted a parent pcDNA5-GFP-P2A-RFP cassette 
by Gibson Assembly. Sequences encoding 1xFLAG-Rho TM1+2 and 1xFLAG-Rho 
TM1+2 (F53C) were ordered as gene blocks (IDT) and inserted into a parent vector 
containing an SP6 promoter and the flexible N-terminus of Sec61β with a 6His tag 
appended to the C-terminus. A glycosylation acceptor site (NGT) was introduced at 
amino acids 13-16. Variants of these parent constructs with a TwinStrep tag, HA 
tag, or lacking a glycosylation site were generated by standard subcloning methods. 
Constructs encoding Rho TM1, where TM2 is replaced by a flexible hydrophilic 
linker (SGSGSGSGSGGSSGGMGGSGS), were ordered as gene blocks containing 
a 5’ SP6 promoter and transcribed directly for in vitro translation. Similar methods 
were used for all Rho TM1+linker polar residue point mutants. Truncated versions 
and variants containing amber codons at specific sites in β1AR were created by PCR-
based cloning methods and site-directed mutagenesis, respectively, and verified by 
sequencing. Constructs encoding the mutant E.coli tyrosyl-tRNA synthetase in the 
pET21 vector and B. stearothermophilus suppressor tRNATyr  sequence in the 
pRSET-A vector have been described (Lin et al., 2019). Templates for in vitro 
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translation of tagged Asterix constructs were ordered as gene blocks containing a 5’ 
SP6 promoter and used directly for transcription and translation. Mammalian ex-
pression constructs for C-terminally FLAG-tagged human Asterix and the various 
cysteine variants were produced as gene blocks, sub-cloned into pcDNA3.1-based 
vectors, and verified by sequencing.  For the creation of stable cells lines expressing 
various membrane protein reporters, the coding sequences for CHRM1 
(NP_000729.2), bovine rhodopsin (NP_001014890.1), Anoctamin-6 
(NP_001020527.2), and MTR1L (NP_004215.2) were PCR amplified and placed 
into a parent pcDNA5/FRT/TO vector backbone with a C-terminal GFP-P2A-RFP 
using Gibson Assembly (NEB). CRISPR-Cas9 mediated gene disruptions of 
CCDC47 and Asterix were performed using the pSpCas9(BB)-2A-Puro (PX459) 
plasmid (Addgene) containing the guide RNAs 5’-GTATGGACTGCCG-
GACTCTT-3’ (CCDC47) and 5’-AAGGCCGGGTTACATTCGCT-3’ (Asterix).  
 
Flow cytometry analysis 
Analysis of reporter expression by flow cytometry was similar to previously de-
scribed methods (Guna et al., 2017; Itakura et al., 2016). Transient transfection of 
fluorescent reporter constructs was performed using either Mirus TransIT 293 (for 
HEK293 T-Rex cells) or Mirus TransIT 2020 (for U2OS cells) according to manu-
facturer’s instructions. In all experiments, 1µg/ml of total plasmid was transfected 
into a dish containing complete medium. The amount of the fluorescent reporter 
plasmid was titrated individually for each protein of interest based on transfection 
efficiency and expression levels, and a non-expressing plasmid was used to maintain 
equal amounts of total plasmid transfected (1µg/ml). For the U2OS ∆EMC5 rescue 
cells, re-expression of EMC5 was induced for 24-30 hours with 1 μg/ml of doxycy-
cline prior to reporter plasmid transfection. For experiments using knockout cell 
lines, ∆CCDC47 and ∆Asterix cells were transiently transfected with 1 µg/ml of the 
appropriate pcDNA5 expression constructs ~24 h before induction with 100 ng/ml 
doxycycline. All transfections were performed using Mirus-Transit 293 according 
to manufacturer’s instructions. For experiments using stably expressed reporter cell 
lines, siRNA depletion was performed over a ~96 h period using the Lipofectamine 
RNAiMAX reagent according to manufactures instructions (Thermo). Briefly, a first 
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round of siRNA treatment was performed in the presence of DMEM and 10% tetra-
cycline-free FCS. Cells were incubated for 48 h before a second round of siRNA 
treatment was performed under the exact same conditions. Following a second ~48 
h incubation, expression of fluorescent reporter constructs was induced with 100 
ng/ml doxycycline for 6 h before analysis by flow cytometry. Acute expression of 
reporters was essential to accurately monitor degradation of reporter constructs and 
avoid saturation of degradation pathways. In all experiments the cells were collected 
by trypsinization, washed once in ice-cold PBS, then resuspended in the equivalent 
culture volume of PBS and 1µg/ml DAPI stain (Thermo). Cells were passed through 
a 70µm filter before flow cytometry analysis using a Beckton Dickinson LSRII in-
strument. 20,000 GFP positive (or RFP positive for SQS and ASGR) were collected. 
Further gating for live cells (negative for DAPI stain) and relatively high soluble 
fluorescent protein was used to focus on the population of cells with productive 
translation of reporter constructs.  
 
In vitro transcription and translation 
In vitro transcription was performed with SP6 polymerase as described and PCR 
products were utilized as the template (Sharma et al., 2010). The transcription reac-
tions were conducted with 5-20 ng/μl PCR product in 40 mM HEPES pH 7.4, 6 mM 
MgCl2, 20 mM spermidine, 10 mM reduced glutathione, 0.5 mM ATP, 0.5 mM 
UTP, 0.5 mM CTP, 0.1 mM GTP, 0.5 mM CAP, 0.4-0.8 U/μl RNasin and 0.4 U/μl 
SP6 polymerase at 37°C. In vitro translation in RRL was as described previously in 
detail (Feng and Shao, 2018; Sharma et al., 2010). Translations were for 20-45 
minutes at 32°C unless indicated otherwise in the individual figure legends. Trans-
lation reactions typically contained 33% by volume nuclease-treated RRL, 0.5 
μCi/μl 35S-methionine, 20 mM HEPES, 10 mM KOH, 40 μg/ml creatine kinase, 20 
μg/ml pig liver tRNA, 12 mM creatine phosphate, 1 mM ATP, 1 mM GTP, 50 mM 
KOAc, 2 mM MgCl2, 1 mM reduced glutathione, 0.3 mM spermidine and 40 μM of 
each amino acid except methionine. The transcription reaction was added to 5% by 
volume to the translation reaction without further purification. For translation reac-
tions in the presence of human cell-derived rough microsomes (hRMs), 0.25-1 μl of 
hRMs (at concentration that gives an absorbance at 280 nm of 75) were added to a 
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10µl translation reaction. Each batch of hRMs was titrated in preliminary experi-
ments to achieve equal translation levels, allowing for functional comparisons be-
tween various microsomes.  
 
Preparation of rough microsomes 
Canine pancreas-derived rough microsomes (cRM) were prepared as described pre-
viously (Walter and Blobel, 1983). Preparation of microsomes from HEK293-based 
cells was slightly modified from earlier protocols (Zhang et al., 2013). Briefly, ten 
15 cm plates of Flp-In 293 T-Rex cells (WT or ∆EMC6) were grown to 80-100% 
confluency, collected in ice-cold PBS, sedimented at 500 x g for 5 min at 4°C, and 
washed twice in ice-cold PBS. The cell pellet was resuspended in 3 pellet volumes 
of ice-cold sucrose buffer (10mM HEPES, pH 7.4, 250 mM sucrose, 2 mM MgCl2). 
Cells were lysed in the cold (4°C) by ~25-30 passes through a 26 guage needle using 
a 1 mL syringe. The lysates were clarified of nuclei and debris by centrifugation 
twice at 3,800 x g for 30 min at 4°C in a tabletop micro-centrifuge. The supernatant 
was centrifuged at 75,000 x g for 1 hr at 4°C in an MLA-80 rotor (Beckman Coulter). 
The supernatant was discarded and the resulting membrane pellet was resuspended 
in microsome buffer (10 mM HEPES, pH 7.4, 250 mM sucrose, 1 mM MgCl2, 0.5 
mM DTT). Total microsome resuspension volume was adjusted such that the ab-
sorbance at 280nm was 75. Wild type RM were also obtained from HEK293 cells 
grown in suspension (Expi293F cells) and prepared similarly to RM from adherent 
cells with a few minor modifications to adjust for the larger scale. In brief, ~2 L of 
cells were grown to a concentration of 5x106 cells/mL then collected by centrifuga-
tion. Cell pellets were washed twice with ice-cold PBS and pooled as necessary. A 
~30 mL pellet was resuspended in 60 mL of sucrose buffer (50 mM HEPES, pH 7.4, 
50 mM KOAc, 6 mM Mg(OAc)2, 1 mM EDTA, 250 mM sucrose, 1 mM DTT) and 
lysis was carried out in a glass dounce homogenizer. Lysate was cleared twice by 
centrifugation at 3,500 x g for 30 min at 4°C. Supernatant was recovered and under-
laid with one-third the volume of sucrose cushion (1.3 M sucrose, 50 mM HEPES, 
pH 7.4, 50 mM KOAc, 6 mM Mg(OAc)2, 1mM EDTA, 1 mM DTT) and centrifuged 
for 1 h at 371,000 x g (60,000 rpm) and 4°C for 1 h in the Type 70Ti rotor (Beck-
man). The supernatant was removed by aspiration, and the pellets were resuspended 
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and pooled by manual homogenization in a dounce using 6 mL resuspension buffer 
(250 mM sucrose, 50 mM HEPES, pH 7.4, 1 mM DTT). The final preparation was 
adjusted to an absorbance of 75 when measured at 280 nm in 1% SDS. Canine pan-
creas-derived rough microsomes (cRM) were prepared as described previously 
(Walter and Blobel, 1983), and were used in very few experiments where explicitly 
stated in the figure legends. All microsome preparations were flash frozen in liquid 
nitrogen and stored at -80°C. 
 
Protease protection assays 
Immediately following the translation reaction, the samples were placed on ice and 
10% of the reactions were set aside for analysis by SDS-PAGE and autoradiography 
of total products. The remainder was subjected to protease protection digests by the 
addition of proteinase K (PK), added to a final concentration of 0.5 mg/ml and in-
cubated at on ice for 50 min. To stop the digestion reaction, PMSF was added to 5 
mM, incubated on ice for 2-5 min, and the entire reaction transferred to 10 volumes 
of boiling 1% SDS, 100mM Tris-Cl, pH 8.0. For subsequent immunoprecipitations 
and pulldowns, samples were diluted 10-fold in ice-cold IP buffer (1x PBS supple-
mented with an additional 250 mM NaCl, 0.5% TX-100, 10 mM imidazole). Subse-
quently, samples were added to 10µl (packed) of either Nickel-NTA resin (to cap-
ture 6His-tagged proteins), or Protein A agarose plus the appropriate antibody typi-
cally used at 1:300 dilution. Immunoprecipitations were incubated for 2 hours rotat-
ing at 4°C. Following binding, the resin was washed twice with 50-100 resin vol-
umes of IP buffer, eluted with sample buffer, and analyzed directly by SDS-PAGE 
and autoradiography.  
 
Carbonate extraction 
Translation reactions were chilled on ice, layered on a sucrose cushion [20% w/v 
sucrose in physiological salt buffer (PSB), 100 mM KOAc, 50 mM HEPES pH 7.4, 
2 mM Mg(OAc)2],  and centrifuged at 186,000 x g for 20 min. The membrane pellet 
was resuspended in 20 µl PSB, 10% was set aside as the total membrane fraction, 
and the remainder was diluted 100-fold in 100 mM NaCO3 pH 11.5 and incubated 
on ice for 25min. The resulting NaCO3 extracted membranes were isolated through 
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centrifugation in the TLA120.2 rotor (Beckman Coulter) at 70,000 rpm at 4°C for 
30min. The NaCO3 extracted pellet was resuspended in SDS-PAGE sample buffer. 
After SDS-PAGE, the gels were either exposed to detect translation products by 
autoradiography, or subjected to immunoblotting to assess the separation of endog-
enous membrane and lumenal proteins (α-Calnexin 1:5,000 or α-PDI 1:1,000). 
 
Analysis of ribosome-nascent chain complexes 
For generating templates of truncated mRNAs, PCR was used to amplify the desired 
region using a 5’ primer that anneals slightly upstream of the SP6 promoter and a 3’ 
primer that anneals at the desired site of truncation. The 3’ primer additionally en-
codes the residues “MLKV” to improve radiolabeling (via the methionine) and sta-
bility of the peptidyl-tRNA from hydrolysis during gel electrophoresis (Shao et al., 
2013). The PCR products were used in transcription and translation reactions as de-
scribed above to generate ribosome-nascent chain complexes (RNCs). Following 
translation, cycloheximide was added to a final concentration of 50µg/ml prior to 
the addition of membranes. Microsomes were then added as indicated in the figure 
legends, incubated for 32°C for 15 min, then returned to ice for subsequent protease-
protection assays as described above. 
 
Site-specific photo-crosslinking 
Incorporation of benzoyl-phenylalanine (Bpa) at specific positions during in vitro 
translation was accomplished by amber suppression as described (Lin et al., 2019). 
In short, an amber codon containing template was translated in RRL as above but 
with 5 μM B. Stearothermophilus tRNATyr, 0.25 μM Bpa tyrosyl-tRNA synthetase, 
and 0.1 mM Bpa. UV irradiation was for 12 min with a hand-held UV lamp (Ther-
moFisher Scientific, cat. #95034) at 254 nm positioned ~2.5 cm above the sample 
sitting on ice. As described before(Lin et al., 2019), E.coli Bpa tyrosyl-tRNA syn-
thetase was purified via the C-terminal His tag on a 5 mL HiTrap Ni-NTA column 
(GE), desalted by a gel filtration column on FPLC and concentrated by Amicon Ul-
tra centrifugal filter (Millipore, Z717185-8EA). B. stearothermophilus tRNATyr, was 
synthesized by in vitro transcription as before(Lin et al., 2019). The pRSET-based 
construct encoding the tRNA was digested with BstN1, yielding a DNA fragment 
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containing the exact tRNATyr sequence under a T7 promoter. 5 mL transcription re-
action was carried out with 1.2 mg DNA template, 1 mM spermidine, 5 mM DTT, 
0.1% Triton, 5 mM NTPs, 25 μM MgCl2, 20 μg/mL E. coli pyrophosphatase, 20 
μg/mL T7 polymerase and 125 U Recombinant RNasin (Promega) for 4 hours at 37 
°C. The reaction product was digested with Turbo DNase (Ambion) and extracted 
by acid phenol chloroform extraction to yield purified tRNA. 
 
Cysteine crosslinking 
Unless explicitly stated, the crosslinking reactions were performed on isolated RMs. 
Here, the translation reactions were placed over a 20% sucrose cushion in physio-
logical salt buffer [PSB - 100mM KOAc, 50mM HEPES pH 7.4, 2.5mM 
Mg(OAc)2], centrifuged in the TLA-55 rotor for 20 min at 4°C, and the pelleted 
RMs resuspend in one-half the original translation reaction volume of PSB. Bis-
maleimidohexane (BMH) was added to a final concentration of 250 µM and the 
reaction was incubated on ice for 1hr to allow the crosslinking reaction to occur. 
BMH was quenched with 5 mM 2-mercaptoethanol. Aliquots of the reaction were 
removed at different stage of the process for analysis, as indicated in the individual 
figure legends. The samples were either used directly for downstream applications 
(primarily immunoprecipitations as described below) or flash frozen in liquid nitro-
gen and stored at -80°C for later analysis.  
 
Large scale affinity purification of crosslinked substrate complexes 
1 mL translation reactions in the presence of 0.8 mM cold methionine were carried 
out to produce 1xFLAG tagged or TwinStrep tagged (as a control) Rho TM1+2 
146mer RNCs. Membranes were isolated and cysteine-based crosslinking was car-
ried out as described above. Isolated membranes resuspended in PSB were solubil-
ized on ice by addition of an equal volume of 2x solubilization buffer (300 mM 
KOAc, 2% deoxyBigChap, 20 mM EDTA). RNase A was added to a final concen-
tration of 10 ng/ml and RNA digestion was carried out on ice for 20 min before the 
solubilised extracts were cleared by centrifugation at 100,000 rpm in the TLA120.2 
(Beckman). Cleared extracts were directly immunoprecipitated with FLAG M2 af-
finity resin (Sigma) in batch at 4°C with end-over-end rotation for 2.5 h. Unbound 
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fraction was removed, and beads were washed 4 times in 1x NSB [200mM KOAc, 
1%DBC, 10mM EDTA, 25mM HEPES, 1mM Mg(OAc)2], then twice in 1x NSB 
without detergent. Beads were resuspended in 1.5x the bead volume of 200 mM 
KOAc and 25mM HEPES pH 7.4 for direct trypsinisation and analysis by quantita-
tive mass spectrometry. 
 
Purification of EMC and SRP receptor 
SRP receptor (SR) was purified using an affinity resin coupled to anti-SR-alpha as 
described (Görlich and Rapoport, 1993). The purified SR was then bound to SP-
sepharose resin, washed, and detergent-exchanged as described (Görlich and 
Rapoport, 1993). The final SR preparation is in a buffer containing 50 mM Hepes, 
pH 7.4, 750 mM KOAc, 5 mM Mg(OAc)2, 0.3% deoxy-BigChap (DBC). EMC was 
purified as described previously (Guna et al., 2017) and minor contaminants re-
moved by a cation exchange step as follows. Flp-In 293T-Rex cells with stably ex-
pressed EMC5-FLAG were induced by the addition of 1µg/mL of doxycycline for 
48 hr prior to collection. A ~2.5 g pellet of cells was resuspended in 20 mL of solu-
bilization buffer [50 mM HEPES, 200 mM NaCl, 2 mM Mg(OAc)2, 1% DBC, and 
EDTA free Protease Inhibitor cocktail (Roche)]. After 30 min on ice, the lysate was 
cleared by centrifugation at 21,000 x g for 20 min at 4°C in the JA-25.50 rotor 
(Beckman Coulter). The cleared lysate was then added to 500 µl (packed) of anti-
FLAG M2 affinity gel pre-equilibrated in wash buffer 1 [50 mM HEPES, 200 mM 
NaCl, 2 mM Mg(OAc)2, 0.3% DBC] and incubated at 4°C rotating for 1 hr. The 
affinity resin was collected by brief centrifugation and washed 5 times in 8 resin 
volumes of wash buffer 1. EMC was eluted in 1 mL elution buffer [50 mM HEPES, 
100 mM NaCl, 2 mM Mg(OAc)2, 0.3% DBC, and 250 µg/mL 3xFLAG peptide] by 
rotating for 30 min at room temperature. The eluate was then passed through a grav-
ity flow column containing 150 µl (packed) SP-Sepharose Fast-Flow that was pre-
equilibrated in wash buffer 2 [50 mM HEPES, 50 mM NaCl 2 mM Mg(OAc)2, 0.3% 
DBC]. The column was washed 4 times with 10 resin volumes of wash buffer 2, and 
eluted in 200 µl of 50 mM HEPES, 200 mM NaCl, 2 mM Mg(OAc)2, and 0.25% 
DBC. 
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Preparation of Total and Sec Depleted protein extracts. 
1 ml of canine rough microsomes (at an absorbance at 280 nm of 50) was diluted in 
an equal volume of ice-cold 50 mM HEPES, pH 7.4, 250 mM Sucrose, 0.15% DBC. 
Membranes were collected by centrifugation at 100,000 rpm for 15 min at 4°C in 
the TL100.3 rotor (Beckman Coulter), resuspended in 1 ml of 400 mM KOAc, 50 
mM HEPES, 5 mM Mg(OAc)2, 15% glycerol, and divided in two (samples 1 and 
2). Sample 1 was adjusted to 10 mM EDTA 0.8% DBC, while sample 2 was adjusted 
with 0.8% DBC. After 15min on ice, the samples were centrifuged in the TL120.1 
rotor (Beckman Coulter) at 100,000 rpm for 30 min at 4°C to pellet insoluble mate-
rial and ribosomes/subunits. The supernatant from Sample 1 was saved as the “total 
ER protein” fraction (550 µl). The supernatant from sample 2, which has now been 
depleted of ~80% of Sec61 via its ribosome association, was passed sequentially 
over two gravity flow columns containing 200 µl of protein A resin containing anti-
Sec61β antibody pre-equilibrated in extraction buffer. The resulting flow through 
was collected and saved as the “Sec61-depleted ER protein” fraction (550 µl).  
 
Proteoliposome Reconstitutions 
Reconstitutions of proteoliposomes (or matched empty liposomes) were performed 
with minor modifications of previous methods (Görlich and Rapoport, 1993; Guna 
et al., 2017) as follows. Purified lipids were obtained from Avanti Polar Lipids and 
a 20 mg/ml stock solution was prepared as before (Guna et al., 2017) containing 
Phosphatidyl-choline (PC; from bovine liver), Phosphatidyl-ethanolamine (PE; 
from bovine liver), and synthetic 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-
N-lissamine rhodamine B (rhPE) in a 8:1.9:0.1 ratio. BioBeads-SM2 (BioRad) were 
prepared by first wetting them with methanol, then washing extensively with dis-
tilled water. After all traces of methanol were removed, the beads were adjusted with 
water so that the settled beads occupied 50% volume. For use in reconstitutions, the 
BioBeads were dispensed from this 50% slurry in the desired amount, and the excess 
liquid was removed by aspiration just before use. The volumes of BioBeads referred 
to below indicate the packed volume of beads. 
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For reconstitutions with total and Sec61-depleted ER proteins, the detergent-sol-
ubilized preparations from above were supplemented with 850 µg lipids from the 
prepared 20 mg/ml stock prepared as above. Control liposome reconstitutions con-
tained extraction buffer instead of protein extracts. These mixtures were then added 
to ~350 µl packed BioBeads (prepared as above) and incubated at 4°C for 18 h with 
gentle end-over-end mixing. The liquid was separated from the BioBeads, diluted 
with 4 volumes of ice-cold water, and centrifuged for 45 min at 75,000 rpm in a 
TL100.3 rotor (Beckman). The pellet was resuspended in 90 µl 100 mM KOAc, 50 
mM HEPES pH 7.4, 1 mM Mg(OAc)2, 250 mM sucrose. The rhodamine-labeled PC 
was used to ensure equal membrane recovery, and protein content was visualized by 
SDS-PAGE followed by Sypro Ruby staining. 
For reconstitutions with purified proteins, purified EMC (or its matched buffer 
control), purified SR (or its matched buffer control), DBC, and lipids were mixed in 
a final volume of 90 µl; the final mixture contained 0.52% DBC, 42 mM HEPES, 
pH 7.4, 333 mM KOAc, 44 mM NaCl, 2.67 mM Mg(OAc)2 and XX pmol EMC and 
YY pmol SR. This was added to 50 ul of BioBeads (packed volume) and incubated 
with gentle mixing for 16 h at 4°C. The liquid was separated from the BioBeads, 
diluted with 10 volumes of ice-cold water, and centrifuged for 45 min at 100,000 
rpm in a TL100.3 rotor (Beckman). The pellet was resuspended in 15 µl 100 mM 
KOAc, 50 mM HEPES pH 7.4, 1 mM Mg(OAc)2, 250 mM sucrose, 1 mM DTT. 
The rhodamine-labeled PC was used to ensure equal membrane recovery, and pro-
tein content was visualized by SDS-PAGE and Sypro Ruby staining. The PLs were 
used immediately for functional assays without freezing.  
 
Sequence analysis 
All GPCRs and tail-anchored membrane proteins were retrieved from the curated 
and reviewed human Uniprot dataset (UniProt Consortium, 2018). GPCRs contain-
ing a signal sequence and tail-anchored proteins destined for mitochondria were 
manually removed from this set. This left 728 GPCRs and 235 tail-anchored pro-
teins. The TMD regions were taken to be those annotated by Uniprot’s automated 
algorithms. Based on these designations, the length of the translocated domain and 
the charge within the flanking domains were determined. Relative hydrophobicity 
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was determined using the transmembrane tendency method (Zhao and London, 
2006). The charge difference was calculated using the difference between the C- and 
N-terminal flanking charges (Hartmann et al., 1989). 
 
Quantitative mass spectrometry using TMT labelling 
Proteins samples on beads were reduced with 5 mM DTT at 56°C and alkylated with 
10 mM iodoacetamide (IAA ) in the dark at 22°C. The alkylation reaction was 
quenched by the addition of DTT and the samples were digested overnight with 
trypsin (Promega, 0.1 µg) at 37°C. After digestion, each supernatant was transferred 
to a fresh Eppendorf tube, the bead samples were extracted once with 50% acetoni-
trile/ 0.1% TFA and combined with the corresponding supernatant. The peptide mix-
tures were then partially dried in Speed Vac and desalted using home-made C18 
(3M Empore) stage tip filled with 2 µl of poros R3 (Applied Biosystems) resin.  
Bound peptides were eluted sequentially with 30%, 50% and 80% acetonitrile in 
0.1%TFA and lyophilized. Dried peptide mixtures from each condition were re-sus-
pended in 20 ul of 7% MeCN and 1 M triethyl ammonium bicarbonate was added 
to a final concentration of 200 mM. 0.8 mg of TMT10plex reagents (Thermo Fisher 
Scientific) was re-constituted in 41 µl anhydrous MeCN. 10 µl of TMT (130C or 
131) reagent was added to each peptide mixture and incubated for 1 hr at 20°C. The 
labelling reactions were terminated by incubation with 2.5 µl of 5% hydroxylamine 
for 15min. The labelled samples were pooled into one Eppendorf tube and the speed 
Vac was used to evaporate acetonitrile. Peptides were separated on an Ultimate 3000 
RSLC nano System (Thermo Scientific), using an acetonitrile gradient, consisting 
of buffer A (2% MeCN, 0.1% formic acid) and buffer B (80% MeCN, 0.1% formic 
acid). Eluted peptides were introduced directly via a nanospray ion source into a Q 
Exactive Plus hybrid quardrupole-Orbitrap mass spectrometer (Thermo Fisher Sci-
entific). The mass spectrometer was operated in standard data dependent mode, per-
formed survey full-scan (MS, m/z = 380-1600) with a resolution of 70000, followed 
by MS2 acquisitions of the 15 most intense ions with a resolution of 35000 and NCE 
of 33%. MS target values of 3e6 and MS2 target values of 1e5 were used.  The 
isolation window was set as 0.7 m/z and dynamic exclusion was enabled for 40s. 
The acquired MS/MS raw files were processed using Proteome Discoverer (version 
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2.1, Thermo Scientific). MS/MS spectra were searched against a Human Reviewed, 
UniProt Fasta database (download in 2016), using Mascot (version 2.4, Matrix Sci-
ence) search engine. Carbamidomethylation of cysteines, TMT6plex (N-term) and 
TMT6plex (K) were set as fixed modifications, while methionine oxidation and N-
terminal acetylation (protein) were selected as variable modifications. For reporter 
ion quantification, the co-isolation threshold is 30 and average reporter S/N thresh-
old is 10. The output file from Proteome Discoverer, the proteins table was filtered 
for proteins FDR of 1% and exported as excel files used to produce the plot in Fig. 
1c. 
 
Preparation of anti-CCDC47 affinity columns  
A 50µl bead volume of protein A agarose was diluted in 750µl PBS, placed in 1 mL 
Pierce Spin columns, then pre-equilibrated with two 800 µl PBS washes. 100 µg of 
CCDC47 antibody #1 (A305-100A), CCDC47 antibody #2 (A305-101A), or an anti-
HA antibody were diluted in 1 mL of PBS then placed over the prepared protein A 
columns and allowed to pass through the resin by gravity flow. Flow through was 
collected and passed over the column a second time. Columns were equilibrated with 
800 µl of 0.1 M Na-Borate pH 9.0, then antibodies were conjugated to resin by pass-
ing through a 1 mL solution by gravity flow of 0.1 M Na-Borate pH 9.0 containing 
5 mg/mL dimethyl pimelimidate (DMP). DMP was quenched with 1 mL of 0.2M 
ethanolamine pH 8.0 and columns were re-equilibrated in 1x PBS and 0.02% NaN3 
for storage at 4°C until use.  
 
Native affinity purification of CCDC47 
The purification was performed at the bench on ice. CCDC47 and HA affinity col-
umns were pre-washed with 300 µl of 0.1 M glycine-HCl pH 2.3, neutralized with 
800 µl of 1x PBS, then equilibrated in 800 µl of 1x native solubilization buffer 
(NSB): 200mM KOAc, 10mM EDTA, 1% DBC, 25mM HEPES pH 7.4. 3 mL of 
RMs, prepared as described above (at an A280 value of 75), were solubilized by ad-
dition of an equal volume of 2x NSB. RNase A was added to a final concentration 
of 10 ng/mL and the samples incubated on ice for 30 min during column preparation. 
The solubilized extract was cleared by centrifugation at 100,000 rpm in the 
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TLA100.3 (Beckman) for 1 h at 4°C. Supernatant was removed, divided into 3 equal 
parts, and passed twice over each column (anti-CCDC47 Ab #1, #2, or an anti-HA 
control). Each column was washed once with 1 mL of 1x NSB. Recovered proteins 
were eluted with 300 µl of 0.1 M glycine pH 2.3 and elutions were immediately 
neutralized with 1 M Tris-Cl pH 8.8. For initial small scale experiments using only 
CCDC47 antibodies (Fig 2A), the protocol was the exact same except 100µl of start-
ing RMs was used and final elutions were TCA precipitated using standard proce-
dures before loading on a gel. 
 
Identification of Asterix by mass spectrometry 
Protein samples eluted from the CCDC47 affinity resin were reduced with DTT and 
alkylated with iodoacetamide. Because initial efforts to identify the co-purifying 10 
kD protein via analysis of tryptic digests failed, we re-did the analysis using other 
proteases. The samples were digested overnight either with trypsin, Glu-C, chymo-
trypsin or elastase (Promega). Digest mixtures were acidified with formic acid (FA) 
and a portion of each of these samples was analyzed by nano-scale capillary LC-
MS/MS (Ultimate U3000 HPLC, Thermo Scientific Dionex) at a flow of  300 
nL/min. A C18 Acclaim PepMap100 5 μm, 100 μm x 20 mm nanoViper (Thermo 
Scientific Dionex), trapped the peptides prior to separation on an EASY-Spray col-
umns with an acetonitrile gradient. The Eluted peptides were introduced directly via 
a EASY-Spray ion source into a Q Exactive mass spectrometer (Thermo Scientific). 
Data dependent analysis was performed using a resolution of 35,000 for the full MS 
spectrum, followed by ten MS/MS spectra in the orbitrap.  MS spectra were col-
lected over a m/z range of 350-1600 m/z. LC-MS/MS data were searched against 
the UniProt KB database using Mascot (Matrix Science), with a precursor tolerance 
of 10 ppm and a fragment ion mass tolerance of 0.1 Da. Two missed enzyme cleav-
ages (or no enzyme for elastase) and variable modifications for oxidized methionine, 
carbamidomethyl cysteine and pyroglutamic acid, were included. MS/MS data were 
validated using Scaffold (Proteome Software Inc). 
Immunoprecipitations 
Unless otherwise indicated, all CCDC47 IPs were performed with CCDC47 anti-
body #1. For immunoprecipitations under denaturing conditions, samples of interest 
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were first denatured in 1% SDS and 100 mM Tris pH 8.0 and boiled for 2-5 min. 
Samples were diluted 10-fold in IP buffer (100 mM NaCl, 50 mM HEPES pH 7.4, 
1% TritonX-100) then immunoprecipitated in batch with desired antibodies at 4°C 
rotating end-over-end for 2-4 h. Unbound supernatant was removed by aspiration 
and beads were washed 3x in IP buffer before elution in 2x SDS-PAGE sample 
buffer. Native immunoprecipitation followed similar protocols but were performed 
in the presence of NSB (200 mM KOAc, 25 mM HEPES pH 7.4, 1% DBC). EDTA 
and RNase A was added prior to solubilization where RNase treatment is indicated 
in the figure legends. Pulldowns of His-tagged β1AR intermediates and full length 
β1AR were performed using Ni-NTA affinity resin (Invitrogen) in 1xPBS +250 mM 
NaCl, 0.5% TritonX-100, 10 mM Imidazole. 
 
Sucrose gradient separation 
The products of the quenched crosslinking reaction was solubilized in NSB (200 
mM KOAc, 25 mM HEPES pH 7.4, 1% DBC). EDTA and RNase A were added to 
release the nascent chain from the ribosome and digest the attached tRNA. The sam-
ple (typically 10 or 20 µL volume) was loaded onto 200 µL micro sucrose gradient 
(5-25% sucrose in NSB), centrifuged at 55,000 rpm in the TLS-55 rotor (with suit-
able adaptors) for 2 h 20 min, and fractionated manually into 11 fractions from the 
top. The final fraction, which contains aggregates and non-solubilized material, was 
not analyzed. Fractions 1-10 were analyzed by SDS-PAGE and autoradiography (or 
Coomassie staining to detect endogenous proteins). 
 
Topology mapping by cysteine accessibility 
Asterix-knockout HEK293 T-Rex cells were transfected with constructs encoding 
human Asterix tagged at the C-terminus with a FLAG tag, including variants lacking 
all cysteines or containing single cysteines as described in the figure. After 48 h, the 
cells from each well of a 6-well plate were washed once and collected in ice-cold 
PBS, pelleted by centrifugation, resuspended on ice in 500 µl permeabilization 
buffer (100 mM KOAc, 10 mM Tris, pH 7.4, 10 mM MgCl2), and adjusted to 0.01% 
digitonin. After 5 min on ice, the cells were re-sedimented by centrifugation, washed 
once in permeabilization buffer lacking digitonin, sedimented again, and 
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resuspended in 30 µl of PSB on ice. An aliquot was removed for the untreated sam-
ple, and the remainder was adjusted to 1 mM final concentration of 5,000 Dalton 
PEG-maleimide prepared in DMSO. After 1 h on ice, the reaction was quenched 
with 10 mM 2-mercaptoethanol, the cells recovered by centrifugation, washed once 
with 600 µl PSB, and finally prepared for analysis by SDS-PAGE and immunoblot-
ting.  
 
SDS-PAGE 
All samples were placed in 2.5x SDS-PAGE sample buffer (125mM Tris-HCL, 
pH6.8, 2.5% SDS, 22.5% glycerol, 0.06% bromophenol blue, 250mM DTT) and 
boiled at 95°C for 3-5min prior to loading on a gel.  Tris-Tricine gels were made 
up of a 12% acrylamide resolving by adding the following amounts of premade 
stock solutions: 5.7mls water, 9mls 40% Acrylamide/Bis (Biorad), 15mls 2M Tris 
-HCl, pH8.45, and 0.3mls 10% SDS. The 4% acrylamide stacking gel was com-
posed of the following amounts of premade stock solutions:  : 5.2mls water, 1mls 
40% Acrylamide/Bis (Biorad), 3.7mls 2M Tris -HCl, pH8.45, and 0.1mls 10% 
SDS. Gels were run a 100V for ~90min.
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